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Methane is a greenhouse gas and a major contributor to climate change. 
Methanogenic Archaea produce more than 1 billion tons of this gas each year through 
methanogenesis, the anaerobic reduction of CO2  to methane. Coenzyme B (CoB) is one 
of eight coenzymes required for methanogenesis and it is unique to methanogens. 
Therefore, this coenzyme is a potential target for inhibiting methanogenesis. To further 
elucidate the CoB biosynthetic pathway, genes from Methanocaldococcus jannaschii 
were cloned and expressed in an effort to identify the CoB homoaconitase. From this 
study, the MJ0499-MJ1277 pair of proteins was identified as the methanogen 
isopropylmalate isomerase involved in leucine and isoleucine biosynthesis. The MJ1003- 
MJ1271  pair  of  proteins  was  characterized  as  the  homoaconitase  required  for  CoB 
biosynthesis. This enzyme exhibited broad substrate specificity, catalyzing the 
isomerization of cis-unsaturated tri-carboxylates with  -chains of 1-5 methylenes in 
length. Previously characterized homoaconitases only catalyzed half of the predicted 
reactions in the isomerization of homocitrate.  The MJ1003-MJ1271 proteins function as 
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the first homoaconitase described to catalyze the full isomerization of homocitrate to 
homoisocitrate. Also, the CoB homoaconitase was identified as specific for (R)- 
homocitrate and cis-unsaturated intermediates, contrary to a previous study that 
suggested the substrate specificity of this enzyme included (S)-homocitrate and trans- 
homoaconitate. The M. jannaschii isopropylmalate isomerase and homoaconitase share 
more than 50% sequence identity and catalyze analogous reactions. Site directed 
mutagenesis of the MJ1271 protein was used to identify residues involved in substrate 
specificity. Arg26 of MJ1271 was critical for the specificity of the CoB homoaconitase. 
Mutation of this residue to the analogous residue in the M. jannaschii isopropylmalate 
isomerase, Val28, altered the substrate specificity of the homoaconitase to include the 
substrates of isopropylmalate isomerase. These homologs of aconitase require a [4Fe-4S] 
cluster for coordinating their respective substrates at the enzyme active site. However, 
methanogens lack most of the proteins required for iron-sulfur cluster assembly. 
Therefore, genes homologous to the Salmonella enterica ApbC iron-sulfur scaffold 
protein were characterized from methanogens. The MMP0704, MJ0283, and SSO0460 
proteins from Methanococcus maripaludis, M. jannaschii, and Solfolobus solfataricus, 
respectively, were identified as scaffold proteins involved in methanogen iron-sulfur 
cluster biosynthesis. 
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Chapter 1: Introduction 
 
 
 
Each year the energy metabolism of methanogenic archaea (methanogens), known 
as methanogenesis, produces over one billion tons of methane, approximately 400 million 
tons of which is emitted to the atmosphere [1,2]. Methane is a potent greenhouse gas, 
second in abundance after CO2, and plays a significant role in the chemistry of the 
atmosphere [1]. Therefore, understanding the biochemical pathway of methanogensis 
may play a crucial role in identifying various means for controlling atmospheric 
concentrations of methane. 
 
 
 
1.1. METHANE AS A GREENHOUSE GAS AND BIOFUEL 
Climate change, commonly referred to as “global warming,” results from energy 
imbalances between the Earth and space, measured as radiative forcings (W m-2), and is 
the current environmental issue posing a threat to the present and future global 
community [3]. The current crisis involves positive radiative forcing, i.e. alterations in 
the chemical composition of the atmosphere that affects the loss of long wavelength 
radiation to space and the redistribution of energy in the atmosphere, resulting in an 
increase in surface temperature [3]. These positive forcings are believed to be a result of 
increasing concentrations of greenhouse gases (GHGs; CO2, CH4, NO2, CFCs) in the 
troposphere and stratosphere. Measurements from 1861 until 2001 indicate an increase in 
the global average surface temperature of 0.6C 0.2C and palaeoclimate studies from 
ice cores indicate that present day levels of CO2  are at concentrations that have not been 
exceeded in at least 450,000 years [3]. The growing consensus attributes at least part of 
2  
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the climate change to increasing emissions of GHGs from the industrialized global 
community, most notably fossil fuel combustion and deforestation. Therefore,  the 
positive radiative forcings are anthropogenic. 
Methane plays a significant role in atmospheric chemistry. Increasing methane 
concentrations result in a reduction in the oxidative capacity of the troposphere by 
consuming hydroxyl radicals (a major sink for methane), sequestering Cl-, influencing 
stratospheric  H2O,  affecting  stratospheric  and  tropospheric  ozone  levels,  as  well  as 
producing CO2, CO, and H2 [4]. Although controlling CO2 emissions is at the forefront of 
the climate change debate, due to its high positive forcing (1.4 0.2 W m-2), concerted 
 
reduction of non-CO2  GHGs, such as methane (0.7 0.2 W m ; lifetime of 8 years), is 
 
predicted to be a realistic and necessary measure in preventing near-term anthropogenic 
influence on the atmosphere [2,5]. Since 1750, the atmospheric concentration of methane 
has increased by 151% to approximately 1800 ppb [3]. While methane growth rates have 
slowly decreased in the 1990’s and early 2000’s (the cause for this decrease is unknown 
although deforestation is thought to play a role) the slowing effect is not expected to be 
permanent [4,6]. Therefore, efforts to reduce the anthropogenic methane emissions are 
predicted to provide a near-term negative radiative forcing necessary to compensate for 
CO2 emissions as “green” technology is developed. 
Although methane is a GHG, there is a growing interest in harnessing methane 
gas for use as a biofuel in the movement away from fossil fuels. In agricultural and 
industrial waste streams, sewage sludge, and landfills, organic waste is converted to CH4 
and CO2 by methanogens after hydrolysis of biopolymers and acetogenesis [7,8]. The 
methane produced from this anaerobic biodegradation can be captured for biofuel use, 
limiting the amount of methane emissions from these waste streams as well as reducing 
our dependency on fossil fuels and therefore reducing CO2  emissions [7].  Methanogens 
3  
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also play a key role, albeit a negative one, in bioethanol and biobutanol production due to 
substrate competition [9]. Studies indicate increases in the production of these alternative 
energy sources by inhibition of methanogenesis [9]. 
The role of methane as a GHG and potential alternative energy source makes it a 
prominent constituent in preventing climate change. It would be desirable to inhibit 
anthropogenic methane production to limit influencing changes in atmospheric 
composition and to stimulate methane production in bioreactors for biofuel production. 
The main target for each of these endeavors is methanogenesis. 
 
 
1.2. METHANOGENESIS 
Methanogens are classified as members of the kingdom Euryarchaeota in the 
domain Archaea. Five orders of methanogens have been identified: Methanococcales, 
Methanopyrales, Methanobacteriales, Methanosarcinales, and Methanomicrobiales [10]. 
Several carbon sources are used to generate methane from methanogenesis, such as CO2 
(with electrons from H2 or formate), acetate, methanol, methylamines, and methylthiols, 
although substrate specificity varies among the five orders [11,12]. Methanogenesis 
plays a significant role in the global carbon cycle, constituting the final step in the 
anaerobic biodegradation of complex organic compounds. These strictly anaerobic 
microbes (the presence of oxygen is detrimental to their survival) have been isolated from 
various anoxic environments, such as wetlands, swamps, rice paddies, landfills, 
hydrothermal vents, and the digestive tracts of ruminants and termites [11]. 
Eight enzymes and six coenzymes are required for methanogenesis from CO2 and 
H2                 (Figure          1.1)          [10,13].                    This          reductive          pathway 
(4 H  + CO  CH  + 2 H O; G’= -131 kJ mol-1 ) commences with the transfer of CO2 
 
to the first C1 carrier, methanofuran [10]. Formylmethanofuran dehydrogenase (EC 
4  
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1.2.99.5), a molybdenum and iron-sulfur cluster-containing enzyme, catalyzes the 
formylation of the methanofuran amino group, producing formylmethanofuran (G’= 
+16 kJ mol-1) [14,15]. The electrons required for the dehydrogenation reaction are 
derived from a membrane bound hydrogenase that oxidizes molecular hydrogen, a 
reaction that translocates Na+ ions into the cytoplasm [12]. Formylmethanofuran:H MPT 
formyltransferase (EC 2.3.1.101) catalyzes the subsequent transfer of the formyl group to 
5,6,7,8-tetrahydromethanopterin (H4MPT), a homolog of tetrahydrofolate, to give formyl- 
H4MPT (G’= -4.4 kJ mol ) [16].  Formyl-H4MPT is cyclized to N5, N10-methenyl- 
H4MPT by way of methenyl-H4MPT cyclohydrolase (EC 3.5.4.27; G’= -4.6 kJ mol ), 
 
followed by two reductive steps [17]. The first reductive step is catalyzed by one of two 
methylene-H4MPT dehydrogenases, depending on whether hydrogen is limiting, to 
produce  N5,  N10-methylene-H4MPT  [10].    The  first  enzyme  is  an  F420-dependent 
methylene-H4MPT  dehydrogenase  (EC  1.5.99.9)  that  functions  when  hydrogen  is 
limiting (G’= +5.5 kJ mol-1) [18]. The coenzyme F 
 
 
420 is a deazaflavin derivative that 
 
can either accept or donate a hydride ion [13].  When hydrogen is not limiting, an H2- 
dependent  methylene-H4MPT  dehydrogenase  is  responsible  for  reducing  N5,  N10- 
methenyl-H4MPT (G’ = -5.5  kJ  mol )  [19]. The  subsequent  reductive  step  is 
 
catalyzed  by  F420-dependent  methylene-H4MPT  reductase  (EC  1.5.99.11),  producing 
N5,N10-methyl-H MPT (G’=  -6.2 kJ mol-1 ) [20,21].   Methyl-H4MPT:coenzyme M 
 
methyltransferase (EC 2.1.1.86), a membrane protein containing a 5- 
hydroxybenzimidazolyl cobamide prosthetic group, transfers the methyl group from N5 
of N5, N10-methyl-H4MPT to the thiol of coenzyme M (CoM; 2-mercaptoethanesulfonic 
acid) with a free energy (G’) of -30 kJ mol-1  [22].  This enzyme is also involved in 
energy conservation, pumping Na+ ions across the cytoplasmic membrane [12].  The Na+ 
ion  gradient  formed  is  thought  to  be  the  driving  force  for  the  initial  oxidation  of 
5  
 
molecular hydrogen as well as the production of ATP from ADP and inorganic 
phosphate. Methyl-coenzyme M reductase (MCR; EC 2.8.4.1) catalyzes the final step of 
methanogenesis: formation of a heterodisulfide bond between CoM and coenzyme B 
(CoB; 7-mercaptoheptanoyl-L-threonine phosphate), releasing methane (G’=  -45 kJ 
mol-1), by way of an active site nickel-tetrapyrrole cofactor (F  430 ) [23,24] Heterodisulfide 
 
reductase   (EC    1.8.98.1)    reductively    cleaves    the    CoM-CoB    disulfide 
(G’= -40 kJ mol-1), releasing the coenzymes for further methane production [25]. The 
reduction of the CoM-CoB heterodisulfide is coupled to a Na+ or H+ gradient, depending 
on the organism, that drives ATP formation [12]. 
6  
 
 
 
 
 
 
 
Figure  1.1.     Methanogenesis.     1,  [NiFe]  hydrogenase;  2,  Formylmethanofuran 
dehydrogenase; 3, Formylmethanofuran:H4MPT formyltransferase; 4, Methenyl-H4MPT 
cyclohydrolase; 5, F420-dependent methylene-H4MPT dehydrogenase or H2-dependent 
methylene-H4MPT dehydrogenase; 6, F420-dependent methylene-H4MPT reductase; 7 
Methyl-H4MPT:coenzyme M methyltransferase; 8, Methyl-coenzyme M reductase; 9, 
A1A0 ATPase; 10, Heterodisulfide reductase. Adapted from [12]. 
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1.3. COENZYME B 
Although methanogenesis differs depending on the carbon source, the reaction 
catalyzed by MCR is common among methanogens for formation of the heterodisulfide 
and requires CoM, CoB, and F430 for activity. Coenzyme B is considered to be unique to 
methanogens: the compound has not been identified in non-methanogenic organisms. 
Therefore, CoB is an attractive target for controlling methane output at the key step of 
methanogenesis. 
 
 
 
1.3.1. Identification and Structure 
Coenzyme B was initially identified in 1980 by Gunsalus and Wolfe during 
experiments to elucidate the cellular components of Methanobacterium 
thermoautotrophicum required for MCR activity [23]. Isolation of the cytosolic fraction 
by ultracentrifugation and anion exchange chromatography revealed three components 
necessary for the reconstitution of MCR: components A, B, and C [23]. Component B 
was identified as a low molecular weight, heat-stable, oxygen-sensitive compound 
necessary for MCR activity but of unknown function[23]. Ultimately the structure of 
component B was determined by NMR and mass spectrometry, consisting of a thiol 
group linked to a phosphothreonine group via a C8 alkyl chain (C11H22NO7PS, 343.3 Da), 
and later renamed coenzyme B [26]. However, these initial studies also observed isolated 
cytosolic fractions containing a larger component (molecular weight greater than 1000 
Da) that could stimulate MCR activity [27,28]. Therefore, the CoB identified was 
proposed to be the degradation product of a larger compound.   Indeed, the works of 
Keltjens,   Marsden,   Sauer,   and   associates  determined   that   the   phosphothreonine 
headgroup of CoB is linked to a N-acetylmannosaminuronate (ManNAcA) (-14) 
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UDP-N-acetylglucosamine  (GlcNAc)  moiety  (UDP-GlcNAc-ManNAcA-CoB)  (Figure 
1.2) [28,29,30,31]. 
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Figure 1.2. The structure of UDP-GlcNAc-ManNAcA-CoB. 
 
 
 
1.3.2. CoB in the Mechanism of Methyl-Coenzyme M Reductase 
 
CoB or UDP-GlcNAc-ManNAcA-CoB is essential for the mechanism of MCR, 
serving as the electron  donor  for  the  reduction  of  CH3-CoM.  The  crystal  structure  of 
MCR from M. thermoautotrophicum was solved at 1.45  Å  as  a  hexamer  of  222 
subunits with  the  three  essential  coenzymes  bound:  CoB,  CoM,  and  F430  [32].  MCR  has 
two identical active sites that are 5.1 nm  apart  with  each  site  composed  of  a  funnel- 
shaped channel from either ’, , ,  or , ’, ’, ’. Coenzyme F430   is located at the 
bottom  of  the  active  site  channel  and  CH3-CoM  is  bound  in  the  channel  by  its  sulfonate 
group  above  F430     in  a  parallel  orientation  to  the  tetrapyrrole  ring  [32].     The 
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phosphothreonine head group of CoB is bound at the top of the channel via salt bridges 
with five basic amino acids, essentially sealing the active site from solvent. The 
negatively charged phosphate and carboxylate of CoB interact with Arg270, His379, 
Lys’256, methyl-His’257, and Arg’225 [32]. The thioheptanoyl chain extends through a 
narrow 8 Å diameter segment of the channel, making van der Waals contacts with several 
hydrophobic residues (Figure 1.3) [32,33].  The sulfhydryl group of CoB is positioned 
near  CH -CoM  in  the  active  site,  interacting  with  Asn481 ,  Val 482 ,  and  a  water 
 
molecule[32,33]. The UDP-disaccharide was not present in the MCR structure with CoB 
and the function of this sugar headgroup has not been determined. 
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Figure 1.3. The active site of MCR. The thiol of coenzyme B extends into the narrow 
channel leading to the enzyme active site (gray). CoM and coenzyme F430 are located at 
the bottom of the channel. The figure was constructed with Pymol and PDB 1MRO. 
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Two models outlining the roles of CoB, CoM, and F430 in the MCR mechanism 
have been postulated based on crystallographic, spectroscopic, theoretical, and 
enzymological studies, although observing reaction intermediates has been problematic 
[33].  In one model (Figure 1.4A), based on theoretical calculations, a free methyl radical 
 
is generated from the attack of the F430  Ni on the CH -CoM sulfur, resulting in Ni
II-S- 
 
CoM [33,34]. The methyl radical then reacts with the bound CoB, abstracting a proton to 
form methane and a CoB thiyl radical [34]. Reaction of the CoB radical with NiII-S-CoM 
generates a heterodisulfide radical anion between CoB and CoM, which in turn reduces 
NiII to NiI, releasing the CoB-CoM heterodisulfide [33].  The second proposed mechanism 
(Figure 1.4B) involves the Sn2 attack of F430   Ni on the methyl group of CH3-CoM, 
producing methyl-F430  Ni 
 
III and free CoM [33,35].  The methyl-Ni 
 
III then oxidizes CoM, 
 
forming a thiyl radical that can interact with the bound CoB to form the heterodisulfide 
radical anion [33]. The resulting methyl-NiII is protonated, releasing methane, and the NiII 
is reduced to NiI by the heterodisulfide radical anion, releasing the CoB-CoM 
heterodisulfide [33]. Recently, evidence has been observed for the formation of a NiIII- 
methyl state of MCR [36]. 
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Figure 1.4.  Proposed mechanisms for methyl-coenzyme M reductase. Adapted from 
[33]. 
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Aside from the role of CoB in either mechanism, there is evidence that CoB may 
also play a role in the conformational change observed in MCR. The two active sites of 
MCR are predicted to be in two different reactive states. These two states are thought to 
couple the release of the CoB-CoM heterodisulfide out of the hydrophobic channel to the 
solvent with an exergonic step in the reaction cycle [37]. Therefore, the binding of CoB, 
which must succeed the binding of CoM, to one active site is proposed to cause a 
conformation change that results in the release of the heterodisulfide from the second 
active site in a “two-stroke mechanism” [37]. 
 
 
1.3.3. Elucidation of the Biosynthetic Pathway 
The proposed biosynthetic pathway to coenzyme B was almost completely 
elucidated by the work of Robert H. White through isotope labeling experiments (Figure 
1.5). Initial studies involving labeled acetate and succinate fed to Methanococcus voltae 
or rumen isolate 10-16B were crucial in identifying a pathway for the synthesis of 2- 
oxosuberate, an eight-carbon dicarboxylate that serves as the alkyl portion of CoB [38]. 
Incorporation of deuterium from [2, 2, 3, 3-2H ] succinate into carbons 1-4 of 7- 
mercaptoheptanoic acid identified 2-oxoglutarate, derived from succinate, as a precursor 
to CoB [38].  Subsequent labeling experiments with [1, 2-13C ] acetate and [2, 2, 2-2H ] 2 3 
 
acetate indicated a series of carbon chain elongation reactions, extending the carbon 
chain of the five-carbon 2-oxoglutarate by three methylenes to the eight-carbon 2- 
oxosuberate [38].  The 2-oxoacid chain elongation pathway was later confirmed from cell 
free extracts of Methanosarcina thermophila [39]. Product analysis from these extracts 
indicated three consecutive reactions were necessary to extend 2-oxoglutarate by one 
methylene,  producing  2-oxoadipate  [39].     These  reactions  were  repeated  with  2- 
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oxoadipate as the starting substrate, producing the seven-carbon 2-oxopimelate and again 
with 2-oxopimelate, producing the end product 2-oxosuberate (Figure 1.5) [39]. 
Deuterium labeling studies were also employed to identify the remaining 
reactions of CoB biosynthesis. These studies indicated the formation of the aldehyde 7- 
oxoheptanoate from the non-oxidative decarboxylation of 2-oxosuberate, a reaction that 
is analogous to the production of sulfoacetaldehyde from sulfopyruvate in the CoM 
biosynthetic pathway [40]. The reduction and thiolation of 7-oxoheptanoate to 7- 
mercaptoheptanoate has been observed, however the source of sulfur and reducing agent 
have not been conclusively identified, though there is precedence for coenzyme F420 to act 
as the reductant [40].   Studies of cell-free extracts of M. volta and Methanosarcina 
thermophila grown in medium containing labeled 7-mercaptoheptanoic acid, 7- 
mercaptoheptanoyl threonine, or DL-threonine identified the final two steps in the CoB 
pathway. First, a peptide bond is generated between the carboxyl of 7- 
mercaptoheptanoate and the amino group of L-threonine in an ATP dependent reaction, 
producing 7-mercaptohepanoylthreonine [41]. In a second ATP dependent reaction, the 
threonine group is phosphorylated, producing 7-mercaptoheptanoylthreonine phosphate 
(Figure 1.5) [42]. 
Recently, the work of Namboori and Graham identified the archaeal biosynthetic 
pathway for the production of UDP-GlcNAc and UDP-ManNAcA from fructose-6- 
phosphate [43]. The enzymes required for this pathway were cloned from 
Methanococcus maripaludis and Methanocaldococcus jannaschii and overexpressed in 
E. coli. Enzyme activity assays and product analysis indicated five enzymes required for 
acetamido sugar biosynthesis in methanogens: glutamine-fructose-6-phosphate 
(glutamine-Fru-6-P) transaminase, phosphoglucosamine mutase, glucosamine-6- 
phosphate (GlcN-6-P) uridylyltransferase/acetyltransferase, UDP-GlcNAc 2-epimerase, 
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and UDP-ManNAc 6-dehydrogenase [43]. This pathway is the first study to elucidate the 
reactions required for production of the ManNAcA (-14) UDP-GlcNAc moiety of 
UDP-GlcNAc-ManNAcA-CoB. 
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Figure 1.5.  Proposed pathway for coenzyme B biosynthesis.  Dashed arrows indicate 
a reaction that has not yet been associated with an enzyme. 
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1.3.4. 2-Oxoacid Chain Elongation Pathway 
 
Although a biosynthetic pathway for CoB has been proposed, gene products from 
M. jannaschii have only been assigned for two enzymes, both from the 2-oxoacid chain 
elongation pathway.  Only one has been purified and characterized.  The chain elongation 
pathway is expected to commence with the condensation of acetyl-coenzyme A (acetyl- 
CoA) with 2-oxoglutarate, producing (R)-homocitrate in a reaction catalyzed by the gene 
product of MJ0503, homocitrate synthase (HCS; EC 2.3.3.14) [39]. A second enzyme, 
predicted to be a homoaconitase (HACN; EC 4.2.1.36) catalyzes the reversible anti- 
elimination of water from homocitrate, producing the unsaturated intermediate cis- 
homoaconitate. HACN then catalyzes the subsequent rehydration of the intermediate by 
the anti-addition of water, giving (2R,3S)-homoisocitrate. Finally, the gene product of 
MJ1596, homoisocitrate dehydrogenase (HICDH; EC 1.1.1.87), catalyzes the NAD+- 
dependent oxidative decarboxylation of (2R,3S)-homoisocitrate, forming 2-oxoadipate 
[44]. Remarkably, methanogen HCS, HACN, and HICDH exhibit broad substrate 
specificity, continuing these 1-carbon elongation reactions by catalyzing the production 
of 2-oxopimelate and 2-oxosuberate from 2-oxoadipate and 2-oxopimelate, respectively. 
It is unusual for one enzyme to catalyze more than one reaction in a metabolic pathway. 
The chain elongation pathway stops at the precursor for 7-oxoheptanoate; 2-oxoazelaic 
acid, a nine-carbon 2-oxoacid with six methylenes, or higher compounds were not 
identified in methanogens [45]. 
While the broad substrate specificity of these enzymes is unusual, analogous 
chain elongation reactions are ubiquitous in nature. These reactions can essentially be 
broken down into four steps. First, a 2-oxoacid undergoes an aldol-type condensation 
with acetyl-CoA, producing an -hydroxydicarboxylate. This secondary alcohol is then 
isomerized, forming a -hydroxydicarboxylate.  Finally, the resulting tertiary alcohol is 
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dehydrogenated to a -keto acid, which then undergoes decarboxylation to produce a 2- 
oxoacid extended by one methylene. The most common and well studied of these 
elongation reactions is found in the tricarboxylic acid (TCA) cycle where the activities of 
citrate synthase (CS, EC 2.3.3.1), aconitase (ACN; EC 4.2.1.3), and isocitrate 
dehydrogenase (ICD; EC 1.1.1.41) function to produce 2-oxoglutarate from oxaloacetate 
(Figure 1.6). Also, leucine biosynthesis requires isopropylmalate synthase (IPMS; EC 
2.3.3.13),  isopropylmalate  isomerase  (IPMI;  EC  4.2.1.33),  and  -isopropylmalate 
dehydrogenase (IPMDH; EC 1.1.1.85) to produce 2-oxoisocaproate from 2- 
oxoisovalerate (Figure 1.6). Euglenoids, higher fungi, some bacteria and archaea use a 
HCS, HACN, and HICDH to catalyze the production of 2-oxoadipate from 2- 
oxoglutarate in the -aminoadipate pathway for lysine biosynthesis (Figure 1.6). 
Although these enzymes are homolgous to the methanogen HCS and HICDH, 2- 
oxoadipate is instead converted to L-2-aminoadipate by 2-aminoadipate transaminase 
(EC 2.6.1.39) and ultimately converted to lysine [46].   These first three enzymes of the 
-aminoadipate pathway are currently being studied as a target for anti-fungal treatment. 
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Figure 1.6. Analogous chain elongation reactions. A, CS, ACN, and ICDH are used in 
the TCA cycle to produce 2-oxoglutarate from oxaloacetate. B, IPMS,  IPMI,  and 
IPMDH are required for leucine biosynthesis from 2-oxoisovalerate. C, HCS, ACN, 
HACN, and HICDH convert 2-oxoglutarate to 2-oxoadipate in the -aminoadipate 
pathway for lysine biosynthesis 
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1.4. IDENTIFICATION  OF  METHANOGEN  HOMOACONITASE,  ISOPROPYLMALATE 
ISOMERASE, AND PROTEINS INVOLVED IN IRON-SULFUR CLUSTER BIOSYNTHESIS 
The broad substrate specificities of the CoB chain elongation reactions may be 
exploited as a means of controlling methanogenesis, such as inhibitor design. However, 
despite previous studies, the pathway remains incomplete. The M. jannaschi HICDH 
(HICDHMJ) was the only enzyme of the CoB pathway to be overexpressed, purified, and 
characterized in terms of steady state kinetics with homoisocitrate, homo2isocitrate, and 
homo3isocitrate [44]. The previous study  involving methanogen  HCS analyzed  the 
reaction products from cell free extracts of M. thermophila and E. coli overexpressing 
MJ0503 [39]. The results of this study identified trans-homoaconitate and (S)- 
homocitrate from the reaction catalyzed by HCS [39].  However, these two compounds 
have not previously been isolated as natural products and homologs of methanogen HCS 
in the -aminoadipate pathway only produce (R)-homocitrate. Also, the subsequent 
reactions of HCS with 2-oxoadipate and 2-oxopimelate produced only - 
hydroxydicarboxylates of (R) stereochemistry and no other trans-unsaturated compounds 
were identified [39].  Because of the nature of that study, the product of the HCS- 
catalyzed reaction with 2-oxoglutarate remains suspect and requires further study. 
Finally, the genes responsible for the synthesis of the methanogen homoaconitase 
remained unknown 
 
 
1.4.1 The Genome Sequence of M. jannaschii 
 
M. jannaschii, a thermophilic methanogen isolated from marine hydrothermal 
vents, was the first member of the domain Archaea to have its genome sequenced. This 
organism has since served as a model organism for studying methanogenesis. The 
genome sequence of M. jannaschii contains two genes, MJ0499 and MJ1003, that were 
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annotated as putative IPMI large subunits [47]. Likewise, the genome also contains two 
genes, MJ1271 and MJ1277, that were annotated as putative IPMI small subunits [47]. 
These genes share more than 50% sequence identity to each other and are more similar to 
each other than to any previously characterized IPMIs or HACNs (Figure 1.7). Also, the 
large and small subunits appear to be randomly placed within the methanogen genomes, 
further complicating gene assignment by genomic analysis alone. One pair of interacting 
large and small subunits was predicted to function as HACNMJ in CoB biosynthesis and a 
second pair as IPMIMJ in methanogen leucine biosynthesis. 
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A 
MJ1003 ..MTLVEKILSKKVG.YEVCAGDSIEVEVDLAMTHDGTTPLAYKALKEMS.DSVWNPDKI 
MJ0499 MGMTIVEKILAKASGKKEVSPGDIVMANIDVAMVHDITGPLTVNTLKEYGIEKVWNPEKI 
 
 
MJ1003 VVAFDHNVPPNTVKAAEMQKLALEFVKRFGIKNFHKGGEGICHQILAE.NYVLPNMFVAG 
MJ0499 VILFDHQVPADSIKAAENHILMRKFVKEQGIKYFYDIREGVCHQVLPEKGHVAPGEVVVG 
 
 
MJ1003 GDSHTCTHGAFGAFATGFGATDMAYIYATGETWIKVPKTIRVDIVGK.NENVSAKDIVLR 
MJ0499 ADSHTCTHGAFGAFATGIGSTDMAHVFATGKLWFKVPETIYFNITGDLQPYVTSKDVILS 
 
 
MJ1003 VCKEIGRRGATYMAIEYGGEVVKNMDMDGRLTLCNMAIEMGGKTGVIEADEITYDYLKKE 
MJ0499 IIGEVGVDGATYKACQFGGETVKKMSIASRMTMTNMAIEMGGKTGIIEPDEKTIQYVKEA 
 
 
MJ1003 RGLSDEDIAKLKKERITVNRDEANYYKEIEIDITDMEEQVAVPHHPDNVKPISDVEGTEI 
MJ0499 MKKHGTE....RPFEVIKGDEDAEFAEVYEIEADKIEPVFACPHNVDNVKQAREVAGKPI 
 
* 
MJ1003 NQVFIGSCTNGRLSDLREAAKYL.KGREVHKDVKLIVIPASKKVFLQALKEGIIDIFVKA 
MJ0499 DQVFIGSCTNGRLEDLRMAIKIIEKHGGIADDVRVVVTPASREEYLKALKEGIIEKFLKY 
 
* * 
MJ1003 GAMICTPGCGPCLGAHQGVLAEGEICLSTTNRNFKGRMGHINSYIYLASPKIAAISAVKG 
MJ0499 GCVVTNPSCSACMGSLYGVLGPGEVCVSTSNRNFRGRQGSLEAEIYLASPITAAACAVKG 
 
 
MJ1003 YITNKLD. 
MJ0499 ELVDPRDL 
 
B 
MJ1271 ..MIIKGRAHKFGDDVDTDAIIPGPYLRTTDPYELASHCMAGIDENFPKKVKEGDVIVAG 
MJ1277 MRSIIKGRVWKFGNNVDTDAILPARYLVYTKPEELAQFVMTGADPDFPKKVKPGDIIVGG 
 
 
MJ1271 ENFGCGSSREQAVIAIKYCGIKAVIAKSFARIFYRNAINVGL..IPIIANTDEIKDGDIV 
MJ1277 KNFGCGSSREHAPLGLKGAGISCVIAESFARIFYRNAINVGLPLIECKGISEKVNEGDEL 
 
 
MJ1271 EIDLDKEEIVITNKNKTIKCETPKGLEREILAAGGLVNYLKKRKLIQSKKGVKT 
MJ1277 EVNLETGEIKNLTTGEVLKGQKLPEFMMEILEAGGLMPYLKK.KMAESQ..... 
Figure 1.7.   Sequence alignment of the homologous HACN/IPMI large and small 
subunits from Methanocaldococcus jannaschii. A, M. jannaschii MJ1003 (Swiss-Prot 
accession no. Q58409), M. jannaschii MJ0499 (Swiss-Prot accession no. P81291). B, M. 
janaschii MJ1271 (Swiss-Prot accession no. Q58667), M. jannaschii MJ1277 (Swiss-Prot 
accession no. Q58673). Conserved amino acid residues are shown in white on a black 
background. Similar residues are shown in black on a gray background. Asterisks 
indicate cysteine residues conserved in pig heart mACN responsible for binding a [4Fe- 
4S] cluster 
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In an effort to identify the genes encoding the HACNMJ, the two large and two 
small subunits were cloned and expressed in E. coli and the interacting proteins were 
purified and characterized based on steady state kinetics and product analysis. 
 
 
 
1.4.2. MJ0499-MJ1277 Functions as the M. jannaschii IPMI 
The gene products of MJ0499-MJ1277 were identified as the methanogen IPMI, a 
member of the aconitase superfamily that requires an iron-sulfur cluster for activity [48]. 
The protein was purified aerobically and the holoenzyme was reconstituted in vitro. The 
steady state kinetics for the substrates involved in leucine biosynthesis were established 
in both direct and coupled assays with MJ0720 (IPMDHMJ). The MJ0499-MJ1277 pair 
was also identified as the isomerase in the citramalate pathway for isoleucine 
biosynthesis, as well as exhibiting malease activity. Finally, MJ0720 from M. jannaschii 
was characterized as the IPMDH involved in leucine and isoleucine biosynthesis [48]. 
 
 
 
1.4.3. MJ1003-MJ1271 Functions as the M. jannaschii HACN 
The MJ1003-MJ1271 protein pair was identified as the M. jannaschii HACN, an 
iron-sulfur cluster containing protein homologous to aconitase [49]. The steady state 
kinetics for the reconstituted holoenzyme were established for cis-homoaconitate, cis- 
homo2aconitate, and cis-homo3aconitate in both direct and coupled assays with HICDHMJ. 
Kinetic assays and product analysis provides insight into the intermediates of the chain 
elongations pathway, and differences with homologous HACNs from the -aminoadipate 
pathway are described. 
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1.4.4. Structure and Function of MJ1271 and MJ1277 
The identified and characterized HACNMJ and IPMIMJ are highly homologous and 
are predicted to follow an aconitase-type mechanism in the isomerization of their 
respective substrates. In an effort to elucidate the active site residues responsible for 
differences in substrate specificity between the two enzymes, site directed mutagenesis of 
the HACNMJ small subunit, MJ1271, was conducted and the steady state kinetics of the 
mutant subunits interacting with wild type MJ1003 were established [50]. A crystal 
structure of MJ1271, solved by Yokoyama and colleagues, as well as a homology model 
of MJ1277 were used to describe the active sites of M. jannaschii HACN and IPMI [50]. 
 
 
 
1.4.5 Archaeal Iron-Sulfur Cluster Biosynthesis 
HACNMJ and IPMIMJ require an iron-sulfur cluster for activity. However, the 
archaeal biosynthetic pathway(s) involved in the in vivo synthesis of these clusters and 
the subsequent transfer to their target apoenzymes remains unknown. Although 
homologs of the SUF pathway for iron-sulfur cluster biosynthesis are present in the 
genome of M. jannaschii, namely SufB and SufC, the function of these proteins has not 
been identified. Also, many archaea do not possess homologs to any cysteine 
desulfurase, the sulfur donor for cluster biosynthesis. The M. jannaschii MJ0283 and M. 
maripaludis MMP0704 proteins were identified as homologs of the Salmonella enterica 
ApbC protein and Saccharomyces cerevisiae Nbp35 protein that function as iron-sulfur 
cluster carrier proteins [51]. The role of MJ0283 and MMP0704 as archaeal iron-sulfur 
cluster carrier proteins was elucidated through complementation studies using an 
established S. enterica genetic system possessing an apbC mutation. The proteins were 
also overexpressed and purified from E. coli to characterize the iron and sulfur content of 
the reconstituted proteins [51]. 
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Chapter 2: Isoleucine and Leucine Biosynthesis – Isopropylmalate 
Isomerase 
 
 
 
 
 
2.1. INTRODUCTION 
 
Several biosynthetic pathways have been identified for the synthesis of isoleucine, 
each varying in their production of a 2-oxobutyrate intermediate [52]. Cyanobacteria, 
fungi, and heterotrophic bacteria synthesize this 2-oxocarboxylic acid using the more 
widely spread biosynthetic pathway requiring a threonine dehydratase [EC 4.2.1.16] 
(Figure 2.1). This enzyme catalyzes the PLP-dependent dehydration and deamination of 
L-threonine, producing 2-oxobutyrate and ammonia [53]. 2-Oxobutyrate is then 
condensed with hydroxyethyl thiamine pyrophosphate to give -aceto--hydroxybutyrate 
in a reaction catalyzed by acetolactate synthase [EC 2.2.1.6]. Three enzymes then work 
in succession to produce isoleucine from -aceto--hydroxybutyrate: Acetohydroxy acid 
isomeroreductase [1.1.1.86], dihydroxy acid dehydratase [4.2.1.9], and valine-3-methyl- 
2-oxovalerate transaminase [2.6.1.32]. 
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Figure 2.1. Isoleucine biosynthesis using a threonine dehydratase for the production 
of 2-oxobutyrate. 
 
 
 
Threonine dehydratase is not present in the genomes of most methanogenic 
archaea. These organisms still synthesize isoleucine, albeit from a different biosynthetic 
pathway to 2-oxobutyrate. Methanobacterium thermoautotrophicum, 
Methanobrevibacter arboriphilus, and Methanosarcina barkeri assimilated exogenous 
propionate and 2-methylbutyrate into isoleucine [54,55]. However, in the absence of 
these compounds, labeled acetate was incorporated into isoleucine via citramalate in a 
chain elongation pathway starting from pyruvate, a pathway that was initially identified 
in spirochetes [55,56]. 
The pyruvate pathway to 2-oxobutyrate is analogous to the isopropylmalate 
pathway for leucine biosynthesis. Citramalate synthase (CMS) [EC 2.3.1.182] catalyzes 
the production of (R)-citramalate from acetyl-CoA and pyruvate. [57].  The product is 
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then dehydrated to the cis-unsaturated intermediate citraconate. The hydration product of 
citraconate, -methylmalate, is then oxidatively decarboxylated to 2-oxobutyrate, which 
is ultimately converted to isoleucine. To produce leucine, 2-oxoisovalerate and acetyl- 
CoA are first condensed to form -isopropylmalate, catalyzed by isopropylmalate 
synthase (IPMS) [58]. Isopropylmalate isomerase (IPMI), a homolog of aconitase 
possessing a [4Fe-4S] cluster, then catalyzes  the anti-elimination of water from - 
isopropylmalate to form the cis-unsaturated intermediate dimethylcitraconate through a 
mechanism proposed to be similar to mitochondrial aconitase (mACN) [59]. The IPMI- 
catalyzed hydration of the intermediate produces -isopropylmalate, which is then 
oxidatively decarboxylated by the NAD+-dependent isopropylmalate dehydrogenase 
(IPMDH) to give 2-oxoisocaproate [44]. 
The CMS from M. jannaschii, MJ1392, was previously purified and characterized 
as specific for pyruvate and acetyl-CoA [57]. The substrate of IPMS, 2-oxoisovalerate, 
was not detected as a substrate, distinguishing CMS from IPMS. CMS was  also 
identified in Leptospira interrogans and a catalytic mechanism was proposed based on 
crystallographic and site-directed mutagenesis studies [60,61]. The overall mechanism is 
consistent the mechanism of malate synthase, involving three main steps: (i) enolization; 
(2) condensation; (3) hydrolysis. A glutamate is proposed to serve as the base for proton 
abstraction from the acetyl-CoA methyl group, producing an  enolate.  An  arginine 
residue functions as a general acid, coordinating the acetyl-CoA enolate as well as 
pyruvate. The divalent metal cation Mn2+ was required for maximal activity of the L. 
interrogans CMS and is therefore proposed to also coordinate pyruvate via the carbonyl 
groups. Rotation of the acetyl-CoA puts this substrate in position for a nucleophilic 
attack on the bound pyruvate, producing the citramalyl-CoA intermediate.  An active site 
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water molecule then hydrolyzes the thioester of citramalyl-CoA, producing the free CoA 
thiol and citramalate [61]. 
Although the CMS from M. jannaschii and L. interrogans have been 
characterized, the enzymes responsible for the isomerization of (R)-citramalate and 
oxidative decarboxylation of -methylmalate were not identified. Yeast strains with 
mutations in the threonine dehydratase gene were able to synthesize isoleucine via the 
pyruvate pathway and the S. cerevisiae IPMI was able to catalyze the hydration of 
citraconate [52,59]. Therefore, it was proposed that IPMI could function in both leucine 
and isoleucine biosynthetic pathways (Figure 2.2). Citraconate hydration and - 
isopropylmalate dehydrogenase activities were observed in L. interrogans extracts 
supplemented with E. coli extracts expressing the L. interrogans IPMI and IPMDH. 
However, these enzymes were not purified and characterized [60]. 
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Figure 2.2. Analogous chain elongation pathways. (A) Malease catalyzes the 
hydration of maleate to form D-malate, which can be oxidatively decarboxylated by TDH 
(or by IPMDH). (B) The pyruvate pathway to 2-oxobutyrate for isoleucine biosynthesis 
requires CMS, IPMI, and IPMDH enzymes. (C) The  isopropylmalate  pathway for 
leucine biosynthesis uses IPMS and shares the IPMI and IPMDH enzymes with the 
pyruvate pathway. (D) the homocitrate pathway for lysine production in some organisms 
requires a homocitrate synthase (HCS), aconitase (ACN), homoaconitase (HACN), and 
homoisocitrate dehydrogenase (HICDH). 
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The M. jannaschii genome contains two genes encoding putative IPMI large 
subunits (MJ0499 and MJ1003) and two genes encoding putative IPMI small subunits 
(MJ1271 and MJ1277) (Figures 1.6 and 2.3). One pair of large and small subunits was 
predicted to function as the homoaconitase in CoB biosynthesis. A second pair of 
subunits was predicted to function as the IPMI in methanogen leucine biosynthesis.  The 
M. jannaschii IPMI was also proposed to function as the citramalate isomerase required 
for the pyruvate pathway. 
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MJ1271    .....MIIKGRAHKFG.DDVDTDAIIPGPYL.RTTDPYELASHCMAGIDE 
MJ1277       ...MRSIIKGRVWKFG.NNVDTDAILPARYL.VYTKPEELAQFVMTGADP 
Tth LeuD MLEKFTVIRGKAVPLRGEDIDTDRILPARFMKVLTFEG.LGQYLFYDERF 
PhHACN-s     .....MITTGKVWKFG.DDISTDEITPGRYN.LTKDPKELAKIAFIEVRP 
Tth LysU      ........MPRVWKFG.DQINTDDILPGKYAPFMVGEDRFHLYAFAHLRP 
Ec LeuD       MAEKFIKHTGLVVPLDAANVDTDAIIPKQFLQKVTRTG.FGAHLFNDWRF 
 
 
MJ1271    NFPKKVKEGD.............VIVAGENFGCGSSREQAVIAIKYCGIK 
MJ1277       DFPKKVKPGD.............IIVGGKNFGCGSSREHAPLGLKGAGIS 
Tth LeuD DEKGNPKPHP...LNDPRYRGATILLVESGFGSGSSREHAPQAIKRAGFK 
PhHACN-s DFARNVRPGD.............VVVAGKNFGIGSSRESAALALKALGIA 
TthLysU       EFAKEVRPGD.............ILVFGRNAGLGSSREYAPEALKRLGVR 
Ec LeuD       LDEKGQQPNPDFVLNFPQYQGASILLARENFGCGSSREHAPWALTDYGFK 
 
 
MJ1271    AVIAKSFARIFY NAINVGLIPIIAN.......TDEIKDGDIVEIDLDKE 
MJ1277       CVIAESFARIFYRNAINVGLPLIECKG.....ISEKVNEGDELEVNLETG 
Tth LeuD AIIGESFAEIFFGNATAIGLPCVSLSPEDLGVLFRSVEENPELEVEIDLV 
PhHACN-s GVIAESFGRIFYRNAINIGIPLLLGK.......TEGLKDGDLVTVNWETG 
TthLysU       AIIA SYARIFFRNLVNLGIVPFESEE.....VVDALEDGDEVELDLESG 
Ec LeuD       VVIAPSFADIFYGNSFNNQLLPVKLSDAEVDELFALVKANPGIHFDVDLE 
 
 
MJ1271    EIVITNKNKTIKC...........ETPKGLEREILAAGGLVNYLKKRKLI 
MJ1277       EIKNLTTGEVLKG...........QKLPEFMMEILEAGGLMPYLKK.KMA 
Tth LeuD NQEVRFGDRTAPLSIREEAREALVEGLWDPIGELLEAGELLDQFDQKLPY 
PhHACN-s     ..EVRKGDEILMF...........EPLEDFLLEIVREGGILEYIRRRGDL 
Tth LysU      ..VLTRGEERFAL...........RPPPPFLLEALKEGSLLDYYKKHGRF 
Ec LeuD       AQEVKAGEKTYRFTIDAFRRHCMMNGL.DSIGLTLQHDDAIAAYEAKQPA 
 
 
MJ1271        QSKKGVKT 
MJ1277        ESQ..... 
Tth LeuD      PRRTE... 
PhHACN-s      CIR..... 
Tth LysU      PGE..... 
Ec LeuD       FMN..... 
 
Figure 2.3. Sequence alignment of hydrolyase small subunits. The sequences are 
Methanocaldococcus jannaschii MJ1271 (Swiss-Prot accession no. Q58667), M. 
jannaschii MJ1277 (Swiss-Prot accession no. Q58673), Thermus thermophilus 
isopropylmalate dehydratase (Tth LeuD; RefSeq accession no. YP_004837.1), 
Pyrococcus horikoshii HACN (PhHACN-s; Swiss-Prot 059393), T. thermophilus HACN 
(Tth LysU; RefSeq accession no. YP_005515.1), Escherichia coli isopropylmalate 
dehydratase (Ec LeuD; Swiss-Prot accession no. P30126). Conserved amino acid residues 
are shown in white on a black background. Similar residues are shown in black on a gray 
background. 
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In this study, the MJ0499/MJ1277 pair of proteins was identified as the IPMI 
involved in leucine and isoleucine biosynthesis [48]. After reconstitution of the [4Fe-4S] 
center, the holoenzyme catalyzed the reversible hydration of citraconate and dehydration 
of (R)-citramalate, -isopropylmalate, and -isopropylmalate. The broad substrate 
specificity of MJ0499/MJ1277 was also extended to the hydration of the minimal 
substrate, maleic acid, to D-malate. The M. jannaschii IPMDH catalyzed the oxidative 
decarboxylation of -methylmalate, as well as -isopropylmalate and D-malate. 
Therefore the M. jannaschii IPMI and IPMDH proteins function in both the 
isopropylmalate pathway and the pyruvate pathway to 2-oxobutyrate. 
 
 
2.2. MATERIALS AND METHODS 
 
2.2.1. Chemicals 
 
-Isopropylmalic acid was purchased from Aldrich. Other commercially 
available reagent grade chemicals were used without further purification. (2R,3S)-3- 
isopropylmalate was chemically synthesized (Abdul Waheed). DL-threo-3- 
isopropylmalic acid was purchased from Wako Chemicals for analytical comparison. 
 
 
2.2.2. Cloning of MJ0499-MJ1277, MJ1003-MJ1277, and MJ0720 
 
Genes were amplified from chromosomal DNA of Methanocaldococcus 
jannaschii JAL-1 using PCR. The large subunit genes at loci MJ0499 (RefSeq accession 
no. NP_247475) and MJ1003 (NP_247997) were cloned between NdeI and KpnI sites of 
plasmid pCDF-Duet1 (Novagen) to create vectors pDG142 and pDG141, respectively. 
The MJ1271 small-subunit gene (NP_248267) was cloned between NcoI and BamHI 
sites of plasmid pDG142 to create vector pDG159 and between the same sites in the 
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plasmid pDG141 to create pDG152. The MJ1277 small-subunit gene (NP_248273) was 
cloned between NcoI and BamHI sites of plasmid pDG141 to create pDG157. The 
IPMDH gene at locus  MJ0720 (NP_247705) was amplified using PCR and cloned 
between the NdeI and BamHI sites of plasmid pET-19b (Novagen) to create vector 
pMYL1. The translational start site for that protein was originally predicted to be 
encoded by a GTG codon, which can be recognized as an initiator codon in some archaea 
[44]. However, there is an ATG codon downstream from the GTG codon that is closer to 
the predicted start site of conserved, orthologous archaeal genes. Because the GTG 
codon appears to be part of a ribosome binding site “GGTGAT,” we believe the ATG 
codon is probably the relevant initiator codon. The MJ0720 protein was expressed from 
this downstream start site fused to an amino-terminal polyhistidine tag in E. coli. 
Plasmids were propagated in E. coli DH5(Invitrogen).  Dideoxyribonucleotide 
 
sequencing confirmed the sequences of inserts in recombinant plasmids. 
 
 
Table 2.1. Oligodeoxyribonucleotide primers used for PCR. Restriction enzyme 
recognition sites used for cloning are underlined, and initiator codons are italicized. 
 
Primer Oligodeoxribonucleotide   sequence 
MJ1003Fwd (5’-GGTCATATGACATTGGTAGAGAAGATAC-3’) 
MJ1003Rev (5’-GCGGGTACCTTAATCCAATTTGTTGGT-3’) 
MJ0499Fwd (5’-GGTCATATGGGAATGACAATTGTAGAG-3’) 
MJ0499Rev (5’-GCGGGTACCTTATAAATCCCTTGGGTC-3’) 
MJ1271Fwd (5’-CATGCCATGGTTATTAAGGGAAGAGC-3’) 
MJ1271Rev (5’-CGGGATCCTTATGTTTTTACACCTTTTTTTGATTG-3’) 
MJ1277Fwd (5’-CATGCCATGGGAAGTATAATAAAGGGAAGAG-3’) 
MJ1277Rev (5’-CGGGATCCTTATTGGCTTTCAGCCATCTTTTTCTTTAAG-3’) 
MJ0720Fwd (5’-GCGCATATGCATAAAATATGTGTTATAG-3’) 
  MJ0720Rev (5’-GCGGATCCTTATTCTTCTCTTACTC-3’)   
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Table 2.2. List of plasmids and microorganisms. 
 
 
 
 Source 
and/or 
Strain or plasmid Description reference 
Methanocaldococcus 
jannaschii 
  
JAL-1 Wild type DSM 2661 
Escherichia coli 
DH5a 
 
General cloning host 
 
Invitrogen 
BL21(DE3) Protein expression host Novagen 
Plasmids pCDF-
Duet1 
 
Protein coexpression vector 
 
Novagen 
 Expression vector for proteins with an N-terminal  
pET-19b decahistidine tag 
MJ1003 PCR product obtained using primers 
Novagen 
 
pDG141 
MJ1003Fwd and MJ1003Rev cloned into NDeI/KpnI 
sites of pCDF-Duet1 
 
This study 
 MJ0499 PCR product obtained using primers  
 
pDG142 
MJ0499Fwd and MJ0499Rev cloned into NdeI/KpnI 
sites of pCDF-Duet1 
 
This study 
 MJ1271 PCR product obtained using primers  
 
pdG152 
MJ1271Fwd and MJ1271Rev cloned into 
NcoI/BamHI sites of pDG141 
 
This study 
 MJ1277 PCR product obtained using primers  
 
pDG157 
MJ1277Fwd and MJ1277Rev cloned into 
NcoI/BamHI sites of pDG141 
 
This study 
 
pDG159 
MJ1271 NcoI/BamHI fragment from pDG152 
cloned into same sites of pDG142 
MJ1271 PCR product cloned into NcoI/BamHI sites 
 
This study 
pDG160 of pET-19b 
MJ1277 PCR product cloned into NcoI/BamHI sites 
This study 
pDG163 of pET-19b This study 
 
pDG164 
MJ1277 NcoI/BamHI fragment from pDG157 
cloned into same sites of pDG142 
TDH NdeI/BamHI fragment from pTDH1 cloned into 
 
This study 
pDG329 same site of pET-19b 
MJ0720 PCR product obtained using primers 
This study 
 
pMYL1 
MJ0720Fwd and MJ0720Rev cloned into 
NdeI/BamHI sites of pET-19b 
 
This study 
pTDH1 Pseudomonas putida R-TDH in pET-3a 67 
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2.2.3. Protein expression and purification 
 
E. coli BL21(DE3) strains transformed with expression vectors were grown in 
Luria broth containing appropriate antibiotics at 37C with shaking at 250 rpm. Cells 
containing pCDF-Duet1 derivatives were grown in the presence of streptomycin (50 g 
ml-1). Cells containing pET-19b derivatives were grown in the presence of ampicillin 
(100 g ml-1). When cultures reached an optical density at 600 nm of 0.6 to 0.8 protein 
expression was induced by the addition of -D-lactose (1%, wt/vol) and shaking was 
continued at 20C for 15 h. Cells were harvested by centrifugation and stored at -20C. 
 
 
 
2.2.4. Protein purification 
 
The MJ0499 and MJ1277 proteins were copurified from cells containing pDG164 
by heat treatment, followed by anion-exchange chromtagraphy. E. coli cells containing 
heterologously expressed protein were suspended in 20 mM Tris-HCl (pH 8.0), lysed by 
passing through a French pressure minicell at 8,000 lb/in2 (Thermo Electron), and 
sonicated on ice for 2 min using a Sonifier 450 with a microtip (15 W, 30% duty; 
Branson) to reduce viscosity. Lysates were clarified by centrifugation (14,000 X g for 10 
min at 4C), and the supernatant was stored on ice. This heat-stable protein was applied 
to a 5-ml HiTrap desalting column (GE Healthcare) equilibrated with 20 mM Tris-HCl 
(pH 8.0). Fractions containing desalted protein were pooled and applied to a 5-ml HiTrap 
DEAE FF column (GE Healthcare) equilibrated in 20 mM Tris-HCl (pH 8.0). 
Chromatography was performed using an ÄKTAprime system (GE Healthcare) at a flow 
rate of 5 ml min-1. Protein was eluted from the column with a linear gradient to 0.5 M 
NaCl-20mM Tris-HCl (pH 8.0) over 20 min. Fractions containing the target protein were 
identified by absorbance at 280 nm and sodium dodecyl sulfate polyacrylamide gel 
electrophoresis  (SDS-PAGE). Fractions  containing  the  proteins  of  interest  were 
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combined, loaded into SpectraPor4 dialysis tubing (molecular mass cutoff = 14,000), and 
dialyzed overnight in 2 liters of buffer containing 20 mM Tris-HCl (pH 8.0 at 4C). The 
protein was transferred to fresh buffer and dialyzed for 5 h.  Protein was concentrated 
inside the dialysis tubing using polyethylene glycol (20,000 Da). The MJ1003-MJ1277 
and MJ1003-MJ1271 proteins were copurified from cells containing pDG141 and 
pDG163 and pDG160 and pDG152, respectively, as described above. Total protein 
concentration was determined using the Bio-Rad protein assay with bovine serum 
albumin as a standard. 
The polyhistidine-tagged M. jannaschii IPMDH protein was purified by heat 
treatment followed by nickel affinity chromatography. E. coli (pMYL1) cells containing 
heterologously expressed protein were suspended in His-tag binding buffer containing 5 
mM imidazole, 500 mM sodium chloride, and 20 mM Tris-HCl (pH 7.6), and cell 
extracts were prepared as described above. Extracts were heated at 60C for 10 min, and 
the denatured protein was removed by centrifugation.  The soluble protein was applied to 
a 5-ml HisTrap FF column (GE Healthcare) charged with NiCl2  and equilibrated in His 
tag binding buffer at a flow rate of 5 ml min-1. Protein was eluted from the column with a 
linear gradient to 0.5 M imidazole, 0.5 M sodium chloride, and 20 mM Tris-HCl (pH 7.6) 
over 20 min.  Fractions containing the target protein were combined and concentrated in 
a stirred ultrafiltration cell (Amicon) with a filter having a 10-kDa molecular mass cutoff 
(Pall) under nitrogen gas 4C. 
After concentration, the buffer was exchanged with 20 mM Tris-HCl (pH 7.6) in 
an ultrafiltration cell. The purifed protein precipitated and lost activity during storage at 
4C.  However, it could be stored in aliquots containing 20% glycerol, frozen at -40C or 
-80C, and thawed without significant loss of activity. Protein stored in this manner 
remained active for at least 2 weeks. 
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2.2.5. Analytical size exclusion chromatography 
 
Interactions between large and small subunits were tested by measuring apparent 
masses of protein pairs using size exclusion chromatography, as described previously 
[62]. The compositions of protein fractions were determined by SDS-PAGE with silver 
staining (Bio-Rad). Separations were performed aerobically on purified, unreconstituted 
apoenzymes. 
 
 
2.2.6. Reconstitution of Fe-S centers 
 
Purified hydrolyase holoenzymes were reconstituted in 2-ml glass serum vial 
(Wheaton) containing a magnetic stir bar and sealed with a 13-mm butyl rubber stopper. 
All buffers and reagents were degassed under a continuous flow of argon for at least 10 
min. Anaerobic  transfers were  performed using gastight syringes (Hamilton). For 
reconstitution, purified apoprotein (0.5 to 1.0 mg ml-1) was mixed with 50 mM Tris-HCl 
(pH 8.0) and 3 mM dithiothreitol [63]. The sealed solutions were placed in an ice-water 
bath at 0 to 4C, and the solution was degassed with argon for 10 min while being stirred. 
To the reconstitution mixture, Fe(NH4)2(SO4)2 · 6H2O was added to a final concentration 
of 0.5 mM.  After 10 min, Na2S · 9H2O was added dropwise to a final concentration of 
0.5 mM, and the reconstitution mixture was stirred under argon until maximum activity 
was observed (typically 2 h). The final reconstitution volume was 1 ml. Hydrolyase 
activity was monitored in a standard assay with 0.4 mM citraconate as described below. 
 
 
2.2.7. Measurment of hydrolyase activities 
 
All continuous assays used a DU-800 spectrophotometer with a Peltier 
temperature-controlled sampler (Beckman).  Reactions (1 ml) were conducted in quartz 
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semimicrocells with screw-cap septa (Starna), including 300 mM KCl, 10 mM MgCl2, 50 
mM TES [N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid]-KOH (pH 7.5), 2.5 
or 10 g ml-1 recontituted protein, and various substrate concentrations. The sealed 
quartz cell containing buffer and substrate was degassed under argon for 10 min and 
equilibrated at 60C for 10 min.  Reactions were initiated by the addition of reconstituted 
enzyme, and the change in UV absorbance was monitored at 60C. Initial rates were 
measured from the linear portion of the reaction progress curve between 5 and 60 s.  For 
-isopropylmalate, -isopropylmalate, and (R)-citramalate, the formation of the reaction 
 
intermediate was observed by measuring the  increase in absorbance at 235 nm, as 
measured in the reaction buffer at 60C with g ml-1 of reconstituted protein. The molar 
absorption coefficient at 235 nm (235) for both citraconate and isopropylmaleate was 
4,668 M-1 cm-1. The hydration of citraconate and maleate was observed as a decrease in 
absorbance with 2.5 g ml-1   of reconstituted enzyme.   Maleate hydration to produce 
malate was monitored at 235, 245, and 255 nm using molar absorption coefficients of 
2,318, 1,297, and 582 M-1 cm-1, respectively, measured in the reaction buffer at 60C. 
Citraconate hydration was monitored at 235 nm, with a molar absorption coefficient of 
4,530 M-1 cm-1. Reaction progress curves were linear from 5 to 60 s. One unit of 
hydrolyase activity catalyzed the conversion of 1 mol substrate to product per minute. 
Steady-state kinetic constants were estimated by nonlinear regression of initial rate data 
fit to the Michaelis-Menten-Henri equation using the KaleidaGraph program (Synergy 
Software). 
 
 
2.2.8. Measurement of oxidative decarboxylation activities. 
The rate of oxidative decarboxylation catalyzed by IPMDHMJ  was measured by 
monitoring the reduction of NAD+  to NADH at 340 nm, assuming a molar absorption 
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MJ 
 
coefficient for NADH of 6,220 M-1 cm-1. Assays were conducted aerobically in optical 
glass cuvettes (Starna) with 200 mM KCl, 10 mM MgCl2, 50 mM TAPS 
[Tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid]-KOH (pH 8.5), 5 mM NAD+, 
2.5 g ml-1 IPMDHMJ, and various substrate concentrations. Reaction mixtures were 
equilibrated at 60C for 10 min, and reactions were initiated with NAD+. Initial rates 
were measured using a linear portion of the reaction progress curve, from 5 to 60 seconds 
for -isopropylmalate and 120 to 180 seconds for D-malate. One unit of enzymatic 
activity catalyzed the reduction of 1 mol NAD+ per min in a 1 ml reaction mixture. 
Apparent kinetic constants were estimated as described above. 
 
 
2.2.9. Coupled assay of dehydratase activity 
 
The -hydrating activity of enzymes incubated with unsaturated intermediates 
 
was measured in reaction mixtures containing IPMDH and NAD+ as described above. 
 
Reaction mixtures contained 300 mM KCl, 10 mM MgCl2, 50 mM TES-KOH (pH 7.5), 
30 g ml-1  IPMDH , 5 mM NAD+, and various substrate concentrations. Reaction 
MJ 
 
mixtures were made anaerobic and preincubated at 60C as described above, before the 
addition of 2.5 g ml-1 MJ0499/MJ1277 to initiate the reaction. Initial rates were 
measured between 5 and 60 seconds for citraconate and between 120 and 180 seconds for 
maleate. 
 
 
2.2.10. Identification of dehydratase reaction products 
 
Hydroxyacids and unsaturated carboxylic acids were derivatized with 
ethylchloroformate and analyzed by gas chromatography-mass spectrometry (GC-MS) 
[64].   Reaction products were mixed with ethylchloroformate in a solution of water- 
40  
 
trifluoroethanol-pyridine (60:32:8, vol/vol/vol) [65]. Derivatives were analyzed on a 
Finnigan MAT GCQ GC-MS with a DB-5MS capillary column (0.32 mm by 29 m, 0.5- 
mm film; J&W Scientific) and analyzed by chemical ionization MS in the positive mode, 
as described previously [62]. Using this method, the trifluoroethyl ester derivatives had 
the following retention times and mass spectral data. The molecular ion (MH+) is shown 
first, if observed (a minus sign indicates that MH+ was not found), followed by the base 
peak (italics), and characteristic fragment ions are listed in decreasing order of intensity. 
The derivatives were as follows: citraconate diester, 3.73 min (295, 195, 275); (R)- 
citramalate, 3.87 min (-, 185, 195, 275, 213); D-malate diester, 4.06 min (299, 171, 261, 
278, 199); -isopropylmalate diester, 4.61 min (-, 199, 213, 241); -isopropylmalate 
 
diester, 4.65 min (341, 213, 195, 241, 321). In most spectra the base peak was assigned 
as the fragment ion following the neutral loss of CF3CH2OH or CH3CH2COOH from the 
molecular ion. 
Alternatively, trimethylsilyl (TMS) derivatives of the hydroxycarboxylic acids 
were prepared by reacting dried sample with 50 l N-methyl-N-(TMS)-trifluoroacetamide 
and 50 l pyridine in a sealed vial at 60C for 20 min.  Derivatives were analyzed by GC- 
MS as described above. The mass range scanned was 70-700 atomic mass units. The 
derivatives were as follows: citraconate-(TMS)2, 5.54 min (275, 185, 149, 73, 259, 277, 
73); citramalate-(TMS)3, 6.03 min (365, 247, 349, 321, 277, 73); -isopropylmalate- 
(TMS)3, 6.30 (-, 275, 191, 377, 73); -isopropylmalate-(TMS)3, 6.35 (393, 213, 275, 377, 
73). 
 
For quantitative analysis of reaction mixtures, carboxylic acids were separated by 
reversed-phase high-pressure liquid chromatography (HPLC). Reaction mixtures or 
standard compounds were applied to a Luna C18(2) column (4.6 by 150 mm, 5 M; 
Phenomenex) with a Security Guard ODS cartridge (4 by 3 mm; Phenomenex) that was 
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equilibrated in mobile phase containing 25 mM phosphoric acid and 2% (vol/vol) 
methanol (pH 2.5). Isocratic elution with this mobile phase was used at a flow rate of 1 
ml min-1 at 35C. Samples (25 l) were injected using a Beckman 508 autosampler. 
Organic acids were detected using a Beckman 168 photodiode array detector. Data were 
collected and chromatograms were integrated using the 32 Karat software (Beckman). 
Under these conditions, retention factors for standard compounds were 0.63 (D-malate), 
0.97 (2-oxoglutarate), 1.4 (maleate), 2.1 (homoisocitrate), 2.0 (fumarate), 2.3 (cis- 
aconitate), 2.7 (R-citramalate), 2.7 (trans-aconitate), and 4.7 (citraconate), with a holdup 
time of 1.47 min. Less-polar compounds were resolved using a mobile phase containing 
25 mM phosphoric acid and 30% (vol/vol) methanol (pH 2.5). Under these conditions, 
retention factors for standard compounds were 0.4 (R-citramalate), 0.7 (citraconate), 2.5 
(-isopropylmalate), 2.9 (-isopropylmalate), and 4.2 (isopropylmaleate), with a holdup 
time of 1.55 min. Analyte concentrations were calculated from the integrated peak areas 
of the chromatogram at 220 nm absorbance using the method of standard additions. 
 
 
2.2.11. Stereochemical analysis of malate product. 
 
Tartrate dehydrogenase (TDH) [EC 1.1.1.93] was used to confirm the 
stereochemistry of IPMI hydration products. Plasmid pTDH1, which encodes the TDH 
enzymes from Pseudomonas putida ATCC 17642, was a gift from Paul Cook (University 
of Oklahoma) [66]. Dideoxynucleotide sequencing using T7 promoter and T7 terminator 
oligonucleotide primers identified several discrepancies with the originally published 
TDH sequence [67]. The NdeI/BamHI fragment of plasmid pTDH1 was subcloned into 
pET-19b to produce plasmid pDG329, which encodes TDH fused to an amino-terminal 
decahistidine  tag.    The  His10TDH  protein  was  expressed  from  pDG329  in  E.  coli 
BL21(DE3).  Protein was purified by heating the extract at 50C for 10 min, precipitating 
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the denatured protein, and isolating the His10TDH by nickel affinity chromatography as 
described above. 
Reaction mixtures to determine the stereochemistry of malate produced by the 
malease activity of the MJ0499/MJ1277 combination contained 5 mM maleate, 
reconstituted MJ0499/MJ1277 protein (5 g ml-1), and reaction buffer incubated at 60C 
for 24 h.  Portions of reaction product were added to an aerobic solution containing IPMI 
buffer salts, TDH (His10TDH; 20 g ml ), and 1 mM NAD
+
 in a volume of 1 ml.  After 
 
incubation at 37C for 1 h, the absorbance of the solution at 340 nm was measured and 
D-malate product concentrations were calculated according to a linear standard curve 
from 5 to 200 M D-malate. Another portion of the malease reaction product was 
analyzed using L-malate dehydrogenase (U.S. Biochemicals) in a 1-ml reaction mixture 
containing 20 g ml-1  enzyme, 100 M phenazine methosulfate, 150 M thiazolyl blue, 
and 1 mM NAD+. Reaction mixtures were incubated at room temperature for 30 min, the 
absorbance of the solution at 570 nm was measured, and L-malate concentrations were 
estimated according to a linear standard curve from 5 to 200 M L-malate [68]. The 
limit of detection for this method was approximately 1.5 M L-malate. 
 
 
2.3. RESULTS 
 
2.3.1. Protein expression, purification, and subunit interaction. 
 
The MJ0499 and MJ1277 pair of proteins were heterologously expressed in E. 
coli and purified from the soluble cell lysate by heat treatment at 60C followed by 
anion-exchange chromatography. MJ0499 and MJ1277 comprised approximately 90% of 
the resulting total protein, as estimated by SDS-PAGE and densiometry (Figure 2.4). The 
apparent mass of MJ0499 was 44 kDa, matching the theoretical mass of 46.1 kDa. 
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Likewise, the apparent mass of MJ1277 correlated well with its theoretical mass (16 kDa 
and 18.4 kDa, respectively). The large and small subunits coeluted during analytical size 
exclusion chromatography with a Stokes radius of 42 Å, corresponding to a 143 kDa 
protein (Figure  2.5). Therefore, the  MJ0499/MJ1277 pair probably associates as a 
heterotetramer of two large and two small subunits. The purified MJ1003/MJ1277 pair 
of proteins coeluted with a Stokes radius of 43 Å, corresponding to a heterotetrameric 
complex with a molecular mass of 153-kDa (Figure 2.5). The MJ0499 and MJ1271 
subunits did not copurify during anion-exchange chromatography and eluted as 
monomers during size exclusion chromatography. 
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Figure 2.4. Purified IPMDHMJ and combinations of large and small subunits of the 
hydrolyase apoenzymes. Lane 1, 8 g His10MJ0720 (IPMDHMJ); lane 2, 10 g MJ1003- 
MJ1277;  land  3,  10  g  MJ0499-MJ1277;  lane  M,  protein  size  markers  (Bio-Rad). 
Proteins were separated by SDS-PAGE on a 15% acrylamide gel and stained with 
Coomassie blue. 
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Figure 2.5 MJ0499-MJ1277 and MJ1003-MJ1277 Subunit Interaction. Proteins were 
separated by analytical size exlcusion chromatography HPLC with UV absorbance 
detection at 220nm in milli-absorbance units (mAU). Standard curves based on elution 
volume with respect to (A) molecular mass and (B) Stokes radius of the following 
standards: cytochrome  c, myoglobin, carbonic  anhydrase, conalbumin, alcohol 
dehydrogenase, aldolase, and -amylase. (C) Chromatogram of 1 g ml-1 purified 
MJ1003-MJ1277. The peak at 16.350 min corresponds to MJ1003-MJ1277, as 
confirmed by SDS-PAGE. (D) Chromatogram of 1 g ml-1 purified MJ0499-MJ1277. 
The peak at 16.433 min corresponds to MJ0499-MJ1277, as confirmed by SDS-PAGE. 
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2.3.2. Reconstitution of iron-sulfur clusters 
Members of the aconitase family of proteins require an active site iron-sulfur 
cluster. These clusters are sensitive to oxidants, such as hydrogen peroxide, oxygen, and 
superoxide [69]. Therefore, the aerobic purification of MJ0499/MJ1277 resulted in an 
inactive enzyme (apoenzyme), i.e. the hydration of citraconate was not observed. The 
cluster was chemically reconstituted by incubating the apoenzyme with iron and sulfide 
under anaerobic reducing conditions. The reconstituted enzyme possessed a broad peak 
between 400 to 450 nm, indicative of an iron-sulfur cluster [70,71]. 
 
 
2.3.3. Identification of the citramalate/isopropylmalate isomerase 
 
The reconstituted MJ0499/MJ1277 was identified as the hydrolyase responsible 
for hydration of citraconate in the pyruvate pathway to 2-oxobutyrate. This enzyme 
catalyzed the hydration of 300 M citraconate with a specific activity of 15 units min-1 
mg-1, and the reaction products, citramalate and -methylmalate, were identified by 
reversed-phase HPLC. MJ0499/MJ1277 also catalyzed the dehydration of (R)- 
citramalate, -isopropylmalate, and the hydration of -isopropylmalate, thus establishing 
this protein pair as the citramalate/isopropylmalate isomerase involved in both isoleucine 
and leucine biosynthesis. The hydration of the minimal substrate maleic acid was also 
observed in a direct assay. No activity was observed in direct assays consisting the 
holoenzyme and the following compounds: fumarate, mesaconate, cis-aconitate, trans- 
aconitate, D-tartrate, L-tartrate, L-malate, DL-isocitrate, citrate, (R)-homocitrate, and (S)- 
citramalate. Therefore, the MJ0499/MJ1277 requirements for substrate specificity 
consist of cis-unsaturated intermediates with -chain consisting of a methyl group, an 
isopropyl group, or the replacement of the -chain with hydrogen, as well as their D-- 
hydroxy  or  -hydroxy  analogs. No  activity  was  observed  with  the  reconstituted 
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MJ1003/MJ1277 protein pair or a control reconstitution mixture containing no protein for 
any of the tested compounds. 
The steady state kinetic parameters for the direct hydration and dehydration 
reactions catalyzed by MJ0499/MJ1277 were established from the initial rate data fit with 
the Michaelis-Menten-Henri equation (Figure 2.6 and Table 2.3). MJ0499/MJ1277 
catalyzed the hydration of maleic acid with a five-fold increase in Km  over the hydration 
of citraconate and a two-fold increase in kcat.  However, the resulting specificity constants 
with these substrates were similar.  The hydration of (R)-citramalate, -isopropylmalate, 
and the dehydration -isopropylmalate were catalyzed at a rate 10 to 25% lower than for 
citraconate hydrolysis. The specificity constants were also considerably lower for these 
compounds. MJ0499/MJ1277  recognizes the  -hydroxyacids with  specificity constants 
two orders of magnitude lower than that of citraconate and one order of magnitude for - 
isopropylmalate. 
48  
 
 
 
 
 
 
 
 
Figure 2.6. Representative of the steady-state kinetics of MJ0499-MJ1277. Steady- 
state kinetic constants for MJ0499-MJ1277 were estimated by nonlinear regression of 
initial rate data fit to the Michaelis-Menten-Henri equation, as described in the text. 
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Equilibrium constants were established for the citraconate hydration and - 
isopropylmalate dehydration reactions from the anaerobic incubation of 5 g ml-1 
reconstituted MJ0499/MJ1277 with 2 mM of either substrate at 60C for 24 h. 
Citramalate could not be separated from -methylmalate under the HPLC conditions 
used. Therefore, the equilibrium ratio of citramalate (with -methylmalate) to citraconate 
was measured as 50:1. The three substrates of MJ0499/MJ1277 in the isopropylmalate 
pathway, -isopropylmalate, -isopropylmalate, and dimethylcitraconate, were identified 
as separate peaks with an equilibrium ratio of 9:30:1, averaged from two analyses. The 
products of this reaction were confirmed as their TMS derivative by GC-MS. 
The equilibrium ratio of malate to maleic acid was estimated to be 146:1 in a 
reaction mixture consisting of 2 mM maleic acid and 5 g ml-1 reconstituted 
MJ0499/MJ1277. No malease activity was observed in a  similar reaction with the 
addition of 5 mM D-malate and maleic acid was not measured after incubating 2 mM D- 
malate with reconstituted MJ0499/MJ1277. In a direct assay containing 200 M maleic 
acid and 2.5 g ml-1 reconstituted enzyme, the addition of 500 M D-malate resulted in 
50% inhibition of malease activity. The same level of inhibition was reached in the 
presence of 5 mM L-malate. Therefore, the greater product inhibition of D-malate 
suggests that this is the correct enantiomer of the MJ0499/MJ1277 catalyzed hydration of 
maleic acid. 
To identify the stereochemistry of the MJ0499/MJ1277 catalyzed hydration of 
maleic acid, L-malate dehydrogenase [EC 1.1.1.37] and TDH were used in discontinuous 
assays. L-Malate dehydrogenase catalyzes the stereospecific dehydrogenation of L- 
malate to oxaloacete and TDH catalyzes the oxidative decarboxylation of D-malate, 
producing pyruvate [67]. Reaction mixtures consisting of 5 g ml-1 reconstituted 
MJ0499/MJ1277 were incubated under anaerobic conditions for 24 h at 60C.  Based on 
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standard curves generated from L-malate with L-malate dehydrogenase and D-malate 
with TDH, only D-malate was identified from the reaction mixture (5.07 0.05 mM). 
No L-malate was identified above background (<8 M). Therefore, D-malate is the sole 
product of maleic acid hydration by MJ0499/MJ1277. 
 
 
Table 2.3. Steady – state kinetic parameters for MJ0499 – MJ1277a. 
 
 
Substrate 
Km 
(µM) 
Vmax 
(U mg-1) 
kcat 
(s-1) 
kcat/Km 
(M-1 s-1) 
Citraconateb 80 ± 20 15 ± 0.9 16 2.0 X 105 
Citraconatec 20 ± 10 13 ± 0.7 14 3.5 X 105 
(R)-Citramalateb 810 ± 80 1.5 ± 0.05 1.6 2.0 X 103 
-Isopropylmalateb 1900 ± 400 4.2 ± 0.3 4.5 2.4 X 103 
 -Isopropylmalateb 39 ± 7 1.8 ± 0.1 1.9 5.0 X 104 
Maleateb 400 ± 50 34 ± 2 36 9.0 X 104 
Maleateb 180 ± 30 19 ± 0.9 20 1.1 X 105 
aKinetic parameters were estimated by nonlinear regression, and the standard errors of 
those parameters are shown. Turnover numbers were calculated assuming one active site 
per MJ0499/MJ1277 pair. 
bInitial rates of hydrolyase activity were determined by measuring UV absorbance. 
cInitial rates of hydratase activity were measured in a coupled assay for NADH 
production using excess IPMDHMJ. 
 
 
2.3.4. Characterizing   isopropylmalate/-methylmalate   dehydrogenase. 
 
The IPMDHMJ  was previously expressed and partially purified from E. coli cell 
extracts [44].  However, only -isopropylmalate was tested as a substrate.  To further 
characterize the IPMDHMJ, MJ0720 was heterologously expressed with an amino- 
terminal polyhistidine tag. The protein was purified to homogeneity by heat treatment 
followed by nickel affinity chromatography.  The purified protein had a Stokes radius of 
51 Å, as measured by analytical size exclusion chromatography, which corresponds to a 
molecular mass of 183 kDa.  The denatured IPMDHMJ  had an apparent mass of 40 kDa 
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(expected 39.1 kDa) according to SDS-PAGE analysis. Therefore, the native protein is 
probably a homotetramer. A mixture of MJ0499/MJ1277 and IPMDHMJ eluted 
separately from the size exclusion column, indicating no complex formation between the 
isomerase and the dehydrogenase. 
The IPMDH kinetic parameters were measured in the previously described 
reaction conditions [44] (Figure 2.7 and Table 2.4) . Reactions were initiated upon 
addition of NAD+ and the reaction progress curve was monitored as a change in 
absorbance at 60C, corresponding to the production of NADH.  IPMDHMJ catalyzed the 
oxidative decarboxylation of -isopropylmalate and D-malate in the presence of NAD+ 
but not NADP+, as previously observed. No activity above background was observed 
with the following compounds: L-malate, L-tartrate, D-tartrate, DL-isocitrate, or DL- 
lactate. 
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Figure 2.7. Representative of the steady-state kinetics of MJ0720. Steady-state 
kinetic constants for MJ0720 were estimated by nonlinear regression of initial rate data 
fit to the Michaelis-Menten-Henri equation, as described in the text. 
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Table 2.4. Kinetic parameters for IPMDH homologs.   
    -Isopropylmalate   D-Malate   
 
kcat/Km  kcat/Km 
Enzyme (reference) Km (µM) (M
-1 s-1) Km (µM) (M
-1 s-1) 
IPMDHMJ
a
 
Sulfolobus sp. IPMDH (72) 
24 ± 3 
1.2 
8.8 X 104 
3.0 X 106 
410 ± 40 
390 
1.4 X 104 
1.0 X 104 
P. putida TDH (67) 14 1.1 X 104 60 2.2 X 105 
T. thermophilus IPMDH (73) 17 1.4 X 104 1,510 7.3 X 103 
a Data from this work.  Initial rates were determined by measuring an increase in 
absorbance at 340 nm due to NADH in reaction mixtures incubated at 60C. 
 
 
 
2.3.5. Coupled assay for -methylmalate oxidative decarboxylation 
 
The IPMDHMJ  required for methanogen leucine biosynthesis was proposed to also 
function  as  the  -methylmalate  dehydrogenase  in  pyruvate  pathway. However,  - 
methylmalate is not a commercially available substrate. Therefore, a coupled assay was 
established with MJ0499/MJ1277 and IPMDHMJ, producing the required -hydroxyacid 
from the MJ0499/MJ1277 catalyzed hydration of citraconate. To test the IPMDH 
catalyzed oxidative decarboxylation of -methylmalate, anaerobic reactions containing 
citraconate, NAD+, and IPMDH were equilibrated to 60C followed by the addition of 
 
reconstituted MJ0499/MJ1277. The rate of -methylmalate oxidative decarboxylation 
was measured as the oxidation of NAD+ at 60C. 
The MJ0499/MJ1277 coupled assay conditions were optimized from standard 
 
reactions of 2.5 g ml-1  MJ0499/MJ1277, 30 g ml-1  IPMDH , 1 mM NAD+, and 300 
MJ 
 
M citraconate (Figures 2.8 and 2.9). The requirement for the divalent metal cation Mg2+ 
was observed up to 10 mM MgCl2; only 5% of the maximal activity was observed in the 
absence of MgCl2.  Activity also increased with increasing concentrations of KCl, with a 
maximal activity at 300 mM.   Citraconate was efficiently converted to 2-oxobutyrate 
over a broad pH range, from pH 6.0 to 8.0, with maximal activity at pH 7.5.  The activity 
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of the two enzymes increased from 50C to a maximum at 70C.  However, 60C was 
used for kinetic assays for technical reasons. 
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Figure 2.8.  MJ0499-MJ1277 and IPMDHMJ Coupled Assay Optimization: MgCl2 and KCl. 
The coupled assay was optimized based on the specific activity of 2.5g ml-1   reconstituted 
MJ0499-MJ1277 with 30 g ml-1  IPMDH and 200 M citraconate. A, optimization of Mg2+ 
concentration. B, optimization of KCl concentration. 
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Figure 2.9.  MJ0499-MJ1277 and IPMDHMJ  Coupled Assay Optimization: buffer, pH, and 
temperature.   The coupled assay was optimized based on the specific activity of 2.5g ml-1 
reconstituted  MJ0499-MJ1277  with  30  g  ml-1    IPMDH and  200  M  citraconate.  A, 
optimization Buffer and pH. B, optimization reaction temperature. 
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The optimized coupled assay was used to estimate the apparent kinetic parameters 
for the hydration of unsaturated intermediates in the -hydroxyacid direction (Table 2.3 
and Figure 2.10). The rate of citraconate hydration to -methylmalate was measured 
with similar Michaelis constants and rates in the direct assay. The hydration of maleic 
acid to D-malate was also measured with a similar specificity constant compared to the 
hydration of maleic acid by MJ0499/MJ1277 alone. 
 
 
Figure 2.10.   Representative of the steady-state kinetics of MJ0499-MJ1277 and 
IPMDHMJ coupled assay. Steady-state kinetic constants for MJ0499-MJ1277 with 
IPMDHMJ were estimated by nonlinear regression of initial rate data fit to the Michaelis- 
Menten-Henri equation, as described in the text. 
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2.4.  DISCUSSION 
The MJ0499/MJ1277 pair of proteins functions as the isopropylmalate/citramalate 
isomerase in methanogen leucine and isoleucine biosynthesis. The thermostable enzyme 
exhibits optimal activity at higher temperatures over a broad pH range. No activity above 
background was observed for the aerobically purified IPMI. Activity was measured after 
incubating the apoprotein with iron and sulfide under anoxic conditions, consistent with 
[Fe-S] cluster containing proteins. IPMIMJ catalyzes similar chemistry to mACN and 
sequence alignments indicate similar structural organization between the two enzymes. 
The large subunit, MJ0499, is homologous to domains 1, 2, and 3 of mACN containing 
most of the active site residues, including the three cysteine residues required for binding 
the [4Fe-4S] cluster [74].  The small subunit, MJ1277, is homologous to domain 4 of 
mACN. Gel filtration analysis of the interacting pair suggests a heterotetramer of two 
large and two small subunits. The S. cerevisiae IPMI is a monomer while the 
Neurospora sp. IPMI functions as a trimer or tetramer. The two P. pseudoalcaligenes 
malease subunits interact as a dimer [75]. Further studies of the IPMIMJ will be required 
to determine the actual shape and subunit interaction of the apoprotein as well as the 
holoenzyme. 
MJ0499/MJ1277 catalyzes the dehydration of (R)-citramalate and - 
isopropylmalate with similar specificity constants, as measured in  direct  assays.  The 
specific activity of -isopropylmalate dehydration (4.2 U mg-1) is similar to the reported 
S.  cerevisiae  IPMI  activity  (6  U  mg-1)  [59]. However,  the  k  /K values  are 
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approximately two orders of magnitude lower than the hydration of citraconate and 
maleic acid. The hydrolysis of these cis-unsaturated intermediates is favorable, as 
observed from equilibrium studies. The calculated G’for the hydration of maleic acid 
by IPMIMJ was -14 kJ mol (at 60C), which is consistent with the P. pseudoalcaligenes 
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malease (-19 kJ mol-1 at 23C) [76]. The direct assay for citraconate hydration measures 
formation of (R)-citramalate and -methylmalate. A coupled assay with IPMIMJ and 
IPMDHMJ was developed to measure only hydration of citraconate to -methylmalate, 
allowing for the comparison of kinetic parameters with the direct assay.  The Michaelis 
constant and turnover were similar between the  two assays with citraconate  as the 
substrate, suggesting that -methylmalate is the dominant product in the direct assay. 
Maleate hydratases [EC 4.2.1.31] catalyze the stereospecific trans-addition of 
water to maleic acid, producing D-malate [70]. These enzymes have been isolated as 
either a monomer or a dimer consisting of a large and small subunit [75]. The hydratase 
activity of most maleases requires the addition of iron and sulfide under reducing 
conditions, consistent with enzymes that require an iron-sulfur cluster for catalysis, such 
as mACN or IPMI. However, the isolated P. pseudoalcaligenes maleate hydratase was 
colorless and resistant to oxidation and metal chelators [75]. Also, the presence of iron 
inhibited the activity of the enzyme. Therefore, the P. pseudoalcaligenes malease may 
not require an iron-sulfur cluster for activity. In addition to functioning as the 
citramalate/isopropylmalate isomerase, the IPMIMJ also catalyzed the hydration of maleic 
acid to D-malate.   The Km  value for maleic acid hydration was similar to previously 
reported value for the P. pseudoalcaligenes maleate hydratase (400 and 350 M, 
respectively). The P. pseudoalcaligenes enzyme also catalyzed the hydration of 
citraconate, though with a Km approximately twice that of IPMIMJ (200 M and 80 M, 
respectively) [75]. 
The IPMIMJ is involved in both the isomerization of -isopropylmalate as well as 
(R)-citramalate for the production of leucine and isoleucine, respectively. IPMDHMJ also 
functions in leucine and isoleucine biosynthesis, catalyzing the oxidative decarboxylation 
of -isopropylmalate with similar specificity constants to the T. thermophilus IPMDH 
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and P. putida TDH [67,73]. The Sulfolobus sp IPMDH had a 20-fold lower Km for - 
isopropylmalate  and  a  specificity  constant  two  orders  of  magnitude  greater  than 
IPMDHMJ [72]. However, the Km and specificity constants for D-malate were almost 
identical for IPMDHMJ and IPMDH from Sulfolobus sp. The T. thermophilus IPMDH 
was less proficient with D-malate as a substrate, having a Km four times greater than M. 
jannaschii and Sulfolobus sp. The M. jannaschii IPMDH was also observed to 
oxidatively decarboxylate -methylmalate to produce 2-oxobutyrate, as observed in the 
coupled assay with IPMIMJ and citraconate as the substrate. Thus, IPMIMJ and IPMDHMJ 
are broad specificity enzymes, recognizing substrates with small hydrophobic -chains. 
The involvement of these two enzymes in leucine and isoleucine biosynthesis is 
consistent with yeast strains with mutations in threonine dehydratase and Serratia 
marcescens isoleucine auxotrophs, both of which produced isoleucine via the pyruvate 
pathway [77]. Therefore, the IPMS and CMS are the only enzymes specific for their 
respective pathways. 
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Chapter 3: Enzymology of the M. jannaschii Homoaconitase Involved 
in Coenzyme B Biosynthesis 
 
 
 
 
 
3.1. INTRODUCTION 
 
Two pathways for lysine biosynthesis have evolved: the diaminopimelate 
pathway of lower fungi, plants, most bacteria and some archaea, and the -aminoadipate 
pathway in higher fungi, euglenoids, some bacteria and archaea. No organism has been 
identified utilizing both pathways. Despite possessing homologs of the first three 
enzymes in the -aminoadiate pathway, methanogens generate lysine via the 
diaminopimelate intermediate [78].  Methanogen homocitrate synthase (HCS), 
homoaconitase (HACN), homoisocitrate dehydrogenase (HICDH) are instead proposed 
for the synthesis of 2-oxosuberate required for the heptanoyl group of CoB [11,39]. The 
gene products of Methanocaldococcus jannaschii MJ0503 and MJ1596 were previously 
identified as the HCS and HICDH, respectively [11]. 
HCSMJ belongs to the acetyltransferase family of proteins that includes 
isopropylmalate synthase (IPMS), citrate synthase (CS), citramalate synthase (CMS), 
malate synthase (MS), and HCS from the -aminoadipate pathway. These enzymes 
catalyze the condensation of acetyl-CoA with their respective 2-oxoacid substrates to 
produce an -hydroxyacid. Members of the acyltransferase family have only been 
observed to catalyze the formation of one product, although their respective products 
differ in stereochemistry [57,58,80,81]. 
HCSMJ is a homolog of the -aminoadipate HCS, sharing more than 30% identity 
and 50% similarity to the Saccharomyces cerevisiae and Thermus thermophilus HCS. 
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Only (R)-homocitrate was produced from the S. cerevisiae HCS [80]. However, a study 
using Methanosarcina thermophila cell extracts identified trans-homoaconitate and (S)- 
homocitrate as the products of the HCSMJ   catalyzed reaction of 2-oxoglutarate with 
acetyl-CoA (Figure 3.1) [39].  The MJ0503 gene has since been annotated as a trans- 
homoaconitate synthase. In subsequent reactions, HCSMJ  only catalyzed the production 
of (R)-homo2citrate and (R)-homo3citrate and no other trans isomers were identified 
(Figure 3.1) [39]. (R)-Homocitrate is also a component of the iron-molybdenum cofactor 
of nitrogenase in some bacteria and methanogens, further implying that (S)-homocitrate is 
not the correct enantiomer of the first HCSMJ product [81]. Previous attempts to 
heterologously express HCSMJ from E. coli resulted in mostly insoluble protein (Drevland 
and Graham, unpublished results). Therefore, the intermediates from the first committed 
step of CoB biosynthesis are currently unknown. 
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Figure 3.1.  Initially proposed 2-oxoacid chain elongation pathway for coenzyme B 
biosynthesis. 
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HICDH is a member of the NAD(P)-dependent -hydroxyacid oxidative 
decarboxylase family, including isocitrate deyhydrogenase (ICDH), isopropylmalate 
dehydrogenase (IPMDH), tartrate dehydrogenase (TDH), and 6-phosphogluconate 
dehydrogenase (6-PGDH) [EC1.1.1.43]. HICDH catalyzes the oxidation and 
decarboxylation of (2R, 3S)-homoisocitrate, forming 2-oxoadipate in a random steady 
state kinetic mechanism that is consistent among members of this family [82]. The M. 
jannashii  HICDH  was  previously  reported  to  oxidatively  decarboxylate  (2R,3S)- 
homoisocitrate, (2R,3S)-homo2isocitrate, and (2R,3S)-homo3isocitreate with similar Km 
and turnover numbers, although isocitrate was not a substrate [44]. Though broad 
substrate specificity of HICDHMJ is required for the CoB chain elongation pathway, such 
specificity is not unique to methanogens.   S. cerevisiae and Deinococcus radiodurans 
HICDHs recognized a number of substrate analogs, including homo2isocitrate and 
homo3isocitrate, although with Michaelis constants approximately ten-fold higher than 
HICDHMJ [83]. 
HACNs are members of the aconitase family of hydrolyases possessing an 
oxygen sensitive iron-sulfur cluster required for catalysis [69]. Homoaconitase activity 
was initially observed during early studies of yeast lysine biosynthesis [84,85]. 
Homocitrate and cis-homoaconitate were identified from S. cerevisiae lysine auxotrophs 
grown in the presence of labeled 14C-acetyl-CoA or 14C-glucose [85,86]. The enzymatic 
oxidative decarboxylation of homoisocitrate to 2-oxoadipate was also observed from S. 
cerevisiae cell extracts [87,88]. The similarity of these intermediates and enzymatic 
activities to reactions of the TCA cycle suggested an aconitase-type enzyme was 
responsible for the isomerization of homocitrate to homoisocitrate. Indeed, the hydration 
of cis-homoaconitate to isohomocitrate was observed from S. cerevisiae cell extracts as 
well as the enzymatic dehydration of isohomocitrate to the unsaturated intermediate. The 
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hydration of cis-homoaconitate was separated from the activity of aconitase, indicating 
the presence of a separate enzyme, homoaconitase [84]. 
After the initial identification of HACN from S. cerevisiae, homologs were 
identified from Aspergillus sp., Pyrococcus horikoshii, and T. thermophilus [89,90,91]. 
HACNs are either monomeric (fungal) or heterodimeric (bacteria and archaea) proteins 
with a molecular mass of approximately 60-80 kDa. Despite the homology to ACN and 
IPMI, genetic and biochemical studies of the S. cerevisiae and A. nidulans HACNs (Lys4 
and LysF, respectively) have only identified the hydration of cis-homoaconitate to 
homoisocitrate (or the reverse dehydration reaction) from cell extracts; the initial 
dehydration of homocitrate has gone undetected [92]. The lack of homocitrate 
dehydratase activity was also confirmed from the purified T. thermophilus HACN [93]. 
Only homoisocitrate was observed as a product from the incubation of cis-homoaconitate 
with the thermophilic HACN and no activity was observed in a coupled assay with the T. 
thermophilus HICDH in the presence of (R)- or (S)-homocitrate. An aconitase was 
proposed to catalyze the initial dehydration reaction (Figure 3.2) [93]. 
The requirement of two aconitase-like enzymes for an isomerization reaction is 
not unprecedented. 2-Methylcitrate dehydratase [EC 4.2.1.79] only catalyzes the initial 
dehydration of (2S,3S)-methylcitrate to 2-methyl-cis-aconitate in fungal and bacterial 
proprionate metabolism (Figure 3.2) [94]. Aconitase was proposed to complete the 
isomerization, catalyzing the hydration of 2-methyl-cis-aconitate to (2R,3S)- 
methylisocitrate. However, unlike the isomerization of (R)-homocitrate to (2R,3S)- 
homoisocitrate, the isomerization of (2S,3S)-2-methylcitrate results in reverse 
stereochemistry. 
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Figure 3.2.   Reactions involved in lysine biosynthesis and propionate metabolism. 
(A) An aconitase is proposed to catalyzed the dehydration of (R)-homocitrate to cis- 
homoaconitate. The -aminoadipate HACN (HACNAAA) catalyzes the second reaction, 
the hydration of cis-homoaconitate to (2R,3S)-homoisocitrate. (B) The S. enterica PrpD 
catalyzes the initial dehydration of (2S,3S)-methylcitrate for propionate metabolism.  The 
S. enterica AcnA or AcnB enzyme catalyzes the hydration of 2-methyl-cis-aconitate to 
form (2R,3S)-methylisocitrate. 
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Although the HACNMJ was previously unidentified, it was predicted to differ 
from the -aminoadipate HACN because methanogens do not possess an aconitase. 
Therefore, one enzyme was proposed for the full isomerization of homocitrate, 
homo2citrate, and homo3citrate. 
Methanogen genomes contain two copies of genes annotated as encoding large 
and small subunits of [4Fe-4S] dependent isopropylmalate isomerases (IPMIs). The 
large subunits (MJ0499 and MJ1003), homologous to domains 1, 2, and 3 of 
mitochondrial aconitase (mACN), and small subunits (MJ1271 and MJ1277), 
homologous to mACN domain 4, were predicted to interact to form the functional IPMI 
and HACN. To identify and characterize the genes encoding methanogen HACN, the 
four combinations of large and small subunits were heterologously expressed in E. coli. 
The MJ0499/MJ1277 pair of proteins was identified as the IPMI required for leucine and 
isoleucine biosynthesis (Chapter 2) [48]. 
In this study, the MJ1003/MJ1271 pair of proteins was identified as the HACN 
involved in CoB biosynthesis [49]. Direct assays showed that this reconstituted Fe4-S4 
enzyme catalyzed the hydration of cis-aconitate, cis-homoaconitate, cis-homo2aconitate, 
cis-homo3aconitate, and cis-homo4aconitate.  The enzyme was also able to cataylze the 
production of D-malate from the minimal substrate maleic acid. In a coupled reaction 
with HICDHMJ, the homoaconitate analogs were converted to their corresponding 2- 
oxoacids, demonstrating that the homoisocitrate products are substrates for HICDHMJ. In 
contrast to previously studied HACN proteins, the methanogen enzyme catalyzed both 
dehydration of (R)-homocitrate to form cis-homoaconitate and the subsequent hydration 
reaction that forms homoisocitrate. Although (S)-homocitrate and trans-homoaconitate 
were initially identified as intermediates in the production of 2-oxoadipate, these 
compounds served as inhibitors of HACNMJ.   Therefore, methanogen HACN cannot 
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catalyze all of the predicted dehydratase reactions in the originally proposed pathway for 
CoB biosynthesis. 
 
 
3.2. MATERIALS AND METHODS 
 
3.2.1. Chemicals and Reagents 
 
(R)-Homocitrate (S)-homocitrate, and (2R,3S)-Homoisocitrate were synthesized 
by Yunhua Jia and Dr. David Palmer (University of Saskatchewan). cis-Homoaconitate, 
and the cis-homoaconitate analogs were chemically synthesized by Dr. David Graham. 
 
 
3.2.2. Protein Expression and Purification 
 
The MJ1003 and MJ1271 proteins were coexpressed in an E. coli BL21(DE3) 
(pDG141 pDG163) strain described previously (Chapter 2). The cells were grown at 
37C with shaking at 250 rpm until the culture reached an optical density at 600 nm of 
0.6-0.8. Expression was then induced by the addition of 50 M isopropyl-1-thio--D- 
galactopyranoside, and the culture was transferred to a 16C water bath and shaken 
continuously for 15-20 h. The MJ1003 and MJ1271 proteins were purified by heat 
treatment of the cell lysate, followed by anion exchange chromatography, dialysis, and 
concentration. The protein was further concentrated using a stirred ultrafiltration cell 
(Amicon) under N2  with a 10-kDa molecular mass cut-off filter (Pall).   The untagged 
MJ1596  HICDH  protein  was  expressed  in  an  E.  coli  Arctic  Express  (DE3)-RIL 
(pDG131) strain. The cells were grown in medium containing streptomycin (50 g ml-1), 
tetracycline (50 g ml-1), and getamycin (50 g ml-1) at 16C with shaking at 250 rpm. 
HICDH protein expression, extraction, purification, and concentration were performed as 
described for the MJ1003/MJ1271 proteins. 
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3.2.3. Recontitution of the Iron-Sulfur Center 
 
In  a  typical  reconstitution  reaction,  copurified MJ1003  and  MJ1271  proteins 
 
(1 mg ml-1 apoenzyme) were mixed with Fe(NH ) (SO ) and sodium sulfide as described 
4  2 4  2 
 
previously (Chapter 2) [48]. The reconstitution mixture was stirred under argon at 0-4C 
until maximum activity was observed (typically 3-4 h). Hydrolyase activity was 
monitored in a standard assay with 0.2 mM cis-homoaconitate as described below. A 
mock reconstitution control consisted of the above mixture without protein. 
 
 
3.2.4. Determination of Iron-Sulfur Content 
The holoenzyme was reconstituted using concentrated MJ1003/MJ1271 
apoprotein (2.5 mg ml-1), and desalted using a PD-10 column (GE Healthcare) 
equilibrated with an anoxic solution of 50 mM Tris-HCl (pH 8.0). Desalting was 
performed at room temperature in an anaerobic chamber (Coy Laboratory Products) with 
an atmosphere of N2:CO2:H2 (75:20:5 by volume). Fractions containing the desalted 
protein were combined, and aliquots were removed for iron and sulfide analysis. Total 
iron analysis was performed using the colorimetric bathophenanthrolinedisulfonate assay 
with a standard curve prepared from ferric choride [95]. The labile sulfide concentration 
was determined using the methylene blue assay with the standard addition of sodium 
sulfide [96]. The total protein concentration was determined by the Bradford dye binding 
method (Thermo-Pierce) using bovine serum albumin as a standard. The standard errors 
calculated for each assay were propagated to estimate the error associated with each 
analysis. 
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3.2.5. Measurement of Hydrolyase Activities 
 
Reactions (1 ml) were conducted in quartz semimicrocells with screw cap septa 
(Starna) containing 50 mM CHES-KOH (pH 9.0), 200 mM KCl, 20 g ml-1 holoenzyme, 
and various substrate concentrations. The sealed quartz cell containing buffer and 
substrate was degassed under argon for 10 min and equilibrated at 60C for 10 min. The 
reactions were initiated by the addition of holoenzyme, and the decrease in UV 
absorbance was monitored at 60C.  Initial rates were measured from the linear portion of 
the reaction progress curve at 235 nm for cis-homoaconitate ( = 4580 M-1 cm-1 ), 235 
 
nm for cis-homo aconitate ( = 4420 M-1 cm-1 ), 240 nm for cis-homo3aconitate (240 = 
3180 M-1  cm-1), and 240 nm and 250 nm for cis-homo aconitate (
 
 
240 = 3140 M
-1  cm-1, 
 
 
250 
 
= 1370 M-1 cm-1). All of the molar absorption coefficients were determined in the 
reaction buffer at 60C.  One unit of hydrolyase activity catalyzed the conversion of 1 
mol of substrate to product per min. Steady-state kinetic constants were estimated by 
nonlinear regression of initial rate data fit to the Michaelis-Menten-Henri equation [48]. 
The inhibitors were screened in direct assays containing buffer, 20 g ml-1 HACN, and 
various concentrations of substrate analogs; these reactions were initiated by the 
anaerobic addition of 100 M cis-homoaconitate, and hydrolyase activity was monitored 
at 240 nm. The stereochemistry of maleate hydration products was determined 
enzymatically using tartrate dehydrogenase and L-malate dehydrogenase enzymes as 
described previously (Chapter 2) [48]. 
 
 
3.2.6. Coupled Assay of Hydratase Activity 
The hydration of unsaturated intermediates in the forward direction was measured 
by a coupled reaction with HICDH by monitoring the reduction of NAD+ to NADH at 
340 nm [93].  Reaction mixtures containing 50 mM TAPS-KOH (pH 8.5), 50 mM KCl, 5 
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mM  MgCl ,  20  mM  -mercaptoethanol,  1  mM  NAD+,  and  30  g  ml-1 HICDH were 
 
degassed as described above, after which MJ1003/MJ1271 holoenzyme was added to a 
final concentration of 10 g ml-1. The reaction mixtures were equilibrated to 60C, and 
the reactions were initiated with 5 l of substrate. The initial rates were measured using 
the linear portion of the reaction progress curve. One unit of enzymatic activity catalyzed 
the reduction of 1 mol NAD+ min-1. The apparent kinetic constants were estimated as 
described above. 
 
 
3.2.7. HPLC Analysis of Reaction Products 
 
Standard reactions containing 10 mM cis-homoaconitate analogs and HACN 
holoenzyme (40 g ml-1) were incubated for 20 h at 60C. A portion of the reaction 
product was analyzed by reversed phase  HPLC using a Synergi Hydro-RP column 
(Phenomenex; 250 by 4.6 mm) with a guard column (4 by 3 mm). Chromatography was 
performed at 35C with an isocratic elution with 20 mM potassium phosphate (pH 2.5) 
and 5% (v/v) acetonitrile in water at a flow rate of 1 ml min-1. Retention factors for 
standard compounds (t0 = 2.5 min) were 0.4 (homoisocitrate), 1.0 (homocitrate), 1.1 (cis- 
homoaconitate), and 2.2 (cis-homo2aconitate).  Reaction products from incubations with 
cis-homo3aconitate and cis-homo4aconitate were analyzed using mobile phase containing 
buffer and 15% (v/v) acetonitrile in water. The retention factors were 1.5 (cis- 
homo3aconitate) and 3.5 (cis-homo4aconitate). A photodiode array detector was used to 
identify analytes; cis-homoaconitate analogs had absorption maxima near 215 nm, 
whereas hydroxyacid products absorbed maximally near 205 nm. 
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3.2.8. LC-MS Analysis of Enzyme Reaction Products 
 
Standard reactions (1 ml) containing 250 M homoaconitate (or analog), and 
MJ1003/MJ1271 holoenzyme were incubated at 60C for 20 h under argon. The reaction 
mixture was adjusted to pH 1 with HCl and extracted twice with ethyl acetate and once 
with diethyl ether. The combined organic phases were dried under N2 at 60C. The 
residue was dissolved in water and analyzed by LC-MS using a Thermo LTQ-XL 
instrument. The sample was applied to a reversed phase column (Macro Bullet 3 M 200 
Å Magic C18AQ; Michrom Bioresources; 25 x 4 to 1 mm tapered) and eluted with a 
gradient from 5 to 95% acetonitrile with 0.1 % formic acid in water at a flow rate of 0.5 
ml min-1. Electrospray ionization mass spectrometry was performed in the negative ion 
mode. 
For the analysis of coupled reaction products, 1 mM NAD+ and HICDH were 
added to the reaction mixture. To form the methoxime derivatives of 2-oxoacid products, 
the pH was adjusted to 13-14 with sodium hydroxide and 0.25 ml of 10% O- 
methylhydroxylamine hydrochloride was added. The mixtures were incubated at room 
temperature for 1 h and then adjusted to pH 1 with HCl and saturated with NaCl. The 
acidic solution was extracted as described above. The concentrated sample was applied 
to a reversed phase column (Hypersil Gold; Thermo; 50 x 2.1 mm) and eluted with a 
gradient from 95-20% acetonitrile in aqueous 0.1% formic acid at a flow rate of 0.5 ml 
min-1. Electrospray ionization mass spectrometry was performed in the positive ion 
mode. 
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3.3. RESULTS 
 
3.3.1. Protein Purification and Subunit Interaction 
Previously, the MJ0499/MJ1277 interacting pair of proteins was identified as the 
IPMI involved in methanogen leucine and isoleucine biosynthesis [48]. To identify the 
HACNMJ, the MJ1003 and MJ1271 pair of proteins was coexpressed in E. coli and the 
soluble proteins were copurified to approximately 90% homogeneity by heat treatment 
and anion-exchange chromatography, as analyzed by SDS-PAGE and densitometry 
(Figure 3.3). The apparent mass of MJ1003 was 46-kDa, matching the theoretical mass 
of 46.1-kDa. Likewise, the apparent mass of MJ1271 correlated well with its theoretical 
mass (18-kDa and 18.6-kDa, respectively). The large and small subunits coeluted during 
analytical size exclusion chromatography with a Stokes radius of 42 Å, corresponding to 
a 143-kDa protein (Figure 3.4). Therefore, the MJ1003/MJ1271 pair probably associates 
as a heterotetramer of two large and two small subunits, consistent with the association of 
MJ0499 and MJ1277. 
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Figure 3.3. Purified HACNMJ. Lane 1, 10 g MJ1003-MJ1271; lane M, protein size 
markers (Biorad). Proteins were separated by SDS-PAGE on a 15% acrylamide gel and 
stained with Coomassie blue. 
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Figure 3.4. MJ1003-MJ1271 Subunit Interaction. Proteins were separated by 
analytical size exlusion chromatographyn HPLC with UV absorbance detection at 220nm 
in milli-absorbance units (mAU). Standard curves based on elution volume with respect 
to (A) molecular mass and (B) Stokes radius of the following standards: cytochrome c, 
myoglobin, carbonic anhydrase, conalbumin, alcohol dehydrogenase, aldolase, and - 
amylase. (C) Chromatogram of 1 g ml-1 purified MJ1003-MJ1271.  The peak at 16.450 
min corresponds to MJ1003-MJ1271, confirmed by SDS-PAGE. 
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3.3.2. Hydrolyase Activity of the MJ1003/MJ1271 Proteins 
 
HACN and IPMI belong to the aconitase family of proteins. These hydrolyases 
possess an oxygen sensitive [4Fe-4S] cluster responsible for coordinating the Cor C 
substrate hydroxyl and carboxyl groups [69]. Exposure to air or other oxidants, such as 
superoxide and hydrogen peroxide, results in a loss of the non-cysteine bound Fe and 
ultimately degradation of the cluster [97]. Therefore, the MJ1003/MJ1271 apoprotein 
was chemically reconstituted to the holoenzyme after incubation with iron (II) and sulfide 
under anaerobic conditions. The reconstituted protein contained 5.1 ± 0.2 moles of iron 
and 5.1 ± 0.8 moles of  sulfide per mole of  MJ1003/MJ1271  dimer after anaerobic 
desalting to remove excess buffer salts. Therefore, the holoenzyme appears to possess a 
single Fe4-S4 cluster per dimer, consistent with other members of the aconitase family. 
Although  no  activity  was  observed  above  background  (0.029  s-1)  with  citraconate, 
citramalate, or 3-isopropylmalate, the reconstituted MJ1003/MJ1271 catalyzed the 
hydration of the chemically synthesized cis-homoaconitate. 
The activity of MJ1003/MJ1271 was measured in a direct assay consisting of the 
holoenzyme, substrate, and buffer salts. Assay conditions were optimized based on the 
MJ1003/MJ1271 catalyzed hydration of cis-homoaconitate (Figure 3.5). The holoenzyme 
was active between pH 8.0 and 10, with maximal activity in CHES-KOH at pH 9.0. 
Although the enzyme was active in the absence of any salt, the highest activity was 
observed in the presence of 200 mM KCl (60% increase in activity compared to 0 mM 
KCl). The presence of divalent metal cations had no effect on activity. Consistent with 
the thermal stability results of MJ0499/MJ1277, the activity of MJ1003/MJ1271 was 
maximal at 60°C. The interacting MJ1003/MJ1277 pair of proteins displayed no activity 
with cis-homoaconitate. 
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Figure 3.5. MJ1003-MJ1271 Direct Assay Optimization. The direct assay was 
optimized based on the specific activity of 20 g ml-1 reconstituted MJ1003-MJ1271 with 
200 M cis-homoaconitate at 60C. Each optimization was conducted in duplicate and 
the results are the average of two data sets. A, optimization of KCl concentration. B, 
optimization of buffer and pH. 
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Methanogen HCS and HICDH are required for the synthesis of 2-oxosuberate 
from 2-oxoglutarate [39]. Therefore, HACNMJ was predicted to exhibit similar broad 
substrate  specificity,  catalyzing  the  isomerization  of  homocitrate,  homo2citrate,  and 
homo3citrate.  To test the predicted substrate specificity of HACNMJ, the hydration of cis- 
homoaconitate, cis-homo2aconitate, and cis-homo3aconitate by MJ1003/MJ1271 was 
measured in the direct assay described above and the steady state kinetics for each 
reaction was determined (Figure 3.6). MJ1003/MJ1271 catalyzed the hydration of the 
three cis-unsaturated intermediates with similar Km and kcat values, indicating that the 
enzyme does not discriminate between the three intermediates (Table 3.1). The broad 
substrate specificity of HACNMJ was further tested in direct assays with maleic acid, cis- 
aconitate, and non-physiological cis-homo4aconitate. (Table 3.1). MJ1003/MJ1271 
catalyzed  the  hydration  of  the  minimal  substrate  maleic  acid  with  a  similar  Km   to 
MJ0499/MJ1277  (400  M)  but  a  seven-fold  lower  k (5.5  s-1 and  34  s-1 for 
 
MJ1003/MJ1271 and MJ0499/MJ1277, respectively). cis-Aconitate, a substrate for ACN 
that has a carbon backbone one methylene shorter than cis-homoaconitate, also served as 
a substrate with a similar Km to the hydration of maleic acid and a kcat on the order of cis- 
homoaconitate.    The  substrate  specificity  of  MJ1003/MJ1271  was  extended  to  cis- 
homo4aconitate, a cis-unsaturated intermediate that has not previously been isolated as a 
natural product. Although MJ1003/MJ1271 catalyzed the hydration of this compound 
with a six-fold greater Km than cis-homo3aconitate, the turnover also increased by 
approximately 2.5. 
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Figure 3.6. Steady – state kinetics of MJ1003-MJ1271. Steady – state kinetic 
constants for MJ1003-MJ1271 were estimated by nonlinear regression of initial rate data 
fit to the Michaelis-Menten-Henri equation, as described in the text. Closed diamonds, 
kinetics for cis-homoaconitate. Closed squares, kinetics for cis-homo2aconitate. Closed 
circles, kinetics for cis-homo3aconitate. 
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Table 3.1. Steady-state kinetic parameters for the direct assay of hydrolyase 
activity. Reactions containing substrate and buffer salts were preincubated at 60C 
before the addition of reconstituted MJ1003/MJ1271 protein to initiate the reaction. 
Hydrolase activity was determined by measuring the rate of decrease in UV absorbance 
caused by the unsaturated substrate, as described under “Experimental Procedures.” 
 
 
aDehydratase activity was determined by measuring the rate of increase in UV 
absorbance caused by homoaconitate formation. 
 
 
 
The reaction products of MJ1003/MJ1271 direct assay were analyzed by reversed 
phase HPLC (Figure 3.7). Incubation of the holoenzyme with cis-homoaconitate 
produced a single product peak corresponding to homocitrate and no homoisocitrate was 
observed. The reaction product was also analyzed by LC-MS and peaks were identified 
at 187 m/z, corresponding to the [M-H]- ion of homoaconitate, and 205 m/z, 
corresponding to the [M-H]- ion of homocitrate or homoisocitrate. No activity was 
observed in the direct assay or product analysis for cis-homoaconitate incubated with 
either the apoenzyme or a mock reconstitution, indicating that the iron-sulfur cluster is 
essential for activity. 
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Figure 3.7.  HACN catalyzed the hydration of cis-unsaturated tricarboxylic acids to 
produce hydroxyacids. Holoenzyme was incubated with cis-homoaconitate analogs for 
20 h at 60C. The reaction products were separated by reversed phase HPLC with UV 
absorbance detection in mAU as described in the text. Substrate peaks (S)  were 
identified by their retention times compared with external standards. Product peaks (P) 
had absorbance maxima near 205 nm, and they were not observed in control reactions. 
The unlabeled peaks were also observed in control reactons without enzyme, so they are 
considered to be contaminants. A, incubation with cis-homoaconitate (S) produced 
homocitrate (P) that was confirmed by coinjection with (R)-homocitrate. No 
homoisocitrate was detected in this experiment. B, incubation with cis-homo2aconitate 
produced two product peaks. C, incubation with cis-homo3aconitate produced a single 
product peak. D, incubation with cis-homo4aconitate produced two product peaks. The 
homoaconitate analogs have significantly higher molar absorptivities than their 
corresponding hydroxy-acids, which preclude direct comparisons of their concentrations 
by peak area integration. 
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The reaction products of the MJ1003/MJ1271 catalyzed hydration of maleic acid 
was analyzed as previously described (Chapter 2). Incubation of HACNMJ with 5 mM 
maleic acid produced 5 mM D-malate and no L-malate was measured above background 
(<10 M). MJ0499-MJ1277 also catalyzed the production of D-malate from maleic acid, 
indicating similar binding modes at the active site for the two enzymes that are consistent 
with the stereochemistry of their physiological reactions [48]. 
 
 
 
3.3.3. Coupled Activity of HACN with HICDH 
The methanogen HICDH was previously purified and the steady state kinetic 
parameters were established for the oxidative decarboxylaton of homoisocitrate, 
homo2isocitrate, and homo3isocitrate [44]. To measure only the forward hydration of the 
cis-unsaturated intermediates of the chain elongation reactions, a coupled assay was 
established with HACNMJ   in the presence excess HICDHMJ   and NAD .   The rate of 
hydration was measured as the rate of NAD+ reduction to NADH in the determined 
optimal assay conditions: 5 mM MgCl2, 100 mM KCl, and 2-mercaptoethanol, at 60C 
in TAPS-KOH (pH 8.5) (Figure 3.8). Compared to direct assay results, similar Michaelis 
constants were observed for the forward hydration of cis-homoaconitate, cis- 
homo2aconitate, and cis-homo3aconitate, although an increase in turnover was observed 
for each substrate due to product removal by HICDHMJ (Figure 3.9 and Table 3.2).  The 
products of these coupled reactions were identified as their methoxime derivative by LC- 
MS based on chemically synthesized standards (Figure 3.10). 2-Oxoadipate, 2- 
oxopimelate, and 2-oxosuberate were detected from homoaconitate, homo2aconitate, and 
homo3aconitate, respectively. HICDHMJ was also demonstrated to oxidatively 
decarboxylate homo4isocitrate to 2-oxoazelate via cis-homo4aconitate in a coupled assay. 
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Therefore, methanogen HACN and HICDH share similar broad substrate specificities by 
recognizing tricarboxylates with -chains extending up to five methylenes long. 
 
 
 
 
 
 
 
Figure 3.8. MJ1003-MJ1271 and HICDHMJ   Coupled Assay Optimization. The 
coupled assay was optimized based on the specific activity of 20 g ml-1  reconstituted 
MJ1003-MJ1271 with 30 g ml-1  HICDH and 200 M cis-homoaconitate at 60C. A, 
optimization  of  Mg2+    concentration. B,  optimization  of  KCl  concentration. C, 
Optimization of buffer and pH. 
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Figure 3.9. Steady – state kinetics of the MJ1003-MJ1271 and HICDHMJ coupled 
assay. Steady – state kinetic constants for the direct assay were estimated by nonlinear 
regression of initial rate data fit to the Michaelis-Menten-Henri equation, as described in 
the text. Closed diamonds, kinetics for cis-homoaconitate. Closed squares, kinetics for 
cis-homo2aconitate. Closed circles, kinetics for cis-homo3aconitate. 
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Table 3.2. Kinetic parameters for the coupled assay of HACN hydrolyase activity 
with HICDH.  Reactions containing 10 g ml-1 HICDH, 30 g ml-1 HACN holoenzyme, 
1 mM NAD+, and buffer salts were preincubated at 60C before the addition of substrate 
to initiate the reaction. Hydrolase activity was determined by measuring the rate of 
increase in UV absorbance at 340 nm caused by the reduction of NAD+, as described 
under “Experimental procedures.” 
 
 
aND, not determined. 
bSpecific activity determined with 0.78 mM cis-homo aconitate. 
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Figure 3.10. HACN and HICDH hydrated cis-homoaconitate analogs and catalyzed 
their oxidative decarboxylation to produce the corresponding 2-oxoacids. 
Methoxime derivatives extracted from the reaction products were analyzed by LC-MS. 
A-D show mass chromatograms for the  MH+ ions of the methoxime-derivatized 2- 
oxoacids depicted in the inset. Similar plots were obtained for the sodium adducts of 
each acid. A, reactions with cis-homoaconitate produced 2-oxoadipate indicated by the 
m/z 190 peak. B, reactions containing cis-homo2aconitate produced 2-oxopimelate 
identified by the m/z 204 peak. C, reactions containing cis-homo3aconitate produced 2- 
oxosuberate identified by the m/z 218 peak. D, reactions containing cis-homo4aconitate 
produced 2-oxoazelate identified by the m/z 232 peak. This derivative formed several 
noncovalent complexes producing multiple peaks. E contains a chromatogram of 2- 
methoxime dicarboxylic acid standards showing the reconstructed total ion current. The 
standards included 2-oxoadipic acid (2OA), 2-oxopimelic acid (2OP), and 2-oxosuberic 
acid (2OS). 
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3.3.4. Dehydration Reaction and Stereospecificity of HACN 
 
Product analysis from the direct and coupled assays indicates that HACNMJ is 
capable of catalyzing the full isomerization of homocitrate. However, the 
stereochemistry of this substrate was not determined from those experiments. Previously, 
(S)-homocitrate was observed from the reaction of HCSMJ with 2-oxoglutarate [39]. 
However, HCSMJ was also observed to produce (R)-homo2citrate and (R)-homo3citrate. 
(R)-Homocitrate and (S)-homocitrate were tested in the coupled assay with 
MJ1003/MJ1271 and HICDHMJ to identify the correct homocitrate enantiomer required 
by HACNMJ (Figure 3.11). No activity was observed in the presence of 1 mM (S)- 
homocitrate. However, 1 mM (R)-homocitrate was effectively isomerized and 
oxidatively decarboxylated to 2-oxoadipate with a specific activity of 0.3 U mg-1 (0.3 s-1). 
The dehydration of (R)-homocitrate to cis-homoaconitate was measured in a direct assay 
with HACN  .  A K  of 1500 M and a rate of 0.37 s-1 was observed for the dehydration 
 
reaction (Table 3.1), which is consistent with the kinetics of MJ0499/MJ1277 for (R)- 
citramalate and -isopropylmalate and aconitase with citrate. 
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Figure 3.11. Homoaconitase and homoisocitrate dehydrogenase specifically 
converted (R)-homocitrate to 2-oxoadipate in a coupled reaction. The reaction 
progress curves show the NADH absorbance in reactions containing 0.5 mM (R)- 
homocitrate (solid circles), 0.5 mM (S)-homocitrate (open squares), or no substrate (solid 
squares). A control reaction without homoaconitase also showed no NADH production. 
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3.3.5. Inhibitors of HACN 
 
Inhibition of HACNMJ was tested in direct assays containing MJ1003/MJ1271 and 
100 M cis-homoaconitate. Hydrolyase activity was inhibited by 50% in the presence of 
100 M trans-aconitate and 400 M trans-homo3aconitate and no activity was observed 
when 100 M (S)-homocitrate was added. No inhibition was detected in the presence of 
up to 200 M citraconate. 
 
 
 
3.4.  DISCUSSION 
 
Methanogens use three enzymes in succession to extend the carbon chain of 2- 
oxoglutarate by three methylenes, producing the 2-oxosuberate required for CoB 
synthesis. Based on sequence homology to mACN, HACNMJ was proposed to catalyze 
each hydration and dehydration reaction in the isomerizations of cis-homoaconitate, cis- 
homo2aconitate, and cis-homo3aconitate. However, HACN homologs from the - 
aminoadipate pathway have only been identified to catalyze the hydration of cis- 
homoaconitate   to   (2R,3S)-homoisocitrate   [93].      The   initial   dehydration   of   (R)- 
homocitrate to cis-homoaconitate had previously gone undetected, despite the homology 
between HACN and mACN. This work describes the first characterized HACN to 
catalyze both dehydration and hydration reactions for the full isomerization of 
homocitrate to homoisocitrate. Steady-state kinetic constants were established in direct 
assays for the dehydration of homocitrate, as well as the hydration of cis-homoaconitate. 
A coupled assay with HICDHMJ  was also used to define the kinetics for the hydration of 
cis-homoaconitate  to  homoisocitrate.    Finally,  the  production  of  2-oxoadipate  was 
observed from the coupled assay with (R)-homocitrate as the substrate.  Therefore, the 
methanogen HACN catalyzes both partial reactions in the isomerization of the three - 
hydroxy acid substrates required for 2-oxosuberate production. 
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The steady state kinetic values for the hydration of cis-homoaconitate by HACNMJ 
were similar to the previously characterized T. thermophilus HACN. The HACNTT 
catalyzed the hydration of cis-homoaconitate with a k of 1.3 s-1 but a lower Km  than 
 
HACNMJ (8 M) [93]. However, the HACNTT did not recognize cis-aconitate as a 
substrate, despite only differing from cis-homoaconitate by one methylene in the -chain. 
HACNMJ was observed to catalyze the hydration of cis-aconitate with a similar turnover 
to cis-homoaconitate although the Km was approximately 20 times greater. cis-Aconitate 
can spontaneously convert to the more stable trans-isomer, which is a potent inhibitor of 
both mACN and HACNMJ. Initial attempts to define cis-aconitate as a substrate for 
HACNMJ were unsuccessful due to a 30% conversion (non-enzymatic) of the stock cis- 
aconitate to trans-aconitate (Drevland and Graham, unpublished results).   Therefore, 
because of the relatively low turnover and high Km, the hydration of cis-aconitate by 
HACNTT may have gone undetected because of trans-aconitate in the reaction mixture. 
The broad substrate specificity of HACNMJ was observed in direct assays with cis- 
unsaturated intermediates containing one to five methylenes in the -chain.  The enzyme 
also catalyzed the stereospecific hydration of maleic acid to (R)-malate, indicating similar 
binding modes for all of the substrates. The HACNTT was not tested with maleic acid or 
longer homoaconitate analogs.  Thus, it is unknown if this broad specificity is unique to 
methanogen HACN. 
Initial studies to elucidate the pathway to 2-oxosuberate identified trans- 
homoaconitate and (S)-homocitrate from the first HCS catalyzed reaction [39]. However, 
only the conversion of (R)-homocitrate to 2-oxoadipate was observed in the coupled 
assay with HICDHMJ. Also, (S)-homocitrate and trans-homoaconitate are inhibitors of 
HACNMJ.    Therefore,  these  compounds  are  probably  not  intermediates  in  the  CoB 
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biosynthetic pathway. The chain elongation reactions are proposed to follow a more 
evolutionarily conserved pathway involving (R)-homocitrate (Figure 3.12). Further 
studies are required using purified HCSMJ  to analyze the stereochemistry of the reaction 
products. 
92  
C 
C 
C 
 
-O  O 
C 
-O   O 
C 
O- 
H C  O 
-O  O 
C 
-O  O 
C 
C O O 
CH2 C -O H 
C
(R)
OH C  O 
CH2 
HCS C  C
(R)
OH 
- 
HACN 
H C C  O
-
 
HACN 
C  C(S)H O 
HICDH CH2 
CH2 
 
 
AcSCoA   HSCoA 
O CH2 H2O 
2 
H2C O 
H2O CH2 
 
NAD+ 
 
 
NADH + 
CH2 
C CH2 C
 CH2 H+ + CO2   CH2 
-O  O C -O C C 
-O   O 
O
 -O  O -O  O 
2-Oxoglutarate (R)-Homocitrate cis-Homoaconitate (R,S)-Homoisocitrate 2-Oxoadipate 
 
 
-O  O 
C 
-O   O 
C 
O- 
H C  O 
-O  O 
C 
(R) 
-O  O 
C 
C  O 
O
 CH2 (R) C -O H C  OH C  O (S) 
CH2 
HCS C  C  OH 
- 
HACN 
H C C  O
-
 
HACN C  C  H 
O 
HICDH CH2 
CH2 
 
 
AcSCoA   HSCoA 
O CH2 H2O 
2 
H2C O 
H2O CH2 
NAD+ 
 
NADH + 
CH2 
CH2 
C 
CH2 
CH2 
H2C 
C 
CH2 
CH2 
H+ + CO2   CH2 
CH2 
-O  O C -O  O C 
C
 
-O  O 
-O   O -O   O 
 
2-Oxoadipate 
 
(R)-Homo2citrate 
 
cis-Homo2aconitate 
 
(R,S)-Homo2isocitrate 2-Oxopimelate 
 
 
-O  O 
C 
-O   O 
C 
O- 
H C  O 
-O  O 
C 
(R) 
-O  O 
C 
C  O 
O
 CH2 (R) C -O H C  OH C  O (S) 
CH2 
HCS C  C  OH 
- 
HACN 
H C C  O
-
 
HACN C  C  H 
O 
HICDH CH2 
CH2 
 
 
AcSCoA   HSCoA 
O CH2 H2O 
2 
H2C O 
H2O CH2 
NAD+ 
 
NADH + 
CH2 
CH2 
CH2 
CH2 
CH2 
H2C 
H2C 
CH2 
CH2 
H+ + CO2   CH2 
CH2 
C -O   O CH2 C 
CH2 CH2 
C -O   O C C 
-O  O 
-O   O -O   O 
 
2-Oxopimelate (R)-Homo3citrate cis-Homo3aconitate (R,S)-Homo3isocitrate 2-Oxosuberate 
 
 
Figure 3.12. The proposed 2-oxoacid chain elongation pathway for methanogen 
coenzyme B biosynthesis. 
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Although HACNMJ was able to catalyze the dehydration of (R)-homocitrate to cis- 
homoaconitate, it did so at half the rate of the hydration of the cis-unsaturated 
intermediates  and  with  a  Km    approximately  70  times  greater  than  that  for  cis- 
homoaconitate.  The resulting specificity constant for HACNMJ with (R)-homocitrate was 
two orders of magnitude lower than the hydration of the intermediates. However, these 
results are consistent with the specificity constants for IPMIMJ with (R)-citramalate and - 
isopropylmalate which were also two orders of magnitude lower than the hydration of 
citraconate [48]. Future studies will be required to measure the equilibrium constant for 
this reaction. 
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Chapter 4: Crystallography and Mutational Analysis of the 
Methanocaldococcus jannaschii Homoaconitase Small Subunit-Insight 
into Structural Determinants for Substrate Recognition 
 
 
 
 
 
4.1. INTRODUCTION 
 
The aconitase (ACN) superfamily consists of five phylogenetic groups: (i) 
mitochondrial aconitases (mACN); (ii) cytoplasmic aconitases (cACN) and iron 
regulatory proteins (IRP1 and IRP2); (iii) bacterial aconitases (AcnB); (iv) 
isopropylmalate isomerases (IPMI); (v) homoaconitases (HACN) [69]. The mACN has 
served as the archetype for this superfamily, having been extensively studied both 
kinetically and structurally for over five decades. Mitochondrial aconitase uses an iron- 
sulfur cluster [4Fe-4S] to catalyze the reversible anti-elimination of water from citrate 
and the subsequent hydration of the unsaturated intermediate, cis-aconitate, producing 
isocitrate in the citric acid cycle (Figure 4.1) [98]. The majority of the ACN family 
literature is dedicated to the first three phyologenetic groups, with more recent interest in 
regulatory roles of IRP1 and IRP2. Thus, most of the information regarding the reaction 
mechanism of IPMI and HACN has been inferred from these previous aconitase studies. 
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Figure 4.1. Reactions catalyzed by members of the aconitase superfamily. (A) 
Reactions catalyzed by malease, IPMI, and HACN.  (B, C) Reactions catalyzed by IPMI. 
(D) Reactions catalyzed by aconitase.  (E) Reactions catalyzed by the -aminoadipate 
HACN (n=1) and methanogen HACN (n=1, 2, 3). 
 
 
 
The HACN and IPMI homologs are monomeric (fungi) or heterotetrameric 
(bacteria and archaea) iron-sulfur cluster proteins that catalyze analogous reactions to 
mACN (Figure 4.1). In the isopropylmalate pathway for leucine biosynthesis, IPMI 
catalyzes the reversible dehydration of α-isopropylmalate to cis-dimethylcitraconate and 
the subsequent trans addition of water, yielding (2R,3S)-3-isopropylmalate (β- 
isopropylmalate) [99].   IPMI also catalyzes the isomerization of (R)-citramalate to β- 
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methylmalate in the pyruvate pathway for isoleucine biosynthesis, an alternative to the 
more common pathway requiring a threonine dehydratase (Chapter 2) [48]. HACN has 
been characterized in the -aminoadipate pathway for lysine biosynthesis in some 
bacteria and fungi, as well as coenzyme B biosynthesis in methanogenic archaea [93,49]. 
In the -aminoadipate pathways of Thermus thermophilus, Saccharomyces cerevisiae, 
and Aspergillus nidulans, HACN has been shown to catalyze  only the  second half 
reaction in the isomerization of (R)-homocitrate: the hydration of cis-homoaconitate to 
(2R,3S)-isohomocitrate [93,84,89]. A second enzyme, predicted to be an ACN, was 
proposed to catalyze the initial dehydration of (R)-homocitrate to cis-aconitate [93]. 
However, HACN from Methanocaldococcus jannaschii has recently been shown to 
catalyze the full conversion of (R)-homocitrate to isohomocitrate, as well as the full 
isomerizations of (R)-homo2citrate and (R)-homo3citrate, in the chain elongation reactions 
of coenzyme B biosynthesis (Chapter 3) [49]. 
Sequence alignments of archaeal HACNs, and IPMIs indicate that the majority of 
the 21 active site residues elucidated through mACN studies are highly conserved, 
implying similar structural organization and catalytic mechanisms. The large subunit of 
these archaeal proteins (~48 kDa) is homologous to domains 1, 2, and 3 of the 
monomeric mACN, including the CX63CXXC motif responsible for ligating the [4Fe-4S] 
cluster. The large subunit interacts with a small subunit (~18 kDa) homologous to 
domain 4 of the mACN, forming the functional enzyme (Figure 4.2). Structural and 
mutational analysis of the pig heart mACN indicates Arg580 from domain 4 is the key 
residue responsible for recognition of citrate, cis-aconitate, and isocitrate in the aconitase 
mechanism [74,100]. The  guanidinium nitrogens of Arg580 hydrogen bond to the 
substrate γ-carboxylate; replacing Arg580 with lysine results in a 30-fold increase in Km. 
However, bioinformatics indicates that this arginine does not align with an arginine in 
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archaeal IPMIs or HACNs, rendering functional assignment of uncharacterized proteins 
problematic by sequence alignment alone. The crystal structure of the proposed HACN 
small subunit from the euryarchaeal Pyrococcus horikoshii shows that the loop region 
between -helicies 1 and 2 corresponds to the flexible loop region of the pig heart mACN 
[101]. However, sequence alignment of the mACN and P. horikoshii HACN shows that 
Arg580 is replaced with a polar threonine residue in the loop region.  Unfortunately,  the 
P. horikoshii putative HACN subunit has not been purified and characterized.  Therefore, 
deriving information about residues responsible for substrate recognition from a protein 
of unknown biochemical function proves challenging. 
98  
MJ1271  LDKEEIVITNKNKTIKCE--TPKGLEREILAAGGLVNYLKKRKLIQSKKG 167 
MJ1277  LETGEIKNLTTGEVLKGQ--KLPEFMMEILEAGGLMPYLKK-KMAESQ-- 168 
PhHACN-s  WETGEVR--KGDEILMFE--PLEDFLLEIVREGGILEYIRRRGDLCIR-- 163 
mACN domain 4 GLKDFAPGKPLTCIIKHPNGTQETILLNHTFNETQIEWFRAGSALNRMKE 750 
 
 
 
 
* 
MJ1271 -------------------MIIKGRAHKFG---DDVDTDAIIPGPYLRTT  28 
MJ1277 -----------------MRSIIKGRVWKFG---NNVDTDAILPARYLVYT  30 
PhHACN-s -------------------MITTGKVWKFG---DDISTDEITPGRYNLTK  28 
mACN domain 4 DLEDLQILIKVKGKCTTDHISAAGPWLKFRGHLDNISNNLLIGAINVENG  600 
 
 
MJ1271 DPYELASHCMAGIDEN-----FPKKVKEGDVIVAGENFGCGSSREQAVIA  73 
MJ1277 KPEELAQFVMTGADPD-----FPKKVKPGDIIVGGKNFGCGSSREHAPLG  75 
PhHACN-s DPKELAKIAFIEVRPD-----FARNVRPGDVVVAGKNFGIGSSRESAALA  73 
mACN domain 4 KANSVRNAVTQEFGPVPDTARYYKKHGIRWVVIGDENYGEGSSREHAALE  650 
 
 
MJ1271  IKYCGIKAVIAKSFARIFYRNAINVGLIPIIAN----TDEIKDGDIVEID 119 
MJ1277  LKGAGISCVIAESFARIFYRNAINVGLPLIECKG--ISEKVNEGDELEVN 123 
PhHACN-s  LKALGIAGVIAESFGRIFYRNAINIGIPLLLGK----TEGLKDGDLVTVN 119 
mACN domain 4 PRHLGGRAIITKSFARIHETNLKKQGLLPLTFADPADYNKIHPVDKLTIK 700 
 
 
 
 
 
 
MJ1271         VKT 170 
MJ1277         --- 
PhHACN-s       --- 
mACN domain 4  LQK 203 
 
 
 
 
 
Figure 4.2. A multiple sequence alignment of proteins homologous to the 
Methanocaldococcus jannaschii HACN small subunit, MJ1271, using the ClustalW 
program (version 1.83). The sequences are M. jannaschii MJ1271 (Swiss-Prot 
accession no. Q58667), M. jannaschii MJ1277 (Swiss-Prot accession no. Q58673), 
Pyrococcus horikoshii HACN (PhHACN-s; Swiss-Prot 059393), domain four of pig heart 
mACN (UniPro reference P16276). Conserved amino acid residues are shown in white 
on a black background. Similar residues are shown in black on a gray background. An 
asterisks above the sequences indicates the position of the pig heart mACN Arg580. The 
MJ1271 and MJ1277 sequences proposed for substrate specificity are boxed. 
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The small subunits of the M. jannaschii IPMI (MJ1277) and HACN (MJ1271) 
underscore the importance of defining the consensus sequence responsible for substrate 
recognition. These proteins are more than 50% identical to each other and were both 
previously annotated as IPMI proteins based on primary sequence alone. To assign 
protein function, the small subunits were overexpressed, purified, and characterized with 
their respective large subunits (Chapters 2 and 3) [48,49]. The interacting MJ0499- 
MJ1277 pair functions as the IPMI in methanogen leucine and isoleucine biosynthesis 
and the MJ1003-MJ1271 pair was identified as the HACN in coenzyme B 
biosynthesis.(4,5) The predicted loop regions of these enzymes, as indicated by 
homology  models  and  sequence  alignments,  are  potentially  the  best  indicators  of 
substrate specificity.  The HACN small subunit has a consensus sequence of Y24 LRT 
 
while the homologous IPMIMJ has the sequence Y 
26LVY.  The polar Arg26 and Thr27 of 
 
HACNMJ could potentially form hydrogen bonds with the γ-carboxylates of cis- 
homoaconitate, cis-homo2aconitate, and cis-homo3aconitate. The hydrophobic Val28 and 
Tyr29 residues of the IPMIMJ loop region may be the structural determinants for 
recognizing  the  substrates  hydrophobic  γ-chains.     These  consensus  sequences  are 
conserved in most of the Euryarchaeota. Thus, defining their role in the IPMI and HACN 
mechanisms would allow for assigning gene function for uncharacterized IPMI and 
HACNs. 
In this work, we present the first structural study of a characterized 
homoaconitase [50]. The M. jannaschii HACN small subunit, MJ1271, was crystallized 
by Yokoyama and colleagues and refined to 2.1Å (PDB 2PKP) [50]. Site directed 
mutagenesis of the proposed flexible loop region of MJ1271 (in combination with wild 
type MJ1003), predicted from the structural model and multiple sequence alignments, 
revealed residues affecting substrate specificity.  Mutating residues Arg26 and Thr27 in 
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the Y24LRT loop region of MJ1271 to the homologous Y26LVY region in the M. 
jannaschii IPMI small subunit (MJ1277) identified Arg26 as a key amino acid in 
substrate recognition. We propose that Arg26 is the equivalent of Arg580 of the pig heart 
mACN, coordinating the γ-carboxylate of the HACN substrates. The results of this study 
aid in predicting uncharacterized HACNs and IPMIs that were previously 
indistinguishable through bioinformatics alone. 
 
 
4.2. MATERIALS AND METHODS 
 
4.2.1. Cloning and Molecular Biology 
 
The E. coli BL21(DE3) strains carrying plasmids pDG141 (expressing MJ1003) 
and pDG163 (expressing MJ1277) were described previously (Table 4.1) [48]. Splicing 
overlap extension (SOE) PCR was used to construct two chimeric genes [102]. The 
MJ1271-MJ1277 chimeric gene contained codons 1 to 29 from MJ1277 fused to codons 
28 to 170 from MJ1271. T7 promoter and MJ1271Rev-overlap primers (Table 4.2) were 
used to amplify the 5’-fragment of this chimeric gene from pDG163, and MJ1271Fwd- 
overlap and T7 terminator primers were used to amplify the 3’-fragment from pDG160. 
The purified fragments were joined by SOE-PCR. The chimeric product was purified and 
digested with NcoI and BamHI restriction enzymes, and then ligated into the same sites 
of vector pET-19b to create vector pDG476. The MJ1271-LysU chimera replaced codons 
23 to 30 of MJ1271 with codons 18 to 23 from the Thermus thermophilus lysU gene 
promoter and 3MJ1271-LysU1 primers were used to amplify the 5’-fragment from 
pDG163, and 5MJ1271-LysU and T7-terminator primers were used to amplify the 3’- 
fragment pDG163 [93]. SOE-PCR produced a full-length chimeric gene that was ligated 
into the NcoI and BamHI sites of pET-19b to form vector pDG476. For crystallography 
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experiments, the MJ1271 gene was amplified from Methanocaldococcus jannaschii 
chromosomal DNA  and ligated  into  vector pET-21a (Novagen) to produce plasmid 
pMJ1271. 
Plasmid pDG160, encoding the wild-type MJ1271 gene, was mutated using the 
QuikChange II Site-Directed Mutagenesis Kit (Stratagene) and the mutagenic primers 
listed in Table 4.2 (together with their reverse complements). The resulting mutations 
were confirmed by DNA sequence of the plasmids listed in Table 1. Plasmid pRD03 was 
used as a template to generate the double mutation in pRD17 by the same strategy. 
Electroporation transformed E. coli BL21 (DE3) pDG141 cells with the new plasmids 
encoding small subunit proteins (Table 4.1). 
 
 
  Table 4.1. List of plasmids and microorganisms   
Strain or plasmid 
(parent plasmid) 
Escherichia coli 
Description Source 
and/or reference 
BL21(DE3) Protein expression host Novagen 
BL21 CodonPlus-RIL Expression host with additional tRNAs Stratagene 
XL-1 Blue General cloning host Stratagene 
Plasmids 
pMJ1271 (pET-21a) MJ1271 This work 
pDG141 (pCDF-Duet1) MJ1003 [48] 
pDG160 (pET-19b) MJ1271 [48] 
pDG163 (pET-19b) MJ1277 [48] 
pDG476 (pET-19b) MJ1271-MJ1277 chimera This work 
pDG625 (pET-19b) MJ1271-LysU This work 
pRD03 (pDG160) MJ1271 Arg26Val This work 
pRD06 (pDG160) MJ1271 Arg26Lys This work 
pRD09 (pDG160) MJ1271 Thr27Ala This work 
pRD17 (pRD03) MJ1271 Arg26Val Thr27Tyr This work 
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Table 4.2. Oligonucleotide primers used to construct MJ1271 mutations. 
 
 
Primer name Sequence (5' to 3') 
 
T7 TAATACGACTCACTATAGGG 
MJ1277Rev-overlap GCTAACTCGTAAGGGTCTGTATAAACTAAATACCTTGCTGG 
MJ1277Fwd-overlap CCAGCAAGGTATTTAGTTTATACAGACCCTTACGAGTTAGC 
T7-terminator GCTAGTTATTGCTCAGCGG 
3MJ1271-LysU1 CCAACCATGAACGGAGCGTATTTTCCTGGAATTATTGCGTC 
5MJ1271-LysU1 CGCTCCGTTCATGGTTGGTGAATACGAGTTAGCTTCACACTG 
Arg26Val1 CCAGGACCTTACTTAGTGACTACAGACCCTTACGAG 
Arg26Lys1 CCAGGACCTTACTTAAAGACTACAGACCCTTACGAG 
Thr27Ala1 CCAGGACCTTACTTAAGGGCTACAGACCCTTACGAG 
Arg26Val/Thr27Tyr1 CCAGGACCTTACTTAGTGTATACAGACCCTTACGAG 
 
1 Mutations are underlined in these sequences. 
 
 
 
4.2.2. Protein Expression and Purification 
 
The plasmids carrying the mutant MJ1271 genes were individually coexpressed 
with the WT MJ1003 (pDG141) in E. coli BL21 (DE3) as described previously (Chapter 
2) [49]. The cells were grown at 37ºC with shaking at 250 rpm until the culture reached 
an optical density at 600 nm of 0.6-0.8.  Expression was then induced by the addition of 
50 µM  isopropyl-1-β-D-galactopyranoside, and the culture resumed shaking for 3-4 
hours. The MJ1003 and mutant MJ1271 proteins were purified by heat treatment of the 
cell lysate, followed by anion exchange chromatography, dialysis and concentration [49]. 
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4.2.3. Analytical Size Exclusion Chromatography 
 
Interactions between MJ1003 and MJ1271 variants were tested by measuring 
apparent masses of protein pairs using size exclusion chromatography, as described 
previously (Chapter 2) [62]. 
 
 
4.2.4. Reconstitution of the Iron-Sulfur Center 
Copurified MJ1003 and MJ1271 mutants (1-2 mg ml-1 apoenzyme) were 
reconstituted in the presence of DTT, Fe(NH4)2(SO4)2, and Na2S as described previously 
(Chapter 3) [49]. A mock reconstitution control consisted of the above mixture without 
protein. 
 
 
 
4.2.5. Measurement of Hydrolyase Activities 
 
Reactions (1 ml) were conducted in quartz semi microcells with screw cap septa 
(Starna) containing 50 mM CHES-KOH (pH 9.0), 200 mM KCl, 10-100 µg ml-1 
holoenzyme, and various substrate concentrations, as described previously (Chapter 3) 
[49]. 
 
 
4.2.6. Homology modeling and Structure Representation 
The Swiss model automated comparative protein modeling server was used to 
construct the MJ1277 homology using pdb 2PKP as the template (21). The MJ1003 
model was constructed using the Swiss-Pdb Viewer Deep View (v4.0) and pdb 1ACO as 
the template [103]. Figures were prepared using the PYMOL program (DeLano 
Scientific LLC). 
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4.3. RESULTS 
 
4.3.1. Structure of MJ1277 Homology Model 
 
The M. jannaschii IPMI small subunit, MJ1277, shares more than 50% sequence 
identity with MJ1271. Therefore, a homology model of MJ1277 was built using pdb 
2PKP as a template, resulting in a structural alignment with an rmsd of 0.1 Å (Figure 
4.3). The model of MJ1277 has an N- to C-terminus arrangement of β1-α2-α3-α4-β5- 
α6-β7-α8-β9-β10-β11-α12-α13, with a similar partition of α-helices and β-strands. The 
GS67SRE sequence is located in the loop region between β6 and α7, parallel to the 
Y26LVY sequence between α3 and α4. 
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Figure 4.3. Homology model of the M. jannaschii IPMI small subunit, MJ1277. The 
MJ1271 homology model was constructed with the Swiss model automated comparative 
protein modeling server using the MJ1277 structure (PDB 2PKP) as a template. 
Sequences indicate the loop regions proposed to function in IPMIMJ substrate specificity 
and catalysis, 
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4.3.2  Expression and Subunit interaction of MJ1003 and the MJ1271 Variants 
 
To confirm that the Y24LRT sequence of MJ1271 confers substrate specificity for 
the HACNMJ, six variant forms of the MJ1271 gene were constructed (Table-mutations 
and primers) and coexpressed with the wild type (WT) MJ1003, as described previously 
(Chapter 3) [49]. The soluble proteins were aerobically purified by heating at 70C 
followed by anion exchange chromatography and subunit interaction was analyzed by 
analytical size exclusion chromatography. The six HACNMJ variants eluted as complexes 
with molecular masses of 144-155 kDa.  The large and small subunits are approximately 
46 kDa and 18 kDa, respectively. Therefore, these mutant forms of  HACNMJ  are 
probably forming heterotetramers consisting of two large and two small subunits, which 
is consistent with WT HACNMJ, which eluted with a molecular mass of 143 kDa. 
 
 
4.3.3. MJ1003 – MJ1271 Arg26Val and Arg26Lys 
Arg26 in the Y24LRT sequence of MJ1271 was predicted to be analogous to 
Arg580 of pig heart mACN. Mutation of Arg580 to lysine resulted in a 30-fold increase 
in Km for aconitase with isocitrate, a decrease in activity, and a loss of tight substrate 
binding [74]. Replacing the MJ1271 Arg26 to lysine resulted in a 6-fold increase in Km 
for cis-homoaconitate. However, activity with citraconate and 3-isopropylmalate was 
observed. Arg26 has to accommodate substrates with varying γ-chain lengths. 
Therefore, mutating Arg26 to the smaller, polar lysine residue probably does not interfere 
with the hydrophobic γ-chains of the smaller citraconate and 3-isopropylmalate.  This is 
apparent when comparing the K and k values for citraconate (315 µM, 8.4 s-1 ) and 
 
maleic acid (310 µM, 8.1 s-1), which are virtually identical.  Replacing Arg26 to valine, 
the analogous residue in MJ1277, has a more obvious effect on substrate recognition. 
Although similar Km values are observed for maleic acid and citraconate, the activity with 
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respect to 3-isopropylmalate was comparable to the WT IPMIMJ. Compared to the WT 
IPMIMJ, the MJ1271 R26V mutant resulted in a less than 2-fold increase in Km for 3- 
isopropylmalate (39 µM and 68 µM, respectively) and similar turnover (1.9 s-1 and 1.1 s-1, 
respectively). Although activity was not completely abolished with the WT HACNMJ 
substrates, the Km values for cis-homoaconitate, cis-homo2aconitate, and cis- 
homo3aconitate increased between 10-30 fold. Therefore, Arg26 of MJ1271 plays a key 
role in HACNMJ  substrate recognition while the corresponding valine residue of IPMIMJ 
accommodates the hydrophobic methyl or isopropyl γ-chain chains of citraconate and 3- 
isopropylmalate. 
 
 
 
Table 4.3. Steady-state kinetic values for the MJ1003-MJ1271 variant enzymes 
compared to WT IPMIMJ 
 
Maleic acid Citraconate  -Isopropylmalate 
 
 
 
Enzyme 
 
Km (M) 
kcat 
(s-1) 
 
Km (M) 
kcat 
(s-1) 
 
Km (M) 
kcat (s-
1) 
IPMIMJ 400 ± 50 36 80 ± 20 14 39 ± 7 1.9 
R26V 230 ± 10 9.9 190 ± 20 5.5 68 ± 5 1.1 
R26K 310 ± 32 8.1 315 ± 71 8.36 180 ± 30 0.8 
T27A 3400 ± 200 24.2 920 ± 230 4.1 ND
a
 ND 
R26V T27Y 489 ± 86 23.1 290 ± 70 9.8 133 ± 37 1.6 
a Not detected.       
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Enzyme Km (M) (s
-1) Km (M) (s
-1) Km (M) (s
-1) Km (M) (s
-1) 
HACNMJ 330 ± 50 6 22 ± 3 0.75 30 ± 5 0.66 36 ± 6 2.5 
R26V 230 ± 10 9.9 220 ± 30 0.48 870 ±150 5.8 660±170 2.8 
R26K 310 ± 32 8.1 135 ± 27 1.43 -a - - - 
T27A 3400±200 24.2 220 ± 20 2.5 269 ± 68 2.2 650 ± 80 4.1 
 
MJ 
 
 
 
Table 4.4. Steady-state kinetic values for the MJ1003-MJ1271 variant enzymes 
compared to WT HACNMJ 
Maleic acid Homoaconitate Homo2aconitate Homo3aconitate 
kcat kcat kcat kcat 
 
 
 
 
 
 
  R26V/T27Y 489 ± 86 23.1   460 ± 80 1.7 1600 ±500 6.6 640 ± 90 1.9   
 
a Dash indicates that the substrate was not tested. 
 
 
 
4.3.4. MJ1003 – MJ1271 Thr27Ala 
 
In  the  conserved  YLRT  and  YLVY  sequences  of  HACNMJ    and  IPMIMJ, 
respectively, the residue adjacent to the critical arginine and valine differ.  In the loop 
region of the pig heart mACN, adjacent to Arg580 is a glycine residue that is not known 
to function in the active site.  To analyze whether Thr27 of HACNMJ  plays a catalytic 
role, the MJ1271 Thr27Ala variant was constructed. While the MJ1271 Arg26Val and 
Arg26Lys mutants maintained similar Km  values for maleic acid, the Thr27Ala mutant 
resulted in an almost 10-fold increase in Km   compared to WT IPMIMJ. Although 3- 
isopropylmalate was not detected as a substrate, most likely because of electrostatic 
interactions of the Arg26 guanadinium group with the nonpolar isopropyl γ-chain of the 
compound, activity with citraconate was observed. Although the resulting Km   with 
citraconate was approximately 1 mM, the mutant enzyme had appreciable turnover, 
resulting in a specificity constant of 3.4 x 104  M-1  s-1.  Compared to the WT HACN 
substrates, the Km values for cis-homoaconitate,  cis-homo2aconitate, and cis- 
homo3aconitate  increased  10-20  fold  for  the  Thr27Ala  mutant  while  the  specificity 
constants decreased 2-10 fold. 
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4.3.5. MJ1003 – MJ1271 Arg26Val/Thr27Tyr 
 
Comparing the loop regions predicted to be responsible for HACNMJ and IPMIMJ 
recognition, Y24LRT and Y26LVY, respectively, the Arg-Val and Thr-Tyr residues 
comprise the structural difference in these regions. Therefore, the MJ1271 
Arg26Val/Thr27Tyr variant was constructed in an effort to alter the loop region of 
MJ1271 to more structurally resemble the loop region of MJ1277. Exchanging the Arg26 
and Thr27 residues resulted in a Km of 489 μM for maleic acid, similar to WT HACNMJ 
and IPMIMJ, and a turnover that was on the order of the Thr27Ala variant and WT 
IPMIMJ. However, compared to the Arg26Val variant, the Km and kcat values for both 
citraconate and 3-isopropylmalate increased slightly. The Km values for cis- 
homoaconitate, cis-homo2aconitate, and cis-homo3aconitate increased 20-50 fold 
compared to WT HACNMJ. Although the double mutation did result in an increase in kcat 
for cis-homoaconitate and cis-homo2aconitate, all three substrates had specificity 
constants that were an order of magnitude lower than the wild type  enzyme. The 
discrepancy between the kinetics for citraconate and 3-isopropylmalate, when compared 
with the Arg26Val variant, probably results from structural changes in the loop region 
with the threonine to tyrosine mutation, as discussed for MJ1271 Thr27Ala above. 
 
 
 
4.3.6. MJ1003-MJ1271/1277 Chimera 
A chimeric MJ1271 protein was constructed which replaced the first 28 amino 
acids with the first 28 amino acids of MJ1277 to test whether the substrate specificity 
could be completely altered from HACNMJ to IPMIMJ. Although the chimera interacted 
with MJ1003 as a heterotetramer, no activity was detected for any of the tested substrates 
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after reconstitution. The failure to detect activity is consistent with expressing MJ1003 
with MJ1277. The HACNMJ large subunit and IPMIMJ small subunit interact but no 
activity was observed for any tested compound. 
 
 
 
4.3.7. Loop replacement: MJ1003-MJ1271/LysU 
 
In previous studies of HACNs involved in lysine biosynthesis, the reversible 
hydration of cis-homoaconitate to (2R,3S)-homoisocitrate has been observed while the 
initial dehydration of (R)-homocitrate has gone undetected [93]. Sequence alignments 
and homology models of the T. thermophilus LysU protein reveals a loop region with the 
sequence Y21APFMV. However, this sequence does not provide insight into the 
mechanism discrepancy. A chimeric form of MJ1271 was created, replacing the loop 
region  containing  the  Y24LRT  region  with  the  corresponding  region  of  the  T. 
thermophilus LysU protein, in an effort to alter the reactions catalyzed by the HACNMJ to 
that of the -aminoadipate HACNs. Although the chimeric protein still interacted with 
MJ1003 and maintained relatively low activity with maleic acid (K  350 M; k    0.45 s1; 
3 -1  -1 
kcat/Km   1.4 x 10 
tested substrates. 
 
 
 
4.3  DISCUSSION 
M s ), no activity was detected for cis-homoaconitate or any other 
 
The structure of the M. jannaschii HACN small subunit, MJ1271, was solved by 
molecular replacement using the P. horikoshii HACN small subunit (PhIPMI-s; pdb 
1V7L) and the structure was refined to 2.1Å. MJ1271 consists of 16 β-strands and α- 
helices with an N- to C-terminus arrangement of β1-α2-α3-α4-β5-α6-β7-α8-β9-α10- 
β11-β12-α13-β14-α15-α16 (Figure 4.4) [50].   -Helices 2-4, 6, 8, 15 and 16 are 
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concentrated next to a β-barrel type structure that is interrupted by α10 and α13. The 
conserved GS65SRE sequence, in which Ser65 is analogous to the catalytic Ser642 of the 
pig heart mACN, is located in a loop region positioned between β5 and α6. This loop is 
spatially adjacent to a loop region between α2 and α3 containing the Y24LRT sequence 
predicted to function in substrate recognition. Tyr24 and Leu25 of this sequence reside 
in α2, while Arg26 and Thr27 are positioned in the loop region between helices. 
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Figure 4.4. Structure of the M. jannaschii HACN small subunit, MJ1271 (PDB 
2PKP). Sequences indicate the loop regions proposed to function in HACNMJ substrate 
specificity and catalysis, 
 
 
 
The MJ1271 protein is clearly a homolog of the fourth domain of mACN and the 
P. horikosii HACN, as evident in both sequence (Figures 4.2 and 4.5) and structural 
alignment.  These three structures consist of an N-terminal network of -helices adjacent 
to a C-terminal -barrel type structure. Structural alignment of MJ1271 with the relaxed 
(without substrate) or tense (substrate bound) structures of pig heart mACN results in an 
rmsd of 1.9 Å (Z scores between 19.0 – 19.2), as indicated by the DALI server. 
Therefore, structural information, including the elucidation of active site residues, can be 
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inferred from the extensive structural and mechanistic studies of mACN, despite the lack 
of interacting large subunit, MJ1003. 
 
 
 
 
Figure 4.5.  Structural alignment of the mACN domain 4 (blue; PDB 1AMJ) and M. 
jannaschii HACN small subunit, MJ1271 (green; 2PKP). 
114  
 
In the relaxed and tense states of mACN, the -helices of domain four are packed 
at the interface with domains 1, 2, and 3, forming the active site cleft [104]. The 
GS642SRE and Arg580 residues, located within the loop regions of these -helices, 
comprise most of the active site residues found in this domain. Therefore, it is predicted 
that the -helices of the MJ1271 structure (and the MJ1277 homology model) are at the 
interface between the large and small subunit and are the location of critical active site 
residues. In a structural alignment of MJ1271 with substrate free mACN (pdb 1AMJ), 
the conserved Cα backbone of the GSSRE sequence align fairly well and the catalytic 
serine residues (Ser642 and Ser65 for mACN and MJ1271, respectively) have side chains 
with similar orientation (Figure 4.6A). The remaining residues in the sequence, most 
notably the Arg644 in mACN (Arg67 in MJ1271), the residue that stabilizes the Ser642 
alkoxide in the mACN mechanism, have side chains that show significant differences in 
orientation. Also, the GSSRE sequence of mACN resides completely in a loop region, 
where the GSSRE sequence of MJ1271 is located at the interface of the loop and α6. 
Aligning MJ1271 with substrate bound mACN (PDB 1AMI) shows a similar alignment 
of Cα backbones and side chain residues of the GSSRE sequence. However, a difference 
in the alignment of S642 of mACN and Ser65 of MJ1271 is observed, indicating an 
almost 180° rotation of the mACN side chain, which is consistent with the alignment of 
the relaxed state (pdb 1AMJ) with the tense (pdb 1AMI) state of mACN (Figure 4.6C). 
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Figure 4.6. Structural alignment of MJ1271 (PDB 2PKP) with domain 4 of mACN 
in the relaxed (PDB 1AMI) and tense states (PDB 1AMJ). (A) Alignment of MJ1271 
Ser65 (magenta) with the mACN Ser642 (green) in the relaxed state; (B) alignment of 
MJ1271 Arg 26 (magenta) with the mACN Arg580 (blue) in the relaxed state; (C) 
alignment of MJ1271 Ser65 (magenta) with the mACN Ser642 (blue) in the tense state; 
(D) alignment of MJ1271 Arg26 (magenta) with the mACN Arg580 (blue) in the tense 
state. 
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The position of the MJ1271 Y24LRT sequence with respect to the conserved 
GS65SRE loop region indicates that this sequence is  aligned to interact with the γ- 
carboxylates of the HACN substrates. However, the Y24LRT sequence aligns poorly with 
the corresponding loop region of pig heart mACN, which is the site of Arg580 (Figure 
4.7). The Arg26 of MJ1271 aligns with Leu577 of mACN, instead of Arg580, and there 
is an approximately 120° difference in the orientation of the two arginine residues. Arg26 
is also oriented perpendicular to the GS65SRE sequence and does not appear to be in line 
to contact the substrate γ-carboxylate as Arg580 is with respect to the mACN GSSRE 
sequence. However, structural alignment of MJ1271 with both relaxed and tense 
structures of aconitase suggest that MJ1271 may be in the relaxed state (Figure 4.6). The 
binding of substrate at the active site of mACN results in conformational changes 30 Å 
from the active site [104]. Therefore, conformational changes resulting from substrate 
binding may change the position of this residue. The orientation of the Y24LRT loop 
region may also be influenced by interaction with MJ1003. A crystal structure of the 
interaction MJ1003-MJ1271 proteins in the presence and absence of protein will be 
required to accurately assess the orientation of Arg26 of MJ1271. 
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Figure 4.7. Structural alignment of the MJ1271 loop regions proposed to function 
in substrate specificity and catalysis with the corresponding loop regions of mACN. 
Left, Y24LRT and S65SR sequence of MJ1271 (green); Right, structural alignment of 
MJ1271 (green) with the loop containing Arg580 and S642SR (blue; PDB 1AMJ). 
 
 
 
The results of the site directed mutagenesis of MJ1271 suggests that Arg26 is a 
critical residue in the substrate specificity of HACNMJ. Mutation of this residue to the 
valine or lysine dramatically increased the Michaelis constants for cis-homoaconitate, 
cis-homo2aconitate, and cis-homo3aconitate compared to the WT HACNMJ. The HACNMJ 
variants were also active with the substrates of IPMIMJ. The Arg26Val mutation resulted 
in Km and kcat values  comparable to IPMIMJ, suggesting that Val28 of the  MJ1277 
Y26LVY sequence is necessary to accommodate the hydrophobic γ-chain of citraconate 
and dimethylcitraconate. 
The residue adjacent to Arg580 of pig heart mACN has not been shown to 
function in the mechanism of aconitase. The adjacent residue to the MJ1271 Arg26 is a 
threonine,  which  corresponds  to  Tyr29  of  MJ1277.    Replacing  Thr27  with  alanine 
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disrupted the activity of HACNMJ for all substrates, most notably by increasing the Km of 
maleic acid 10 fold compared to WT HACNMJ. The MJ1271 structure indicates that the 
Thr27 side chain is oriented away from the predicted active site of HACNMJ. Based on 
the structural and kinetic data, Thr27 probably plays a structural role in the flexibility of 
the loop region, potentially making contacts with other active site amino acids, but does 
not appear to interact directly with the substrate. 
In an attempt to completely alter the substrate specificity of HACNMJ to mimic 
IPMIMJ, a chimeric protein was constructed where the first 28 amino acids of MJ1271 
were replaced with the corresponding residues of MJ1277.   Although these proteins 
interacted as a heterotetramer and bound an iron-sulfur cluster, no activity was observed 
above background with any of the tested substrates. The inability to observe activity with 
maleic acid, the minimal substrate, indicates that, although the proteins interact, they may 
interact in a way where the catalytic residues of MJ1277 do not align with the active site 
of MJ1003. Similar results were observed after coexpressing and reconstituting MJ1003 
with MJ1277. 
Although the substrate specificity of the HACNMJ protein was altered to 
accommodate the substrates of IPMIMJ, activity was not completely lost for HACNMJ 
substrates.  Thus, it is likely that the interacting large subunits of these proteins, MJ1003 
and MJ0499, respectively, also play a role in substrate specificity. However, the 
characterizations of HACNMJ and IPMIMJ, the crystallography and homology modeling of 
MJ1271 and MJ1277, and the site directed mutagenesis of MJ1271 all indicate that the 
conserved Y24LRT and Y26LVY sequences are sufficient indicators of protein function in 
archaea. Therefore, uncharacterized proteins with the Y24LRT sequence are likely 
HACNs, while proteins with the YLV(Y/I/M) sequence are IPMIs. These studies should 
allow for the proper annotation of these uncharacterized proteins. 
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The HACNMJ, IPMIMJ, and mACN catalyze the dehydration of their respective - 
hydroxyacid substrates and subsequent rehydration of the resulting cis-unsaturated 
intermediates, forming a -hydroxyacid. Given the homology of the -aminoadipate 
HACN to these enzymes, it is surprising the initial dehydration of (R)-homocitrate has 
not been observed. We replaced the region of MJ1271 containing the Y24LRT sequence 
with the corresponding sequence from the T. thermophilus HACN in an attempt to alter 
the catalytic mechanism to accommodate only the hydration of cis-homoaconitate to (2R, 
3S)-homoisocitrate. Although the MJ1003-MJ1271/LysU variant interacted as a 
heterotetramer and was active with maleic acid as a substrate, no activity was observed 
with any of the other HACNMJ or IPMIMJ  substrates.  Therefore, a crystal structure of an 
-aminoadipate HACN with bound substrate as well as mutagenesis of active site amino 
 
acids will be required to resolve this difference in overall mechanism. 
Although most crenarchaea use both the α-aminoadipate and isopropylmalate 
pathways for lysine and leucine biosynthesis, respectively, they appear to only have one 
HACN/IPMI homolog with a conserved YL(K/V)Y sequence. These putative enzymes 
are expected to accept a broad pool of hydroxyacid substrates. While these crenarchaeal 
proteins have yet to be purified and characterized, the results of the MJ1271 mutagenesis 
show that mutating Arg26 of YLRT to either lysine or valine allows for the recognition 
of both HACNMJ and IPMIMJ substrates. However, the WT HACNMJ did not accept the 
substrates of IPMIMJ and, similarly, IPMIMJ did not accept HACN substrates. Therefore, 
future studies will involve the characterization, crystallization, and mutagenesis of these 
crenarchaeal proteins to evaluate more closely how these ancestral proteins recognize 
their substrates. 
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Chapter 5: Archaeal Iron-Sulfur Cluster Biosynthesis 
 
 
 
 
5.1. INTRODUCTION 
 
Iron-sulfur clusters are versatile inorganic cofactors involved in oxidation- 
reduction (redox), non-redox, and radical chemistry, as well as serving as biological 
sensors for the regulation of gene expression [105]. Proteins requiring these clusters have 
been identified in all known organisms. Although these protein-bound  iron-sulfur 
clusters are readily synthesized in vitro, intricate mechanisms for cluster biosynthesis and 
transfer are required in vivo to prevent toxicity from free iron and sulfur. 
Three main systems have been identified for iron-sulfur cluster biosynthesis in 
bacteria and eukaryotes: NIF, ISC, and SUF [106,107]. The NIF system is required for 
maturation of nitrogenase in bacteria while ISC plays a general “house-keeping” role in 
bacteria and eukaryotes. The SUF system, present in bacteria, archaea, and plants is 
expressed under oxidative stress or iron starvation. These three systems involve proteins 
with common functions. NifS, IscS, and SufS are cysteine desulfurases, producing 
sulfane sulfur and alanine from cysteine. IscU, IscA, NifU, SufU, and SufA function as 
scaffolding proteins for the synthesis of iron-sulfur clusters and transfer to target 
apoproteins [106,107]. The SUF system also possess the proteins SufB, a persulfide 
acceptor, and SufC, an ABC-type ATPase, which form a complex that may potentially 
serve as a scaffold for cluster synthesis and transfer [108]. 
Recently, the apbC locus from Salmonella enterica serovar Typhimurium LT2 
was identified to encode for an iron-sulfur scaffold protein [109]. Strains with lesions at 
this locus were conditional thiamine auxotrophs, similar to S. enterica strains with 
disruptions in the isc operon, blocking thiazole synthesis [110,111].  A role for ApbC in 
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iron-sulfur cluster biosynthesis was suggested when apbC mutations resulted in 
decreased aconitase and succinate dehydrogenase activity, two enzymes requiring these 
clusters for catalysis [111]. Lesions in the apbC locus of S. enterica also prevented 
growth when tricarballylate was the sole carbon source. Tricarballylate, a citrate 
analogue, is metabolized via the FAD-dependent tricarballylate dehydrogenase (TcuA), 
which converts the substrate to cis-aconitate for the TCA cycle [112]. The FAD of TcuA 
is regenerated by the membrane bound TcuB protein, which uses two [4Fe-4S] clusters 
and heme to transfer electrons from FADH2 to the cytoplasmic membrane quinone pool 
[113]. The dependence of ApbC for growth on tricarballyate and not the Isc or Suf 
analogues suggests that this protein functions in iron-sulfur cluster formation on TcuB. 
Indeed, the activity of TcuB in S. enterica strains lacking apbC was diminished compared 
to wild type [109]. 
The S. enterica ApbC is a 40-kDa cytosolic protein homologous to the P-loop 
NTPases Cfd1 and Nbp34. These two NTPases have been implicated as iron-sulfur 
scaffold components of the yeast CIA machinery, binding and transferring their clusters 
to target proteins in the cytosol [114,115].  Cfd1 possesses a C-terminal CX18CPXCXnC 
motif and binds four moles of iron and sulfur while Nbp35 has an N-terminal ferredoxin- 
like CX13CX2CX5C motif in addition to the conserved C-terminal motif of Cfd1, and 
binds 8 moles of iron and sulfur [114,115]. Although Cfd1 and Nbp35 have been shown 
to function independently in vitro, the two proteins form a complex that binds 12 moles 
of iron and 12 moles of sulfur per mole of dimeric complex [114]. These two proteins 
also have conserved Walker A box motifs for binding and hydrolyzing ATP. 
Similar to the Cfd1 and Nbp35 proteins, ApbC is also a member of the P-loop 
NTPass family, possessing a Walker A box motif. However, ApbC has two conserved C- 
terminal cysteine residues, with a consensus sequence of CXXC, and no conserved N- 
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terminal cysteines [111]. After anaerobic reconstitution, ApbC bound two moles of iron 
and two moles of sulfur per mole of protein, consistent with a [2Fe-2S] cluster, although 
a [4Fe-4S] cluster may form at the dimer interface [116]. Consistent with Cfd1 and 
Nbp35, the reconstituted ApbC effectively transferred its bound cluster to apo- 
isopropylmalate isomerase  (apo-IPMI) [116,114]. Although the S. entericia protein 
exhibits ATPase activity, ATP was not required for transfer of the cluster to apo-IPMI 
[116,117]. However, a mutation in the Walker A box motif resulted in an inactive 
protein, suggesting that ATP is required for binding or loading of the iron-sulfur cluster, 
but not transfer [116,117]. 
Iron-sulfur cluster dependent proteins have been identified from Archaea, such as 
the isopropylmalate isomerase and homoaconitase (HACN) (Chapters 2 and 3) [48,49]. 
However, the genome sequences of many archaea lack homologs of the Nif and Isc 
systems. Homologs of the iscS and iscU are present in some euryarchaea while others, 
such as Pyrococcus furiosus, methanogens Methanocaldococcus jannashii and 
Methanococcus maripaludis, and the crenarchaeal Sulfolobus solfataricus are lacking 
homologs of these genes [47,118]. Two components of the Suf system, sufB and sufC, 
have homologs in archaea but not sufS or sufA. A cysteine desulfurase may not be 
required for anaerobic archaea due to their sulfur-rich environments. Instead, inorganic 
sulfur may be incorporated directly into scaffold proteins for cluster synthesis. 
Despite the absence of some Nif, Isc, or Suf components, archaea possess 
homologs of the S. enterica ApbC and S. cerevisiae Nbp35 proteins. The M. maripaludis 
MMP0704 protein shares 40% amino acid identity with the two scaffold proteins, 
including the conserved ATP-binding motif and cysteine motifs for binding iron-sulfur 
clusters.  The MMP0704 protein has an N-terminal ferredoxin-like CX3CXXCX5C motif 
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and a C-terminal CXXC motif that were proposed to bind clusters for transfer to target 
apo-proteins. 
 
 
 
 
Figure 5.1. A protein sequence alignment of bacterial, archaeal, and eukaryotic 
ApbC/Nbp35 homologs was constructed using the ClustalW program (version 1.83) 
(Ref). The sequence of the S. enterica serovar Typhimurium protein (ApbC; RefSeq 
accession no. NP_461098.1) is shown without the amino-terminal domain that is not 
homologous to the amino-terminal domains of the archaeal and eukaryotic proteins. The 
archaeal homologs are from S. solfataricus (SSO0460; accession no. NP_341994.1), P. 
furiosus (PF1145; accession no. NP_578874.1), Methanosarcina acetivorans (MA4246; 
accession no. NP_619111.1), M. jannaschii (MJ0283; accession no. NP_247256.1), and 
M. maripaludis (MMP0704; accession no. NP_987824.1). The two paralogs from S. 
cerevisiae are Nbp35 (accession no. NP_011424.1) and Cfd1 (accession no. 
NP_012263.1). Conserved amino acid residues are shown in white on a black 
background. Similar residues are shown in black on a gray background. The four 
conserved amino-terminal cysteine residues shared by the MMP0704 and Nbp35p 
proteins are boxed. Asterisks above the sequences indicate MMP0704 residues replaced 
by mutagenesis in this study. A vertical bar indicates the N termini of the truncated 
proteins MJ0283(19-290) and MMP0704(20-289). 
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In this study, the S. solfataricus SSO0460, M. jannaschii MJ0283, and MMP0704 
proteins were identified as the first archaeal proteins that form functional Fe-S carrier 
proteins [51]. These apbC/NBP35 homolgs were able to complement an S. enterica 
strain with an apbC null mutation for growth on tricarballyate. Although the Walker A 
box and C-terminal CXXC motif of MMP0704 were required for in vivo activity, the N- 
terminal ferredoxin-like domain was not. Purified and reconstituted MMP0704 bound a 
[4Fe-4S] cluster at its N-terminus and a [2Fe-2S] cluster at the C-terminus. 
 
 
5.2. MATERIALS AND METHODS 
 
5.2.1. Cloning of MJ0283 and MMP0704 
 
The M. janaschii gene at locus MJ0283 (RefSeq NP_247256.1) was amplified by 
PCR using oligonucleotide primers 5MJ0283BN and 3MJ0283B. The  product was 
ligated between the NdeI and BamHI sites of vector pET-11a to produce plasmid 
pDG499. A PCR product obtained using primers 5MJ0283BN2 and 3MJ0283B lacked 
codons 1-18, which encode the amino-terminal ferredoxin-like domain of MJ0283. The 
ligation of this DNA between the NdeI and BamHI sites of vector pET-11a produced 
pDG530. 
The M. maripaludis gene at locus MMP0704 (RefSeq NP_987824.1) was 
amplified using primers 5MMP0704N and 3MMP0704X. The PCR product was ligated 
between the NdeI and XhoI sites of vector pET-20b to produce plasmid  pDG549. 
Primers 5MMP0704N2 and 3MMP0704X were used to amplify a truncated sequence that 
lacked codons 1-19. 
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5.2.2. Protein expression and purification 
 
Expression vectors were transformed into Escherichia coli BL21(DE3) cells by 
electroporation. Grown aerobically at 37C in LB Miller medium supplemented with 
ampicillin (100 g ml-1), these cultures were induced with 0.1% D-lactose in mid- 
logarithmic growth phase. Cells were harvested and lysed as described previously, and 
the MMP0704 proteins were purified by nickel affinity chromatography using standard 
methods [48]. Fractions containing the MMP0704-His6 protein were combined  in 
dialysis tubing (SpectraPor4, 14,000 molecular mass cutoff), and dialyzed for 15 h in 2 L 
of buffer containing 50 mM KCl and 20 mM Tris-HCl (pH 8.0) at 4C.  Dialysis was 
continued for 5 h in fresh buffer before the protein inside the dialysis tubing was 
concentrated by dehydration with polyethylene glycol (20,000 Da). The MJ0283 proteins 
were purified by heat treatment of cell-free extracts prepared in 50 mM KCl and 20 mM 
Tris-HCl (pH 8.0) [48]. Total protein concentrations were determined by the Bradford 
dye-binding method (Thermo-Pierce) using bovine serum albumin as a standard. 
 
 
5.2.3. Reconstitution of the protein iron-sulfur centers and determination of iron- 
sulfur content. 
 
The purified apoproteins were diluted to a final concentration of 2.5 mg ml-1 in 
625 l reactions, sealed under argon gas [48]. The reconstitution buffer contained 200 
mM KCl, 3 mm dithiothreitol, 0.64 mM ATP, 1.3 mM MgCl2  and 50 mM Tris-HCl (pH 
8.0).  A five-fold molar excess of FeCl3  was added to the stirred reactions at 0C.  After 
10 min, a five-fold excess of Na2S was added dropwise, and the mixture was stirred under 
argon for two hours to reconstitute clusters in holoproteins. The MMP0704 holoproteins 
were desalted using a PD-10 column (GE Healthcare) equilibrated with an anoxic 
solution of 50 mM Tris-HCl (pH 8.0) in an anaerobic chamber [49].   Iron and sulfide 
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analyses were performed using standard methods [95,96].  The standard errors for each 
mean value were calculated by propagating errors from each analysis. 
 
 
5.2.4. Size exclusion chromatography 
 
Analytical size exclusion chromatography was performed as described previously 
[62]. The mobile phase, 50 mM sodium phosphate (pH 6.8), was sparged with helium, 
although chromatography was performed under aerobic conditions. Absorbances of UV 
and visible light were recorded using a photodiode array detector, and chromatograms 
were analyzed using 32 Karat software (ver. 7.0, Beckman-Coulter) 
 
 
5.3. RESULTS 
 
 
5.3.1. Expression and purification of methanogen ApbC/Nbp35 proteins 
 
The full length and truncated forms of MMP0704-His6 were both expressed as 
soluble proteins from E. coli BL21(DE3). The proteins were substantially pure after 
nickel affinity chromatography and had molecular masses of 33 kDa for the full length 
MMP0704-His6 (expected 32.1 kDa) and 29 kDa for the truncated MMP0704[20-289]- 
His6 (expected 30.4 kDa), as analyzed by SDS-PAGE (Figure 5.2). The anaerobically 
purified proteins did not display the characteristic UV-visible absorption peak around 
400nm that is indicative of an FeS charge  transfer (Figure: 5.3). Therefore, the 
purified proteins were lacking iron-sulfur clusters. 
The MJ0283 proteins were also expressed as soluble proteins in E. coli. The 
thermostable proteins were purified by heat treatment at 70C and had molecular masses 
of 31 kDa for the full length MJ0283 (expected 31.2 kDa) and 30 kDa for the truncated 
MJ0283[19-290], as analyzed by SDS-PAGE (Figure 5.2) 
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Figure 5.2. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of 
an overloaded, Coomassie blue-stained gel shows the purities and solubilities of 
heterologously expressed MMP0704 and MJ0283 proteins (10 g each). Marker 
proteins, shown in lane M, have the molecular masses indicated to the left. Lane 1 
contains affinity purified MMP0704-His6 protein, with an apparent molecular mass of 33 
kDa (calculated mass, 32.1 kDa). Lane 2 contains affinity-purified MMP0704[20-289]- 
His6 protein, with an apparent molecular mass of 29 kDa (calculated mass, 30.4 kDa). 
Lane 3 contains heat-stable, purified MJ0283 protein, with an apparent molecular mass of 
32 kDa (calculated mass, 31.2 kDa). Lane 4 contains heat-stable, purified MJ0283[19- 
290] protein, with an apparent molecular mass of 30 kDa (calculated mass, 29.5 kDa). 
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5.3.2. Reconstitution of the protein iron-sulfur centers 
ATP is required for the reconstitution and stability of the MMP0704 proteins. In 
the absence of ATP, the proteins formed insoluble aggregates in the presence of iron and 
sulfide. However, the addition of a five fold molar excess of ATP resulted in soluble 
proteins. After reconstitution, the proteins were anaerobically desalted and analyzed for 
the presence of iron-sulfur clusters as well as iron and sulfide content. The full length 
MMP0704-His6 and truncated MMP0704[20-289]-His6 holoenzymes displayed broad 
UV-Vis absorption peaks around 400 nm, characteristic of a protein bound iron-sulfur 
cluster (Figure 5.3). The truncated MMP0704[20-289]-His6 holoenzyme bound 1.7 1 
moles of iron and 2.2  0.3 moles of sulfide per mole of protein.   Therefore, the C- 
terminal portion of the MMP0704 protein possesses a monomeric [2Fe-2S] cluster. The 
full length MMP0704-His6 holoenzyme bound 7.5 1.2 moles of iron and 7.7 1.6 
moles of sulfide per mole of protein. Therefore, the full length MMP0704 holoenzyme 
probably forms a [4Fe-4S] cluster at the N-terminus and a [2Fe-2S] cluster at the C- 
terminus per monomer. 
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Figure 5.3. UV-visible absorption spectra of reconstituted MMP0704-His6 and 
MMP0704(20-289)-His6 holoproteins. The MMP0704-His6 apoprotein (Broken line, 
bottom spectrum) was treated with ferric chloride, sulfide, and Mg-ATP and then 
desalted to reconstitute the holoprotein (solid line, top spectrum). The MMP0704(20- 
289)-His6 apoprotein had an absorption spectrum identical to that of the full length 
apoprotein (data not shown), while the truncated holoprotein had an intermediate 
absorption spectrum (dashed line, middle spectrum). The millimolar absorption 
coefficient () was calculated from measured absorbance and protein concentration 
values. 
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5.3.3. MMP0704 proteins interact in a complex dynamic equilibrium 
The apparent molecular masses of the MMP0704 proteins were measured by 
analytical size exclusion chromatography. Reconstitution of the full length and truncated 
proteins with ferric chloride, sodium sulfide, and Mg-ATP resulted in stable oligomeric 
forms of MMP0704, consistent with the S. enterica ApbC and yeast Nbp35/Cfd1 
proteins. The MMP0704[20-289]-His6 apoprotein eluted as mostly a monomeric protein 
with an apparent mass of 27 kDa and Stokes radius of 24 Å (Figure 5.4). Approximately 
20% of the protein eluted as a dimer with an apparent mass of 68 kDa and Stokes radius 
of 33 Å. However, after reconstitution, the holoprotein eluted as a mixture of 66% dimer 
and 33% monomer. An absorbance peak at 410 nm was observed for the dimeric 
holoprotein, suggesting an iron-sulfur cluster was present. No peak was observed for the 
apoprotein or the monomeric holoprotein. 
The full length MMP0704-His6 apoprotein eluted from the analytical size 
exclusion column as a mixture of different oligomeric states (Figure 5.5). Approximately 
12% of the protein appeared to elute as an aggregate with a high molecular mass. The 
major form of the apoprotein was monomeric (35 kDa apparent mass, Stokes radius 26 
Å), comprising 50% of the total protein. Approximately 23% of the protein eluted with 
an apparent mass of 64 kDa (Stokes radius 32 Å), which could be a dimer, and 15% 
eluted as a trimer with an apparent mass of 94 kDa (Stokes radius 37 Å). After 
reconstitution, the oligomeric forms of the full length MMP0704-His6 consisted of a 40% 
204 kDa protein (Stokes radius 48 Å), 26% 110 kDa protein (Stokes radius 39 Å) and 
33% 64 kDa (Stokes radius 23 Å). A peak at 410 nm was observed for the 62 kDa dimer 
protein, consistent with the truncated holoprotein, as well as for the 197 kDa protein. 
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Figure 5.4. Analytical size exclusion chromatography of the MMP0704[20-289]-His6 
protein.  (A)  Chromatogram (detector wavelength of 220 nm) of 1 g ml-1 purified apo- 
MMP0704[20-289]-His6 protein. Indicated molecular weights are based on the elution 
times of standard proteins, as previously described (Chapter 2). (B) Chromatogram 
(detector wavelength of 220 nm) of 1 g ml-1 purified and reconstituted MMP0704[20- 
289]-His6, as described in the text. 
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Figure 5.5. Analytical size exclusion chromatography of the MMP0704-His6 protein. 
(A)    Chromatogram  (detector  wavelength  of  220  nm)  of  1  g  ml-1   purified  apo- 
MMP0704 protein. Indicated molecular weights are  based on the elution times of 
standard proteins, as previously described (Chapter 2). (B) Chromatogram (detector 
wavelength of  220 nm)  of  1 g  ml-1   purified and  reconstituted  MMP0704-His ,  as 
described in the text. 
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5.4. DISCUSSION 
 
The genome sequence of M. maripaludis contains nine paralogs of the MMP0704 
protein. However, only MMP0704 possesses the conserved cysteine residues found in 
ApbC and Nbp35. Homologs were subsequently identified in the euryarchaeal M. 
jannaschii and the crenarchaeal S. solfataricus genome sequences. The S. cerevisiae 
Nbp35 contains an N-terminal ferredoxin-like domain with four conserved cysteine 
residues, a Walker A box for ATP binding and hydrolysis, and four conserved C-terminal 
cysteine residues. Overexpression and purification of the Nbp35 resulted in an oxygen 
stable [4Fe-4S] cluster at the N-terminal domain [119]. However, no clusters were 
observed after heterologous expression and aerobic purification of MMP0704 (Figure 
5.2). Incubating the purified protein with ferric iron, sulfide, and DTT under anaerobic 
conditions resulted in [4Fe-4S] and [2Fe-2S] clusters for the full length MMP0704 in a 
complex mixture of varying oligomeric states. The truncated holoprotein bound a [2Fe- 
2S] cluster in a predominantly dimeric form. This is consistent with the hypothesis that 
the C-terminal cysteine residues are at the interface of the MMP0704 dimer, forming a 
[4Fe-4S] cluster from the two monomeric [2Fe-2S] clusters. Further studies involving 
Mössbauer and electron paramagnetic resonance (EPR) will be required to determine the 
actual structure of the holoprotein Fe-S clusters. 
The ApbC protein was required for S. enterica growth on tricarballylate [109]. 
To test the  role  of the archaeal homologs in iron-sulfur biosynthesis, Jeffrey Boyd 
(University of Wisconsin, Madison) transfected an S. enterica apbC null mutant strain 
with plasmids containing MMP0704, MJ0283, or SSO0460 [51]. Although all strains 
were able to grow in the presence of glucose, the archaeal apbC homologs were required 
for growth on tricarballylate (Table 5.1) [51]. Removing the N-terminal ferredoxin-like 
domain of MMP0704 resulted in faster doubling times compared to cells containing the 
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plasmid expressing the full length MMP0704. Replacing the four N-terminal cysteine 
residues of the full length MMP0704 to alanine resulted similar doubling times to S. 
enterica cells containing the wild type MMP0704, although the lag time to exponential 
growth was significantly shorter [51]. The full length MJ0283 protein was unable to 
complement the S. enterica apbC null mutant strain. However, removal of the N- 
terminal domain resulted in doubling times comparable to the full length MMP0704. 
Bacterial and most archaeal homologs of the Nbp35 protein lack the N-terminal 
ferredoxin domain. The complementation studies indicate that this domain is also not 
required for MMP0704 or MJ0283 function in S. enterica. These results are consistent 
with the in vitro reconstitution of the full length and truncated  MMP0704  proteins 
(Figure 5.3). Although the N-terminal domain was shown to possess a [4Fe-4S] cluster 
after reconstitution, it was not required for reconstituting the  C-terminal iron-sulfur 
cluster. The in vivo and in vitro results indicate that the M. maripaludis  and  M. 
jannaschii ApbC homologs transfer the C-terminal iron-sulfur cluster for reconstitution 
of the TcuB protein in S. enterica. Further studies will be required to test the role of N- 
terminal domain in M. maripaludis and M. jannaschii. 
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Table 5.1. Archaeal ApbC/Npb35 homologs can function in place of S. enterica 
ApbC in vivo [51]. 
 
 
 
a Complentation was conducted as outlined [51]. 
b Doubling times were calculated using the following formulas: = 
ln(X/Xo)/T, where  is the growth rate, X is the OD650 value at a given time point, 
Xo is the OD650 value at time zero, and T is the time between readings X and Xo, and 
doubling time (g) = (ln2)/ .  The numbers shown represent the averages of results 
for three independent cultures.  Minimal media with the indicated carbon sources 
were used.  The media were supplemented with thiamine. 
c NG, no growth. 
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The S. enterica ApbC protein did not require ATP for in vitro transfer of an iron- 
sulfur cluster. However, mutation of the Walker A motif resulted in an inactive protein, 
suggesting that the  ATPase activity is required for cluster loading but not transfer. 
Consistent with the ApbC study, an MMP0704 plasmid bearing a mutation of  the 
catalytic serine to alanine failed to complement the S. enterica apbC null mutant for 
tricarballylate dependent growth [51]. Similarly, in vitro reconstitution of the full length 
or truncated MMP0704 protein in the absence of MgATP resulted in insoluble protein. 
The addition of MgATP to the reconstitution mixture was required for successful Fe-S 
cluster reconstitution (Figure 5.3). Thus, ATP is required for loading an Fe-S cluster. 
Further in vitro testing will be required to assess whether ATP is required for cluster 
transfer from MMP0704 to a target apoprotein. 
The C-terminal domain of MMP0704 contains the CXXC motif that binds either a 
[2Fe-2S] or [4Fe-4S] cluster. Mutation of the cysteine residues in the CXXC motif to 
serine in the yeast Cfd1 resulted in an inactive protein [115]. Also, mutation of the 
cysteines in the CXXC motif of the S. enterica ApbC protein disrupted the in vivo 
functionality of this protein, although the varient proteins were still able to bind two 
moles of iron and two moles of sulfide per mole of protein [117]. Mutation of the CXXC 
motif of the full length MMP0704 also disrupted the in vivo functionality of this protein 
[51]. However, mutation of either cysteine to alanine in the truncated MMP0704 did not 
affect S. enterica apbC null mutant strain complementation compared to the non-mutated 
truncated protein; a double mutation of Cys218,220Ala of the truncated protein was 
required to disrupt in vivo function [51]. The functional dependency of the MMP0704 
protein on the CXXC motif, and not the N-terminal ferredoxin-like motif, suggests that 
this C-terminal motif is responsible for [Fe-S] cluster transfer to target apo-proteins. 
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The S. solfataricus SSO0460 was able to complement the S. enterica abpC mutant 
strain for growth on tricarballylate [51]. The N-terminal motif is absent in this protein, 
which is consistent with most crenarchaeal homologs. Also, the second cysteine residue 
in the CXXC motif is replaced with an aspartic acid. The activity of this protein, despite 
the missing cysteine residue, is consistent with mutational studies of the ApbC and 
MMP0704 CXXC motifs. Aspartic acid has been observed as a ligand for [4Fe-4S] 
cluster binding of the Pyroccocus furiosus ferredoxin [120]. 
In E. coli, SufB interacts with SufC, enhancing the ATPase activity of SufC 
[121]. The SufBC complex also interacts with the SufES complex, as well as SufD 
[108]. SufES transfer a persulfide to SufB, which acts as a scaffold for a [4Fe-4S] 
cluster, potentially for transfer to a target apoprotein [108]. The genome sequence of M. 
jannaschii contains two genes encoding homologs of the SufB and SufC proteins, 
MJ0034 and MJ0035, respectively. However, M. jannaschii does not possess homologs 
of SufS or SufE, although this methanogen may use inorganic sulfur for iron-sulfur 
cluster biosynthesis [122]. A role for MJ0283, MJ0034, and MJ0035 proteins is 
proposed in Figure 5.6. 
In Figure 5.6 the MJ0283 homodimer hydrolyzes ATP to assemble a [4Fe-4S] 
cluster at the proposed C-terminal dimer interface. The S. enterica ApbC was previously 
shown to be required for the in vivo assembly of the TcuB [4Fe-4S] cluster as well as the 
in vitro reconstitution of an IPMI [4Fe-4S] cluster [109,116]. Therefore, MJ0283 may 
transfer the bound cluster to a target apoprotein, such as the M. jannaschii IPMI and 
HACN proteins.  However, the MJ0283 protein may also serve as a scaffold for accepting 
a cluster as well. In Figure 5.7 the MJ0034 and MJ0035 proteins interact, assembling a 
[2Fe-2S] or [4Fe-4S] cluster on MJ0034 in the presence of ATP. In this hypothetical 
model, the bound cluster is transferred from the MJ0034-MJ0035 complex to MJ0283 in 
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an ATP dependent reaction.  The [4Fe-4S] cluster of MJ0283 could then be transferred to 
a target apoprotein. In an alternative model, the MJ0034-MJ0035 complex could transfer 
an iron-sulfur cluster directly to a target apoprotein. However, this activity has not been 
demonstrated with the bacterial SufBC complex. Therefore, future work will involve in 
vivo and in vitro experiments to analyze the role of the MJ0283, MJ0034, and MJ0035 
proteins in M. jannaschii iron-sulfur cluster biosynthesis. 
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Figure 5.6. Model for iron-sulfur cluster biosynthesis in M. jannaschii with MJ0283. 
The MJ0283 assembles a [4Fe-4S] cluster at the dimer interface using inorganic sulfur, 
iron from an unknown source, and ATP. The cluster is then transferred to a target 
apoprotein, such as the IPMIMJ (MJ0499-MJ1277) 
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Figure 5.7. Model for iron-sulfur cluster biosynthesis in M. jannaschii with MJ0283 
and MJ0034-MJ0035. The MJ0034-MJ0035 interacting pair uses inorganic sulfur, iron 
(from an unknown donor), and ATP to assemble a [4Fe-4S] cluster on MJ0034. The 
cluster is then transferred to the MJ0283 scaffold protein for the subsequent transfer to a 
target apoprotein, such as the IPMIMJ (MJ0499-MJ1277) 
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Chapter 6: Summary and Future Directions 
 
 
 
 
 
 
 
6.1. OVERVIEW 
 
Methanogenic archaea produce over 1 billion tons of methane each year through 
methanogenesis from a variety of anaerobic environments, including wetlands, landfills, 
hydrothermal vents, and animal rumens. Approximately 400 million tons of the methane 
produced via methanogenesis escapes from these environments to the atmostphere where 
methane affects tropospheric and stratospheric chemistry [1,2]. Atmospheric methane 
concentrations have more than doubled since the industrial revolution and the effects of 
this greenhouse gas on climate change are currently a critical environmental concern [3]. 
Therefore, identifying methods of controlling methane production from these 
microorganisms could have a significant impact on slowing or reducing global warming 
until political and technological institutions are put in place to reduce CO2 emissions. 
Coenzyme B (CoB) is involved in the terminal step of methanogenesis, forming a 
heterodisulfide bond with methyl-coenzyme M catalyzed by methyl-coenzyme M 
reductase, a reaction that is common among all methanogens [32]. CoB has only been 
identified in methanogens and inhibiting the production of this coenzyme would be 
lethal. Therefore, CoB is an attractive target for developing inhibitors for 
methanogenesis. 
Inhibiting methanogenesis would be useful for controlling the methane output of 
ruminant animals. Eructation of methane from ruminant animals accounts for more then 
10% of the 400 million tons of methane produced each year by these microorganisms 
[123,124].  Also, these animals lose 2-12% of their ingested energy to methanogenesis. 
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Thus, producing inhibitors of methanogenesis that are environmentally safe would aid in 
reducing or eliminating methane output from ruminants and, therefore, aiding in reducing 
climate change. 
Inhibiting methanogenesis would also aid in biofuel production. In organic waste 
streams used for ethanol and n-butyrate production, methanogens compete with acetate 
reduction for acetate and hydrogen. The efficiency of mixed cultures to produce these 
biofuels can be reduced by more than 50% due to the presence of methanogens [9]. 
Selective inhibition of methanogenesis in these cultures would increase the efficiency of 
ethanol and n-butyrate, providing alternative energy sources in the move away from 
fossil fuels. 
The research presented herein was centered on further elucidating the biosynthetic 
pathway of CoB. Only two enzymes had previously been identified from the proposed 
CoB biosynthetic pathway: homocitrate synthase (HCS) and homoisocitrate 
dehydrogenase (HICDH). To further understand the pathway for CoB production, this 
study was centered on the identification and characterization of the Methanocaldococcus 
jannaschii homoaconitase. The homologous isopropylmalate isomerase (IPMI) was also 
characterized and a structural study involving the two enzymes provided insight into the 
residues responsible for substrate specificity. Finally, proteins involved in the synthesis 
of iron-sulfur clusters required for the function of the HACN and IPMI were identified. 
 
 
6.2. METHANOGEN LEUCINE AND ISOLEUCINE BIOSYNTHESIS 
Although Methanogens produce isoleucine, they do not possess a threonine 
dehydratase for the production 2-oxobutyrate. However, a citramalate synthase from M. 
jannaschii was identified, suggesting methanogens produce isoleucine via the citramalate 
pathway from pyruvate and acetyl-CoA.  To synthesize 2-oxobutyrate from citramalate, 
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the M. jannaschii leucine biosynthetic enzymes, IPMI and IPMDH, were proposed to 
also function as the citramalate isomerase and -methylmalate dehydrogenase, 
respectively. In this study, the MJ0499-MJ1277 pair of proteins was characterized as the 
IPMI required for methanogen leucine and isoleucine biosynthesis [48]. This iron-sulfur 
cluster protein catalyzed the isomerization of -isopropylmalate to -isopropylmalate as 
well as (R)-citramalate to -methylmalate. The minimal substrate maleic acid was also a 
substrate for MJ0499-MJ1277. Similarly, the isopropylmalate dehydrogenase (IPMDH) 
catalyzed the oxidative decarboxylation of -isopropylmalate, -methylmalate, and D- 
malate. IPMIMJ and IPMDHMJ exhibit broad substrate specificity for the biosynthesis of 
leucine  and  isoleucine.    Only  the  citramalate  synthase  (CMS)  and  isopropylmalate 
synthase (IPMS) are specific for their respective pathways. 
 
 
 
6.3. METHANOGEN COENZYME B BIOSYNTHESIS 
 
Methanogens use a 2-oxoacid chain elongation pathway to produce 2-oxosuberate 
for CoB biosynthesis. This pathway involves three iterations of reactions catalyzed by 
HCS, HACN, and HICDH. The CoB HACN (MJ1003-MJ1271) described in Chapter 3 
was the first HACN identified to catalyze both partial reactions in the isomerization of 
homocitrate  to  homoisocitrate  [49].    This  study  also  defined  the  broad  substrate 
specificity of HACNMJ, establishing the steady state kinetic parameters for cis- 
unsaturated tricarboxylates with -chains ranging from 1 – 5 methylenes in length as well 
as the minimal substrate maleic acid. The observed specificity of HACNMJ for (R)- 
homocitrate and cis-unsaturated intermediates is contrary to the initially proposed CoB 2- 
oxoacid-chain elongation pathway.  Previously, (S)-homocitrate and trans-homoaconitate 
were observed as intermediates of this pathway [43].  However, these products served as 
inhibitors of HACNMJ.  These results, coupled with previous studies involving homologs 
144  
 
of HACN and HCS, suggest that the biosynthesis of 2-oxosuberate involves a simpler, 
more conserved pathway that does not include (S)-homocitrate or trans- 
homoaconitate.(2,3) HCSMJ  has not been characterized and previous attempts to express 
and purify this protein were unsuccessful (Drevand and Graham, unpublished results). 
Therefore, to confirm the proposed CoB 2-oxoacid-chain elongation pathway, future 
work will involve obtaining purified HCSMJ and analyzing the stereochemistry of the 
reaction products. 
Although genes have not been identified for the remaining reactions in the 
proposed CoB biosynthetic pathway, the homoaconitase is a potential target for 
developing inhibitors against methanogenesis. The broad substrate specificity of this 
enzyme could be exploited to produce analogs of the longer chain substrates that have not 
been  isolated  from  non-methanogenic  organisms,  such  as  (R)-homo2citrate  and  (R)- 
homo3citrate.     Flurocitrate  and  nitro  analogs  of  citrate  and  isocitrate  are  known 
competitive inhibitors of aconitase [125].  Future studies will test longer chain analogs of 
these aconitase inhibitors for inhibition of HACNMJ. It is not currently known whether 
aconitase or the -aminoadipate HACN recognize the longer chain substrates of the CoB 
HACN, such as cis-homo2aconitate, cis-homo3aconitate, or even the non-physiological 
cis-homo4aconitate. Therefore, these enzymes will be tested for their substrate specificity 
with the substrates of the CoB HACN. 
 
 
 
6.3. HACNMJ AND IPMIMJ  STRUCTURAL STUDY 
The small subunits of IPMIMJ and HACNMJ (MJ1277 and MJ1271, respectively) 
are homologous to domain 4 of mitochondrial aconitase (mACN). Multiple sequence 
alignments indicate that the GS642SRE sequence of pig heart mACN, containing the 
catalytic  Ser642  responsible  for  proton  abstraction  in  the  aconitase  mechanism,  is 
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conserved in these two proteins. However, Arg580 of mACN, responsible for 
coordinating the aconitase substrate in the active, is not conserved. A structural model of 
MJ1271 and a homology model of MJ1277 were presented and site directed mutagenesis 
was used to evaluate residues responsible for substrate specificity [50]. These studies 
indicate that Arg26 of the MJ1271 Y24LRT sequence is critical for substrate specificity of 
WT HACNMJ.  Mutation of Arg26 to the corresponding residue in WT IPMIMJ, Val28, 
broadened the specificity of HACNMJ to include the substrates of IPMI. Therefore, Val28 
of IPMIMJ is proposed to be required for recognizing  substrates  with  hydrophobic  - 
chains.   The Y24LRT and Y26LVY sequences of MJ1277 and MJ1271, respectively,  can 
serve as indicators of protein function for uncharacterized euryarchaeal genes. However, 
mutation of Arg26 or Thr27 of MJ1271 did not completely abolish HACN activity, 
suggesting a role of the interacting large subunits in substrate specificity. A crystal 
structure of the MJ1003-MJ1271 protein pair with bound substrate will be required to 
elucidate other residues that might affect substrate recognition. 
Although the HACNMJ catalyzed both hydration and dehydration reactions in the 
isomerization of homocitrate, bacterial and fungal HACNs have only been observed to 
catalyze  the  hydration  of  cis-homoaconitate  to  (2R,  3S)-homoisocitrate  [93].  In  an 
attempt to evaluate the difference in mechanism, the loop region of MJ1271 bearing the 
Y24LRT sequence was replaced with the corresponding region of the Thermus 
thermophilus HACN small subunit, LysU. Only activity with maleic acid was observed 
for the purified and reconstituted protein. Therefore, site direct mutagenesis of the T. 
thermophilus HACN, as well as a crystal model with bound substrate, will be required to 
determine the structural differences responsible for the mechanistic discrepancy. 
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6.4. IRON-SULFUR CLUSTER BIOSYNTHESIS IN ARCHAEA 
A [4Fe-4S] cluster is required for IPMIMJ and HACNMJ activity, consistent with 
previously characterized members of the aconitase superfamily [69]. Three conserved 
cysteine residues bind the [4Fe-4S] cluster at the enzyme active site where it serves a 
non-redox function in substrate coordination. To prevent stress from free iron and 
sulfide, organisms have developed intricate systems for synthesizing and transferring 
iron-sulfur clusters to target apo proteins. The ISC, SUF, and NIF function as the main 
biosynthetic machineries in prokaryotes and eukaryotes for iron-sulfur cluster synthesis 
[106,107]. Recently, the ApbC protein from Salmonella enterica and the yeast Nbp35 
and Cfd1 proteins were also shown to function in transferring these clusters to target 
proteins [109,114]. The study of the Methanococcus maripaludis, M. jannaschii, and 
Sulfolobus solfataricus ApbC/Nbp35 homologs marks the first study of archaeal iron- 
sulfur cluster biosynthesis [51]. The M. maripaludis MMP0704 protein requires MgATP 
to bind a [4Fe-4S] cluster at the N-terminal domain and a [2Fe-2S] cluster at its C- 
terminal domain. Upon protein reconstitution, MMP0704 exists in a complex mixture of 
oligomeric states, although the functional protein is probably a dimer. The Walker A 
motif, for ATP binding and hydrolysis, and the C-terminal domain were necessary to 
complement an ApbC deficient S. enterica strain. The N-terminal domain was shown to 
be dispensable. These results indicate that MMP0704 and the homologous proteins of M. 
jannaschii (MJ0283) and S. solfataricus (SSO0460) function as scaffolding proteins for 
the formation and transfer of iron-sulfur clusters. Future studies will require in vivo 
experiments to confirm the function of MMP0704 in an M. maripaludis strain. Also, in 
vitro experiments will examine the ability of MMP0704 or MJ0283 to transfer an iron- 
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sulfur cluster to an apoprotein, such as IPMIMJ, and the role of ATP in cluster binding and 
delivery. 
The genome of M. jannaschii also contains two genes encoding homologs of the 
prokaryotic SufB and SufC proteins: MJ0034 and MJ0035. Previous studies have 
indicated that SufC has ATPase activity and SufB can accept a persulfide as well bind a 
[4Fe-4S]. SufB interacts with SufC, SufD, and the SufES complex and both SufB and 
SufC are essential for the Suf machinery to function. However, the exact role of SufBC 
iron-sulfur cluster biosynthesis is not currently known. Future studies will involve 
testing the ability of MJ0034 and MJ0035 to bind an iron-sulfur cluster and transfer it to 
either MJ0283 or a target apoprotein. 
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